P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
7.158e-17 | -37.18 | synaptic membrane | cellular component | GO:0097060 | 400 | 17 | 19108 | 49 |
GRIN2A,HCN1,RIMS2,GABRA1,KCNMA1,GABRB2,UNC13C,DLG3,GABRD,CACNA1C,GRID2,GABRA6,GABBR2,RIMS4,LRRC7,NRXN1,NRXN3 |
6.725e-15 | -32.63 | anterograde trans-synaptic signaling | biological process | GO:0098916 | 415 | 16 | 18204 | 49 |
GABRD,RIMS2,NRXN1,UNC13C,GABBR2,CPLX1,GABRB2,GRID2,GABRA6,GABRA1,INSYN1,CELF4,DLG3,GRIN2A,RIMS4,PCLO |
6.725e-15 | -32.63 | chemical synaptic transmission | biological process | GO:0007268 | 415 | 16 | 18204 | 49 |
GRID2,GABRA6,GABRD,NRXN1,RIMS2,UNC13C,GABBR2,CPLX1,GABRB2,RIMS4,PCLO,GABRA1,INSYN1,CELF4,GRIN2A,DLG3 |
1.211e-14 | -32.04 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 16 | 18204 | 49 |
GRIN2A,DLG3,CELF4,INSYN1,GABRA1,RIMS4,PCLO,NRXN1,RIMS2,GABRD,GABBR2,UNC13C,GABRB2,CPLX1,GRID2,GABRA6 |
1.556e-14 | -31.79 | synapse | cellular component | GO:0045202 | 1473 | 24 | 19108 | 49 |
CACNA1C,GABRB2,UNC13C,ZNF804A,KCNMA1,RIMS2,GRIN2A,NRXN3,LRRC7,NRXN1,GABRA6,GABRD,DLG3,INSYN1,CELF4,GABRA1,HCN1,IL1RAPL2,PCLO,RIMS4,GABBR2,CPLX1,OLFM1,GRID2 |
3.213e-14 | -31.07 | synaptic signaling | biological process | GO:0099536 | 459 | 16 | 18204 | 49 |
UNC13C,GABBR2,GABRB2,CPLX1,NRXN1,GABRD,RIMS2,GRID2,GABRA6,INSYN1,DLG3,CELF4,GRIN2A,GABRA1,RIMS4,PCLO |
3.675e-14 | -30.93 | regulation of membrane potential | biological process | GO:0042391 | 463 | 16 | 18204 | 49 |
GRID2,GABRA6,NRXN1,RIMS2,GABRD,CACNA1C,HCN1,GABRB2,RIMS4,SLC24A4,GRIN2A,CELF4,INSYN1,RYR2,GABRA1,KCNMA1 |
1.175e-13 | -29.77 | cell-cell signaling | biological process | GO:0007267 | 822 | 19 | 18204 | 49 |
GRID2,GABRA6,SMPD3,RIMS2,GABRD,NRXN1,CACNA1C,GABBR2,UNC13C,CPLX1,GABRB2,PCLO,RIMS4,RYR2,GABRA1,INSYN1,CELF4,DLG3,GRIN2A |
1.897e-13 | -29.29 | postsynapse | cellular component | GO:0098794 | 646 | 17 | 19108 | 49 |
GABRA6,CPLX1,GRID2,PCLO,GABBR2,LRRC7,HCN1,GRIN2A,GABRB2,ZNF804A,DLG3,GABRD,CACNA1C,CELF4,GABRA1,INSYN1,KCNMA1 |
4.412e-12 | -26.15 | postsynaptic membrane | cellular component | GO:0045211 | 280 | 12 | 19108 | 49 |
LRRC7,GABBR2,GRID2,GABRA6,KCNMA1,GABRA1,CACNA1C,GABRD,GABRB2,DLG3,GRIN2A,HCN1 |
6.596e-12 | -25.74 | monoatomic ion channel activity | molecular function | GO:0005216 | 441 | 14 | 18094 | 49 |
KCNIP4,KCNMA1,HCN1,GRID2,RYR2,KCNT1,SLC24A4,TRPM3,GABRB2,CACNA1C,GRIN2A,GABRA6,GABRA1,GABRD |
9.218e-12 | -25.41 | regulation of postsynaptic membrane potential | biological process | GO:0060078 | 106 | 9 | 18204 | 49 |
HCN1,GABRB2,GRIN2A,CELF4,INSYN1,GABRD,GABRA1,GRID2,GABRA6 |
1.551e-11 | -24.89 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 43 | 16828 | 48 |
CACNA1C,CPLX1,RIMS4,AK5,GABRD,R3HDM1,ST8SIA5,GABRB2,RBFOX3,RGS7,RIMS2,SLC24A4,ZNF804A,GABBR2,KCNIP4,OPRL1,CELF6,KSR2,RBFOX1,CR2,STXBP5L,RYR2,GRID2,NRXN3,DLG3,CELF4,GRIN2A,UNC13C,ZFPM2,PPP2R5B,NRXN1,LRRC7,PCLO,HCN1,CELF5,PTPRG,GABRA1,IL1RAPL2,GABRA6,TRPM3,SMPD3,KCNT1,ASTN1 |
2.524e-11 | -24.40 | neuron projection | cellular component | GO:0043005 | 1331 | 20 | 19108 | 49 |
HCN1,GRIN2A,UNC13C,DLG3,OPRL1,ZNF804A,KCNIP4,GABRB2,CACNA1C,SLC24A4,GABRD,GABRA1,RGS7,OLFM1,GABRA6,CPLX1,GRID2,PCLO,GABBR2,LRRC7 |
3.708e-11 | -24.02 | channel activity | molecular function | GO:0015267 | 502 | 14 | 18094 | 49 |
GABRB2,TRPM3,GABRA6,GRIN2A,GABRA1,GABRD,CACNA1C,KCNIP4,HCN1,KCNMA1,SLC24A4,RYR2,KCNT1,GRID2 |
3.808e-11 | -23.99 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 14 | 18094 | 49 |
CACNA1C,GRIN2A,GABRA1,GABRA6,GABRD,TRPM3,GABRB2,GRID2,SLC24A4,RYR2,KCNT1,KCNIP4,KCNMA1,HCN1 |
4.860e-11 | -23.75 | monoatomic ion channel complex | cellular component | GO:0034702 | 344 | 12 | 19108 | 49 |
GABRD,CACNA1C,DLG3,KCNIP4,GABRB2,KCNMA1,GABRA1,HCN1,GRIN2A,GABRA6,RYR2,GRID2 |
6.002e-11 | -23.54 | ligand-gated monoatomic ion channel activity | molecular function | GO:0015276 | 186 | 10 | 18094 | 49 |
HCN1,KCNMA1,GABRB2,RYR2,GABRD,KCNT1,GRIN2A,GABRA6,GABRA1,GRID2 |
6.328e-11 | -23.48 | ligand-gated channel activity | molecular function | GO:0022834 | 187 | 10 | 18094 | 49 |
GRID2,GRIN2A,GABRA1,GABRA6,GABRD,KCNT1,RYR2,GABRB2,KCNMA1,HCN1 |
1.159e-10 | -22.88 | cell junction | cellular component | GO:0030054 | 2224 | 24 | 19108 | 49 |
GRIN2A,HCN1,RIMS2,GABRA1,CELF4,KCNMA1,INSYN1,DLG3,ZNF804A,UNC13C,GABRB2,CACNA1C,GABRD,GRID2,GABRA6,OLFM1,CPLX1,GABBR2,RIMS4,NRXN1,LRRC7,PCLO,NRXN3,IL1RAPL2 |
2.875e-10 | -21.97 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 11 | 10285 | 26 |
GABRA1,CPLX1,GRIN2A,GABBR2,GABRB2,GABRA6,DLG3,HCN1,NRXN3,NRXN1,KCNMA1 |
6.990e-10 | -21.08 | transmembrane transporter complex | cellular component | GO:1902495 | 434 | 12 | 19108 | 49 |
GRID2,RYR2,GABRA6,GRIN2A,HCN1,GABRA1,KCNMA1,DLG3,KCNIP4,GABRB2,CACNA1C,GABRD |
7.142e-10 | -21.06 | gated channel activity | molecular function | GO:0022836 | 320 | 11 | 18094 | 49 |
HCN1,KCNMA1,GABRB2,RYR2,KCNT1,GABRD,GABRA6,GABRA1,GRIN2A,GRID2,CACNA1C |
7.413e-10 | -21.02 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 27 | 16828 | 48 |
RIMS4,AK5,MYT1L,OLFM1,R3HDM1,ST8SIA5,RIMS2,ZNF804A,GABBR2,KSR2,STXBP5L,RYR2,GRID2,NRXN3,CELF4,ZFPM2,GRIN2A,UNC13C,LRRC7,CELF5,PCLO,PTPRG,IL1RAPL2,GABRA1,TRPM3,KCNT1,ASTN1 |
1.005e-09 | -20.72 | plasma membrane region | cellular component | GO:0098590 | 1278 | 18 | 19108 | 49 |
GRID2,GABRA6,NRXN1,LRRC7,RIMS4,GABBR2,NRXN3,GRIN2A,RIMS2,HCN1,KCNMA1,GABRA1,CACNA1C,GABRD,SLC24A4,DLG3,UNC13C,GABRB2 |
1.386e-09 | -20.40 | transporter complex | cellular component | GO:1990351 | 461 | 12 | 19108 | 49 |
GABRA6,GRID2,RYR2,HCN1,GRIN2A,GABRB2,KCNIP4,DLG3,CACNA1C,GABRD,GABRA1,KCNMA1 |
1.687e-09 | -20.20 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 15 | 16828 | 48 |
OLFM1,ZFPM2,GRIN2A,CELF4,IL1RAPL2,PTPRG,HCN1,PCLO,STXBP5L,KSR2,ZNF804A,GABBR2,GALNT9,RYR2,GRID2 |
1.774e-09 | -20.15 | GABA receptor complex | cellular component | GO:1902710 | 21 | 5 | 19108 | 49 |
GABRD,GABRA6,GABRB2,GABBR2,GABRA1 |
1.893e-09 | -20.09 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 26 | 16828 | 48 |
ASTN1,KCNT1,IL1RAPL2,GABRA1,CELF5,PCLO,PTPRG,LRRC7,CELF4,ZFPM2,GRIN2A,UNC13C,NRXN3,GRID2,RYR2,KSR2,STXBP5L,ZNF804A,GABBR2,ST8SIA5,RIMS2,R3HDM1,AK5,MYT1L,OLFM1,RIMS4 |
2.851e-09 | -19.68 | regulation of biological quality | biological process | GO:0065008 | 2936 | 26 | 18204 | 49 |
NRXN1,CACNA1C,UNC13C,GABRB2,CPLX1,HCN1,OLFM1,GRID2,CELF4,DLG3,GRIN2A,KCNMA1,PCLO,GABRD,RIMS2,IL1RAPL2,OPRL1,LRRC7,SMPD3,GABRA6,INSYN1,RYR2,GABRA1,ZNF804A,RIMS4,SLC24A4 |
3.003e-09 | -19.62 | GABA receptor activity | molecular function | GO:0016917 | 22 | 5 | 18094 | 49 |
GABRA6,GABRA1,GABRB2,GABRD,GABBR2 |
3.667e-09 | -19.42 | cell projection | cellular component | GO:0042995 | 2398 | 23 | 19108 | 49 |
ZNF804A,UNC13C,GABRB2,KCNIP4,CACNA1C,GRIN2A,RIMS2,NRXN1,LRRC7,NRXN3,GABRA6,GABRA1,RGS7,DLG3,OPRL1,GABRD,SLC24A4,HCN1,GABBR2,PCLO,GRID2,OLFM1,CPLX1 |
5.990e-09 | -18.93 | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | molecular function | GO:1904315 | 53 | 6 | 18094 | 49 |
GRID2,GABRD,GRIN2A,GABRA1,GABRA6,GABRB2 |
7.101e-09 | -18.76 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 14 | 18094 | 49 |
TRPM3,GABRB2,CACNA1C,GABRD,GABRA1,GRIN2A,GABRA6,KCNMA1,HCN1,KCNIP4,GRID2,RYR2,KCNT1,SLC24A4 |
7.533e-09 | -18.70 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | molecular function | GO:0099529 | 55 | 6 | 18094 | 49 |
GABRD,GABRB2,GABRA6,GRIN2A,GABRA1,GRID2 |
1.069e-08 | -18.35 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 44 | 16828 | 48 |
SLC24A4,ZNF804A,CR2,KSR2,GRID2,RYR2,CACNA1C,RBFOX3,RGS7,GABRA6,SMPD3,KCNT1,ASTN1,NRXN1,PPP2R5B,PTPRG,HCN1,PCLO,KCNMA1,CELF6,GABBR2,KCNIP4,STXBP5L,RBFOX1,NRXN3,RIMS4,CPLX1,GABRD,MYT1L,OLFM1,AK5,R3HDM1,RIMS2,GABRB2,ST8SIA5,TRPM3,ZFPM2,UNC13C,GRIN2A,CELF4,LRRC7,CELF5,GABRA1,IL1RAPL2 |
1.075e-08 | -18.35 | synaptic transmission, GABAergic | biological process | GO:0051932 | 28 | 5 | 18204 | 49 |
GABRA1,GABRD,GABRA6,GABRB2,GABBR2 |
1.161e-08 | -18.27 | transmitter-gated channel activity | molecular function | GO:0022835 | 59 | 6 | 18094 | 49 |
GABRB2,GRID2,GABRD,GABRA6,GABRA1,GRIN2A |
1.161e-08 | -18.27 | transmitter-gated monoatomic ion channel activity | molecular function | GO:0022824 | 59 | 6 | 18094 | 49 |
GRID2,GABRD,GABRA1,GABRB2,GABRA6,GRIN2A |
1.296e-08 | -18.16 | gamma-aminobutyric acid signaling pathway | biological process | GO:0007214 | 29 | 5 | 18204 | 49 |
GABBR2,GABRB2,GABRA6,GABRD,GABRA1 |
1.486e-08 | -18.02 | lung-middle_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-middle_lobe-carcinoma-adenocarcinoma | 1368 | 18 | 16828 | 48 |
SLC24A4,ZNF804A,GABRA6,TRPM3,RBFOX1,STXBP5L,RYR2,KCNT1,NRXN3,GRIN2A,UNC13C,ZFPM2,PPP2R5B,MYT1L,LRRC7,HCN1,PTPRG,ST8SIA5 |
1.535e-08 | -17.99 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 14 | 18204 | 49 |
TRPM3,SLC24A4,GRIN2A,KCNT1,KCNIP4,GABRA1,RYR2,KCNMA1,GABRA6,GRID2,GABRD,GABRB2,HCN1,CACNA1C |
1.742e-08 | -17.87 | middle_lobe | COSMIC cancer mutations | middle_lobe | 1382 | 18 | 16828 | 48 |
KCNT1,RYR2,NRXN3,GABRA6,ZNF804A,SLC24A4,STXBP5L,RBFOX1,TRPM3,PTPRG,HCN1,ST8SIA5,ZFPM2,UNC13C,GRIN2A,MYT1L,LRRC7,PPP2R5B |
2.628e-08 | -17.45 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 18 | 16828 | 48 |
NRXN3,GALNT9,GRID2,RYR2,TRPM3,KSR2,STXBP5L,CR2,GABBR2,ZNF804A,GABRA6,IL1RAPL2,RBFOX3,HCN1,PCLO,PTPRG,ZFPM2,GRIN2A |
2.751e-08 | -17.41 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 22 | 16828 | 48 |
ASTN1,KCNT1,LRRC7,CELF4,GRIN2A,UNC13C,IL1RAPL2,PCLO,HCN1,PTPRG,KSR2,CR2,STXBP5L,GABBR2,ZNF804A,NRXN3,RYR2,GRID2,AK5,CACNA1C,RBFOX3,RIMS2 |
2.751e-08 | -17.41 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 22 | 16828 | 48 |
RBFOX3,RIMS2,AK5,CACNA1C,NRXN3,RYR2,GRID2,KSR2,STXBP5L,CR2,ZNF804A,GABBR2,IL1RAPL2,PCLO,HCN1,PTPRG,LRRC7,CELF4,GRIN2A,UNC13C,ASTN1,KCNT1 |
3.225e-08 | -17.25 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 22 | 16828 | 48 |
CELF4,GRIN2A,UNC13C,LRRC7,PCLO,HCN1,PTPRG,IL1RAPL2,KCNT1,ASTN1,CACNA1C,AK5,RBFOX3,RIMS2,GABBR2,ZNF804A,KSR2,CR2,STXBP5L,GRID2,RYR2,NRXN3 |
3.304e-08 | -17.23 | postsynaptic neurotransmitter receptor activity | molecular function | GO:0098960 | 70 | 6 | 18094 | 49 |
GABRB2,GRIN2A,GABRA6,GABRA1,GABRD,GRID2 |
3.375e-08 | -17.20 | inorganic ion transmembrane transport | biological process | GO:0098660 | 715 | 13 | 18204 | 49 |
CACNA1C,HCN1,GABRB2,GABRD,GABRA6,KCNMA1,GABRA1,RYR2,KCNIP4,KCNT1,GRIN2A,SLC24A4,TRPM3 |
3.563e-08 | -17.15 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 13 | 18094 | 49 |
KCNMA1,HCN1,KCNIP4,KCNT1,SLC24A4,RYR2,TRPM3,GABRB2,CACNA1C,GABRD,GABRA6,GABRA1,GRIN2A |
3.921e-08 | -17.05 | extracellular ligand-gated monoatomic ion channel activity | molecular function | GO:0005230 | 72 | 6 | 18094 | 49 |
GABRB2,GABRD,GRIN2A,GABRA1,GABRA6,GRID2 |
7.391e-08 | -16.42 | CELF3/4/5/6_RRM1 | interpro domains | IPR034648 | 4 | 3 | 18521 | 50 |
CELF5,CELF4,CELF6 |
8.128e-08 | -16.33 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 48 |
SMPD3,TRPM3,ASTN1,ZFPM2,UNC13C,GRIN2A,CELF4,PTPRG,CELF5,HCN1,PCLO,KCNMA1,IL1RAPL2,TTC9B,ZNF804A,CR2,RBFOX1,GRID2,RYR2,NRXN3,RIMS4,CACNA1C,MYT1L,AK5,RIMS2,RGS7,GABRB2 |
8.128e-08 | -16.33 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 48 |
SMPD3,TRPM3,ASTN1,ZFPM2,UNC13C,GRIN2A,CELF4,PTPRG,HCN1,CELF5,PCLO,KCNMA1,IL1RAPL2,TTC9B,ZNF804A,CR2,RBFOX1,RYR2,GRID2,NRXN3,RIMS4,CACNA1C,MYT1L,AK5,RIMS2,RGS7,GABRB2 |
8.861e-08 | -16.24 | presynaptic active zone cytoplasmic component | cellular component | GO:0098831 | 17 | 4 | 19108 | 49 |
RIMS4,UNC13C,PCLO,RIMS2 |
9.568e-08 | -16.16 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 38 | 16828 | 48 |
NRXN3,GRID2,RYR2,RBFOX1,KSR2,CR2,STXBP5L,ZNF804A,KCNIP4,OPRL1,ST8SIA5,GABRB2,RBFOX3,RGS7,RIMS2,R3HDM1,GABRD,MYT1L,CACNA1C,RIMS4,ASTN1,GALNT9,KCNT1,TRPM3,SMPD3,GABRA6,GABRA1,IL1RAPL2,KCNMA1,PCLO,HCN1,PTPRG,PPP2R5B,NRXN1,LRRC7,UNC13C,GRIN2A,ZFPM2 |
9.642e-08 | -16.15 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 18 | 16828 | 48 |
GABBR2,ZNF804A,GABRA6,KSR2,TRPM3,CR2,STXBP5L,RYR2,GRID2,NRXN3,GALNT9,ZFPM2,GRIN2A,HCN1,PCLO,PTPRG,RBFOX3,IL1RAPL2 |
1.271e-07 | -15.88 | neurotransmitter secretion | biological process | GO:0007269 | 88 | 6 | 18204 | 49 |
RIMS2,NRXN1,PCLO,RIMS4,CPLX1,UNC13C |
1.271e-07 | -15.88 | signal release from synapse | biological process | GO:0099643 | 88 | 6 | 18204 | 49 |
RIMS4,PCLO,CPLX1,UNC13C,NRXN1,RIMS2 |
1.296e-07 | -15.86 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 13 | 19108 | 49 |
GRIN2A,HCN1,GABRA1,ZNF804A,KCNIP4,CACNA1C,GABRD,GRID2,ASTN1,OLFM1,GABRA6,CPLX1,NRXN1 |
1.304e-07 | -15.85 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 15 | 18094 | 49 |
CPLX1,KCNIP4,HCN1,KCNMA1,GRID2,KCNT1,RYR2,SLC24A4,TRPM3,GABRB2,CACNA1C,GABRA1,GRIN2A,GABRA6,GABRD |
1.305e-07 | -15.85 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 36 | 16828 | 48 |
GABRB2,RIMS2,MYT1L,GABRD,CACNA1C,NRXN3,RYR2,GRID2,RBFOX1,KSR2,CR2,STXBP5L,KCNIP4,ZNF804A,SLC24A4,GABBR2,OPRL1,IL1RAPL2,GABRA1,KCNMA1,PCLO,CELF5,HCN1,PTPRG,PPP2R5B,NRXN1,LRRC7,CELF4,GRIN2A,UNC13C,ZFPM2,ASTN1,GALNT9,KCNT1,TRPM3,GABRA6 |
1.437e-07 | -15.76 | plasma membrane | cellular component | GO:0005886 | 5538 | 32 | 19108 | 49 |
KCNT1,HCN1,GABRA1,RGS7,OPRL1,DLG3,SLC24A4,GABRD,GRID2,CR2,GABBR2,RIMS4,IL1RAPL2,GRIN2A,TRPM3,STXBP5L,RIMS2,KCNMA1,UNC13C,ZNF804A,GABRB2,KCNIP4,CACNA1C,RYR2,GABRA6,ASTN1,SMPD3,PTPRG,NRXN1,KSR2,LRRC7,NRXN3 |
1.438e-07 | -15.76 | GABA-A receptor complex | cellular component | GO:1902711 | 19 | 4 | 19108 | 49 |
GABRD,GABRB2,GABRA6,GABRA1 |
1.473e-07 | -15.73 | monoatomic ion transport | biological process | GO:0006811 | 964 | 14 | 18204 | 49 |
KCNIP4,KCNT1,GRIN2A,RYR2,GABRA1,KCNMA1,TRPM3,SLC24A4,GABRD,CACNA1C,GABRB2,HCN1,GRID2,GABRA6 |
1.785e-07 | -15.54 | GABA-A receptor activity | molecular function | GO:0004890 | 19 | 4 | 18094 | 49 |
GABRA1,GABRB2,GABRA6,GABRD |
2.221e-07 | -15.32 | monoatomic cation channel activity | molecular function | GO:0005261 | 331 | 9 | 18094 | 49 |
KCNIP4,HCN1,KCNMA1,TRPM3,GRIN2A,RYR2,SLC24A4,KCNT1,CACNA1C |
2.256e-07 | -15.30 | presynaptic membrane | cellular component | GO:0042734 | 168 | 7 | 19108 | 49 |
NRXN1,RIMS4,UNC13C,NRXN3,GRIN2A,RIMS2,HCN1 |
2.357e-07 | -15.26 | neurotransmitter receptor activity | molecular function | GO:0030594 | 97 | 6 | 18094 | 49 |
GRIN2A,GABRA1,GABRB2,GABRA6,GABRD,GRID2 |
2.662e-07 | -15.14 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 15 | 16828 | 48 |
NRXN3,GRID2,RYR2,KCNT1,KSR2,SMPD3,ZNF804A,IL1RAPL2,RGS7,HCN1,PCLO,PTPRG,LRRC7,CELF4,ZFPM2 |
2.687e-07 | -15.13 | cell periphery | cellular component | GO:0071944 | 6020 | 33 | 19108 | 49 |
CR2,GRID2,IL1RAPL2,PCLO,GABBR2,RIMS4,HCN1,KCNT1,GABRD,SLC24A4,DLG3,OPRL1,RGS7,GABRA1,PTPRG,ASTN1,GABRA6,SMPD3,RYR2,NRXN3,NRXN1,KSR2,LRRC7,RIMS2,STXBP5L,TRPM3,GRIN2A,CACNA1C,UNC13C,ZNF804A,GABRB2,KCNIP4,KCNMA1 |
2.884e-07 | -15.06 | humerus | COSMIC cancer mutations | humerus | 546 | 11 | 16828 | 48 |
PCLO,R3HDM1,HCN1,IL1RAPL2,GRIN2A,ZFPM2,RIMS4,GRID2,RYR2,NRXN3,KSR2 |
2.942e-07 | -15.04 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 20 | 19108 | 49 |
GRID2,CPLX1,OLFM1,GABRA6,LRRC7,GABBR2,PCLO,GRIN2A,HCN1,RGS7,GABRA1,CACNA1C,SLC24A4,GABRD,KCNIP4,GABRB2,OPRL1,DLG3,ZNF804A,UNC13C |
3.099e-07 | -14.99 | Nicotine addiction | KEGG pathways | ko05033 | 40 | 5 | 7161 | 27 |
GABRA1,GABRA6,GABRB2,GABRD,GRIN2A |
3.099e-07 | -14.99 | Nicotine addiction | KEGG pathways | hsa05033 | 40 | 5 | 7161 | 27 |
GABRA6,GABRA1,GABRD,GABRB2,GRIN2A |
3.167e-07 | -14.97 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 38 | 16828 | 48 |
CELF6,OPRL1,GABBR2,SLC24A4,CR2,STXBP5L,RBFOX1,KSR2,RYR2,DLG3,NRXN3,CACNA1C,GABRD,MYT1L,OLFM1,AK5,R3HDM1,RIMS2,RGS7,GABRB2,GABRA6,SMPD3,TRPM3,KCNT1,GALNT9,ASTN1,ZFPM2,GRIN2A,UNC13C,CELF4,LRRC7,NRXN1,PTPRG,HCN1,PCLO,KCNMA1,IL1RAPL2,GABRA1 |
3.167e-07 | -14.97 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 38 | 16828 | 48 |
RIMS2,RGS7,GABRB2,R3HDM1,MYT1L,GABRD,OLFM1,AK5,CACNA1C,DLG3,NRXN3,RYR2,STXBP5L,CR2,RBFOX1,KSR2,CELF6,OPRL1,GABBR2,SLC24A4,KCNMA1,IL1RAPL2,GABRA1,PTPRG,HCN1,PCLO,LRRC7,NRXN1,ZFPM2,GRIN2A,UNC13C,CELF4,GALNT9,ASTN1,KCNT1,SMPD3,TRPM3,GABRA6 |
3.316e-07 | -14.92 | GABAA/Glycine_rcpt | interpro domains | IPR006028 | 22 | 4 | 18521 | 50 |
GABRB2,GABRA1,GABRD,GABRA6 |
3.368e-07 | -14.90 | membrane protein complex | cellular component | GO:0098796 | 1261 | 15 | 19108 | 49 |
RYR2,GRID2,CPLX1,GABRA6,GABBR2,GRIN2A,STXBP5L,HCN1,KCNMA1,GABRA1,GABRD,CACNA1C,DLG3,GABRB2,KCNIP4 |
3.602e-07 | -14.84 | regulation of alternative mRNA splicing, via spliceosome | biological process | GO:0000381 | 55 | 5 | 18204 | 49 |
CELF4,RBFOX3,CELF5,RBFOX1,CELF6 |
4.023e-07 | -14.73 | transporter activity | molecular function | GO:0005215 | 1211 | 15 | 18094 | 49 |
KCNIP4,CPLX1,HCN1,KCNMA1,RYR2,KCNT1,SLC24A4,GRID2,GABRB2,TRPM3,GRIN2A,GABRA1,GABRA6,GABRD,CACNA1C |
4.239e-07 | -14.67 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 18 | 16828 | 48 |
TRPM3,KSR2,GABBR2,DLG3,ASTN1,NRXN3,GRID2,RYR2,LRRC7,MYT1L,ZFPM2,GRIN2A,UNC13C,CELF4,RIMS2,RGS7,IL1RAPL2,PCLO |
4.550e-07 | -14.60 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 20 | 16828 | 48 |
ZNF804A,GABBR2,GABRA6,KSR2,STXBP5L,RYR2,GRID2,ASTN1,NRXN3,CELF4,ZFPM2,UNC13C,GRIN2A,AK5,LRRC7,OLFM1,HCN1,PCLO,PTPRG,IL1RAPL2 |
4.550e-07 | -14.60 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 20 | 16828 | 48 |
GRID2,RYR2,ASTN1,NRXN3,GABRA6,ZNF804A,GABBR2,STXBP5L,KSR2,PTPRG,HCN1,PCLO,IL1RAPL2,ZFPM2,UNC13C,GRIN2A,CELF4,LRRC7,OLFM1,AK5 |
5.571e-07 | -14.40 | mouth | COSMIC cancer mutations | mouth | 9004 | 42 | 16828 | 48 |
RBFOX3,RGS7,RIMS2,ST8SIA5,GABRB2,R3HDM1,GABRD,MYT1L,RIMS4,CACNA1C,DLG3,NRXN3,GRID2,RYR2,STXBP5L,CR2,KSR2,RBFOX1,OPRL1,GABBR2,KCNIP4,SLC24A4,ZNF804A,IL1RAPL2,GABRA1,KCNMA1,PTPRG,PCLO,HCN1,CELF5,LRRC7,PPP2R5B,NRXN1,UNC13C,GRIN2A,ZFPM2,GALNT9,ASTN1,KCNT1,SMPD3,TRPM3,GABRA6 |
6.671e-07 | -14.22 | signal release | biological process | GO:0023061 | 188 | 7 | 18204 | 49 |
SMPD3,CPLX1,UNC13C,NRXN1,RIMS2,PCLO,RIMS4 |
6.977e-07 | -14.18 | GABAergic synapse | KEGG pathways | hsa04727 | 88 | 6 | 7161 | 27 |
GABRD,GABRB2,GABRA6,GABRA1,CACNA1C,GABBR2 |
6.977e-07 | -14.18 | GABAergic synapse | KEGG pathways | ko04727 | 88 | 6 | 7161 | 27 |
GABRA6,GABRD,GABBR2,CACNA1C,GABRA1,GABRB2 |
7.162e-07 | -14.15 | synaptic vesicle exocytosis | biological process | GO:0016079 | 63 | 5 | 18204 | 49 |
RIMS2,PCLO,RIMS4,UNC13C,CPLX1 |
7.270e-07 | -14.13 | synapse assembly | biological process | GO:0007416 | 118 | 6 | 18204 | 49 |
GABRA1,NRXN1,PCLO,GABRA6,GRID2,GABRB2 |
7.439e-07 | -14.11 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 10 | 16828 | 48 |
NRXN3,IL1RAPL2,GRID2,TRPM3,MYT1L,CELF4,GABBR2,UNC13C,GRIN2A,ZFPM2 |
7.902e-07 | -14.05 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 7 | 10285 | 26 |
CPLX1,GRIN2A,DLG3,GABRA6,GABRA1,GABRB2,GABBR2 |
8.318e-07 | -14.00 | receptor complex | cellular component | GO:0043235 | 409 | 9 | 19108 | 49 |
GABRD,DLG3,GABRB2,GABBR2,GABRA1,CR2,GABRA6,GRIN2A,GRID2 |
8.756e-07 | -13.95 | GABAARECEPTR | prints domains | PR00253 | 22 | 4 | 5227 | 19 |
GABRA6,GABRA1,GABRD,GABRB2 |
8.795e-07 | -13.94 | cytoskeleton of presynaptic active zone | cellular component | GO:0048788 | 8 | 3 | 19108 | 49 |
RIMS4,RIMS2,PCLO |
1.066e-06 | -13.75 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 35 | 16828 | 48 |
ZFPM2,GRIN2A,UNC13C,LRRC7,PPP2R5B,PTPRG,CELF5,HCN1,PCLO,KCNMA1,GABRA1,GABRA6,SMPD3,TRPM3,KCNT1,ASTN1,RIMS4,CACNA1C,MYT1L,GABRD,R3HDM1,RBFOX3,RGS7,OPRL1,SLC24A4,ZNF804A,KCNIP4,GABBR2,STXBP5L,CR2,RBFOX1,KSR2,GRID2,RYR2,DLG3 |
1.345e-06 | -13.52 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | REACTOME pathways | R-HSA-112314 | 146 | 6 | 10285 | 26 |
GABRB2,GABBR2,GRIN2A,DLG3,GABRA1,GABRA6 |
1.463e-06 | -13.44 | presynapse | cellular component | GO:0098793 | 569 | 10 | 19108 | 49 |
GRIN2A,HCN1,CPLX1,RIMS2,RIMS4,NRXN1,ZNF804A,PCLO,UNC13C,NRXN3 |
1.677e-06 | -13.30 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 13 | 16828 | 48 |
TRPM3,OPRL1,GABBR2,ZNF804A,GALNT9,NRXN3,KCNT1,MYT1L,ZFPM2,UNC13C,CACNA1C,RIMS2,PCLO |
1.677e-06 | -13.30 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 13 | 16828 | 48 |
TRPM3,GABBR2,ZNF804A,OPRL1,NRXN3,GALNT9,KCNT1,MYT1L,CACNA1C,ZFPM2,UNC13C,RIMS2,PCLO |
1.757e-06 | -13.25 | presynaptic active zone | cellular component | GO:0048786 | 79 | 5 | 19108 | 49 |
RIMS2,PCLO,UNC13C,HCN1,RIMS4 |
1.759e-06 | -13.25 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 21 | 16828 | 48 |
CR2,KSR2,GABBR2,ZNF804A,NRXN3,ASTN1,KCNT1,GRID2,RYR2,GABRD,LRRC7,GRIN2A,RIMS4,ZFPM2,CELF4,CPLX1,IL1RAPL2,ST8SIA5,GABRB2,PTPRG,HCN1 |
1.884e-06 | -13.18 | cell cortex region | cellular component | GO:0099738 | 35 | 4 | 19108 | 49 |
PCLO,UNC13C,RIMS2,RIMS4 |
1.935e-06 | -13.16 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 8 | 16828 | 48 |
KSR2,GRIN2A,ZFPM2,RIMS4,NRXN3,IL1RAPL2,GRID2,HCN1 |
1.980e-06 | -13.13 | neurotransmitter transport | biological process | GO:0006836 | 140 | 6 | 18204 | 49 |
NRXN1,RIMS2,UNC13C,CPLX1,RIMS4,PCLO |
2.102e-06 | -13.07 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 10 | 16828 | 48 |
NRXN3,IL1RAPL2,HCN1,GRID2,PTPRG,KSR2,ZNF804A,RIMS4,ZFPM2,GRIN2A |
2.167e-06 | -13.04 | trunk | COSMIC cancer mutations | trunk | 3554 | 25 | 16828 | 48 |
NRXN3,RYR2,GRID2,KSR2,RBFOX1,CR2,STXBP5L,ZNF804A,GABBR2,RIMS2,RGS7,RBFOX3,R3HDM1,MYT1L,CACNA1C,ASTN1,KCNT1,GABRA6,GABRA1,HCN1,CELF5,PTPRG,NRXN1,ZFPM2,GRIN2A |
2.215e-06 | -13.02 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 28 | 16828 | 48 |
KCNT1,ASTN1,GABRA6,TRPM3,HCN1,PCLO,PTPRG,IL1RAPL2,ZFPM2,GRIN2A,UNC13C,PPP2R5B,LRRC7,RYR2,GRID2,NRXN3,ZNF804A,GABBR2,CELF6,KSR2,STXBP5L,R3HDM1,ST8SIA5,RIMS2,RGS7,CACNA1C,MYT1L,OLFM1 |
2.215e-06 | -13.02 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 28 | 16828 | 48 |
GRID2,RYR2,NRXN3,GABBR2,ZNF804A,CELF6,KSR2,STXBP5L,R3HDM1,ST8SIA5,RIMS2,RGS7,CACNA1C,MYT1L,OLFM1,KCNT1,ASTN1,GABRA6,TRPM3,HCN1,PCLO,PTPRG,IL1RAPL2,ZFPM2,GRIN2A,UNC13C,PPP2R5B,LRRC7 |
2.463e-06 | -12.91 | postsynaptic specialization | cellular component | GO:0099572 | 345 | 8 | 19108 | 49 |
GRID2,GRIN2A,DLG3,PCLO,GABRB2,CACNA1C,LRRC7,INSYN1 |
2.465e-06 | -12.91 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 9 | 18094 | 49 |
RYR2,KCNT1,SLC24A4,GRIN2A,CACNA1C,HCN1,KCNMA1,KCNIP4,TRPM3 |
2.577e-06 | -12.87 | presynaptic cytoskeleton | cellular component | GO:0099569 | 11 | 3 | 19108 | 49 |
PCLO,RIMS2,RIMS4 |
3.274e-06 | -12.63 | cell communication | biological process | GO:0007154 | 5010 | 29 | 18204 | 49 |
INSYN1,RYR2,KSR2,GABRA1,SLC24A4,RIMS4,RIMS2,GABRD,IL1RAPL2,CR2,SMPD3,GABRA6,PPP2R5B,OPRL1,CELF4,GRIN2A,DLG3,RGS7,PCLO,CACNA1C,GABBR2,UNC13C,CPLX1,HCN1,GABRB2,NRXN1,PTPRG,GRID2,OLFM1 |
3.353e-06 | -12.61 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 32 | 16828 | 48 |
RGS7,RIMS2,GABRB2,CACNA1C,MYT1L,OLFM1,AK5,GRID2,RYR2,NRXN3,OPRL1,ZNF804A,SLC24A4,CR2,STXBP5L,RBFOX1,PTPRG,PCLO,HCN1,GABRA1,IL1RAPL2,KCNMA1,UNC13C,GRIN2A,ZFPM2,CELF4,LRRC7,KCNT1,ASTN1,GABRA6,SMPD3,TRPM3 |
3.353e-06 | -12.61 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 32 | 16828 | 48 |
ASTN1,KCNT1,TRPM3,SMPD3,GABRA6,IL1RAPL2,GABRA1,KCNMA1,PCLO,HCN1,PTPRG,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,NRXN3,RYR2,GRID2,RBFOX1,CR2,STXBP5L,SLC24A4,ZNF804A,OPRL1,GABRB2,RGS7,RIMS2,AK5,OLFM1,MYT1L,CACNA1C |
3.800e-06 | -12.48 | transmembrane transport | biological process | GO:0055085 | 1264 | 14 | 18204 | 49 |
TRPM3,SLC24A4,RYR2,GABRA1,KCNIP4,KCNT1,GRIN2A,KCNMA1,GRID2,GABRA6,GABRD,CACNA1C,HCN1,GABRB2 |
4.034e-06 | -12.42 | GABA A receptor activation | REACTOME pathways | R-HSA-977441 | 13 | 3 | 10285 | 26 |
GABRA6,GABRA1,GABRB2 |
4.318e-06 | -12.35 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 24 | 16828 | 48 |
ASTN1,TRPM3,PTPRG,PCLO,CELF5,GABRA1,KCNMA1,GRIN2A,UNC13C,ZFPM2,CELF4,NRXN1,RYR2,GRID2,KCNIP4,ZNF804A,CR2,STXBP5L,KSR2,R3HDM1,RGS7,RBFOX3,RIMS2,CACNA1C |
4.502e-06 | -12.31 | transport | biological process | GO:0006810 | 3615 | 24 | 18204 | 49 |
KCNT1,GRIN2A,KCNMA1,PCLO,TRPM3,NRXN1,CACNA1C,STXBP5L,UNC13C,HCN1,CPLX1,GABRB2,GRID2,RYR2,GABRA1,KCNIP4,RIMS4,SLC24A4,GABRD,RIMS2,RBFOX1,LRRC7,SMPD3,GABRA6 |
5.001e-06 | -12.21 | export from cell | biological process | GO:0140352 | 485 | 9 | 18204 | 49 |
UNC13C,STXBP5L,CPLX1,NRXN1,RIMS2,SLC24A4,SMPD3,PCLO,RIMS4 |
5.074e-06 | -12.19 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 27 | 16828 | 48 |
SMPD3,TRPM3,GABRA6,ASTN1,LRRC7,PPP2R5B,GRIN2A,KCNMA1,GABRA1,HCN1,PCLO,STXBP5L,RBFOX1,KSR2,CELF6,ZNF804A,SLC24A4,DLG3,NRXN3,RYR2,MYT1L,AK5,CACNA1C,RIMS2,RBFOX3,RGS7,R3HDM1 |
5.157e-06 | -12.18 | Neuroactive ligand-receptor interaction | KEGG pathways | ko04080 | 276 | 8 | 7161 | 27 |
OPRL1,GABRB2,GABRA1,GABBR2,GABRD,GABRA6,GRID2,GRIN2A |
5.157e-06 | -12.18 | Neuroactive ligand-receptor interaction | KEGG pathways | hsa04080 | 276 | 8 | 7161 | 27 |
GABRB2,OPRL1,GABRA1,GABBR2,GABRD,GABRA6,GRID2,GRIN2A |
5.237e-06 | -12.16 | GABA-gated chloride ion channel activity | molecular function | GO:0022851 | 13 | 3 | 18094 | 49 |
GABRB2,GABRA1,GABRA6 |
5.366e-06 | -12.14 | Neurotransmitter_ion_chnl_CS | interpro domains | IPR018000 | 43 | 4 | 18521 | 50 |
GABRD,GABRA1,GABRB2,GABRA6 |
5.891e-06 | -12.04 | Neurotrans-gated_channel_TM | interpro domains | IPR006029 | 44 | 4 | 18521 | 50 |
GABRA6,GABRD,GABRA1,GABRB2 |
6.351e-06 | -11.97 | Neur_chan_memb | pfam domains | PF02932 | 44 | 4 | 17795 | 49 |
GABRB2,GABRD,GABRA1,GABRA6 |
6.453e-06 | -11.95 | Neur_chan_lig-bd_sf | interpro domains | IPR036734 | 45 | 4 | 18521 | 50 |
GABRD,GABRA1,GABRB2,GABRA6 |
6.453e-06 | -11.95 | Neuro_actylchol_rec | interpro domains | IPR038050 | 45 | 4 | 18521 | 50 |
GABRA6,GABRA1,GABRB2,GABRD |
6.453e-06 | -11.95 | Neuro-gated_channel_TM_sf | interpro domains | IPR036719 | 45 | 4 | 18521 | 50 |
GABRD,GABRB2,GABRA1,GABRA6 |
6.453e-06 | -11.95 | Neur_channel | interpro domains | IPR006201 | 45 | 4 | 18521 | 50 |
GABRA1,GABRB2,GABRD,GABRA6 |
6.453e-06 | -11.95 | Neur_chan_lig-bd | interpro domains | IPR006202 | 45 | 4 | 18521 | 50 |
GABRB2,GABRA1,GABRD,GABRA6 |
6.956e-06 | -11.88 | Neur_chan_LBD | pfam domains | PF02931 | 45 | 4 | 17795 | 49 |
GABRA1,GABRA6,GABRD,GABRB2 |
7.860e-06 | -11.75 | - | gene3d domains | 1.10.287.70 | 148 | 6 | 14470 | 47 |
CACNA1C,KCNMA1,HCN1,RYR2,GRID2,KCNT1 |
8.098e-06 | -11.72 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 11 | 16828 | 48 |
GRID2,RYR2,NRXN3,PCLO,RGS7,IL1RAPL2,CELF4,CACNA1C,ZFPM2,NRXN1,MYT1L |
8.155e-06 | -11.72 | NEUROTR_ION_CHANNEL | prosite domains | PS00236 | 43 | 4 | 12186 | 37 |
GABRD,GABRA1,GABRA6,GABRB2 |
8.978e-06 | -11.62 | modulation of excitatory postsynaptic potential | biological process | GO:0098815 | 49 | 4 | 18204 | 49 |
CELF4,GRIN2A,NRXN1,RIMS2 |
1.001e-05 | -11.51 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 3 | 18204 | 49 |
NRXN3,ASTN1,NRXN1 |
1.033e-05 | -11.48 | signaling | biological process | GO:0023052 | 4968 | 28 | 18204 | 49 |
OLFM1,GRID2,PTPRG,NRXN1,GABRB2,CPLX1,UNC13C,CACNA1C,GABBR2,PCLO,RGS7,GRIN2A,DLG3,CELF4,OPRL1,PPP2R5B,GABRA6,SMPD3,CR2,IL1RAPL2,RIMS2,GABRD,RIMS4,SLC24A4,GABRA1,KSR2,RYR2,INSYN1 |
1.078e-05 | -11.44 | GABA receptor activation | REACTOME pathways | R-HSA-977443 | 56 | 4 | 10285 | 26 |
GABRB2,GABRA6,GABRA1,GABBR2 |
1.105e-05 | -11.41 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 5 | 18521 | 50 |
RYR2,KCNMA1,CACNA1C,TRPM3,HCN1 |
1.185e-05 | -11.34 | regulation of mRNA splicing, via spliceosome | biological process | GO:0048024 | 111 | 5 | 18204 | 49 |
RBFOX3,CELF4,CELF5,CELF6,RBFOX1 |
1.210e-05 | -11.32 | Ion_trans | pfam domains | PF00520 | 109 | 5 | 17795 | 49 |
KCNMA1,RYR2,CACNA1C,HCN1,TRPM3 |
1.227e-05 | -11.31 | bone | COSMIC cancer mutations | bone | 8157 | 38 | 16828 | 48 |
OLFM1,GABRD,MYT1L,AK5,RIMS4,CACNA1C,RGS7,GABRB2,ST8SIA5,R3HDM1,STXBP5L,CR2,KSR2,CELF6,GABBR2,ZNF804A,SLC24A4,KCNIP4,NRXN3,RYR2,GRID2,LRRC7,NRXN1,PPP2R5B,ZFPM2,GRIN2A,UNC13C,CELF4,IL1RAPL2,PTPRG,HCN1,PCLO,SMPD3,TRPM3,GABRA6,GALNT9,ASTN1,KCNT1 |
1.231e-05 | -11.30 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 22 | 16828 | 48 |
GRIN2A,RIMS4,ZFPM2,CELF4,CPLX1,LRRC7,GABRD,PTPRG,HCN1,IL1RAPL2,ST8SIA5,GABRB2,OPRL1,ZNF804A,GABBR2,CR2,KSR2,KCNT1,GRID2,RYR2,NRXN3,ASTN1 |
1.241e-05 | -11.30 | Interactions of neurexins and neuroligins at synapses | REACTOME pathways | R-HSA-6794361 | 58 | 4 | 10285 | 26 |
NRXN3,NRXN1,GRIN2A,DLG3 |
1.243e-05 | -11.30 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 10 | 16828 | 48 |
CACNA1C,CELF4,NRXN1,MYT1L,GRID2,PCLO,RYR2,NRXN3,IL1RAPL2,RGS7 |
1.260e-05 | -11.28 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 10 | 16828 | 48 |
RYR2,GRID2,PCLO,IL1RAPL2,RGS7,NRXN3,CACNA1C,CELF4,MYT1L,NRXN1 |
1.271e-05 | -11.27 | chloride channel complex | cellular component | GO:0034707 | 56 | 4 | 19108 | 49 |
GABRB2,GABRA6,GABRD,GABRA1 |
1.320e-05 | -11.24 | Neurotransmitter-gated ion-channel ligand-binding domain | gene3d domains | 2.70.170.10 | 45 | 4 | 14470 | 47 |
GABRA1,GABRB2,GABRA6,GABRD |
1.320e-05 | -11.24 | Neurotransmitter-gated ion-channel transmembrane domain | gene3d domains | 1.20.58.390 | 45 | 4 | 14470 | 47 |
GABRA1,GABRD,GABRA6,GABRB2 |
1.376e-05 | -11.19 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 5 | 7161 | 27 |
RIMS2,RYR2,KCNMA1,PCLO,CACNA1C |
1.407e-05 | -11.17 | NRIONCHANNEL | prints domains | PR00252 | 43 | 4 | 5227 | 19 |
GABRB2,GABRD,GABRA6,GABRA1 |
1.414e-05 | -11.17 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 3 | 19454 | 49 |
NRXN3,DLG3,NRXN1 |
1.454e-05 | -11.14 | calcium ion-regulated exocytosis of neurotransmitter | biological process | GO:0048791 | 18 | 3 | 18204 | 49 |
UNC13C,RIMS2,RIMS4 |
1.471e-05 | -11.13 | human chr5q34 | chromosome location | human chr5q34 | 25 | 3 | 26134 | 50 |
GABRA1,GABRA6,GABRB2 |
1.479e-05 | -11.12 | secretion by cell | biological process | GO:0032940 | 420 | 8 | 18204 | 49 |
PCLO,RIMS4,SMPD3,RIMS2,NRXN1,UNC13C,STXBP5L,CPLX1 |
1.530e-05 | -11.09 | postsynaptic density | cellular component | GO:0014069 | 317 | 7 | 19108 | 49 |
GRID2,GRIN2A,CACNA1C,PCLO,DLG3,LRRC7,INSYN1 |
1.569e-05 | -11.06 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 43 | 16828 | 48 |
RGS7,RIMS2,ST8SIA5,GABRB2,R3HDM1,GABRD,MYT1L,OLFM1,AK5,RIMS4,CACNA1C,DLG3,NRXN3,GRID2,RYR2,CR2,STXBP5L,KSR2,RBFOX1,OPRL1,TTC9B,CELF6,SLC24A4,GABBR2,ZNF804A,GABRA1,KCNMA1,PTPRG,PCLO,CELF5,HCN1,LRRC7,PPP2R5B,NRXN1,UNC13C,GRIN2A,ZFPM2,CELF4,ASTN1,KCNT1,SMPD3,TRPM3,GABRA6 |
1.569e-05 | -11.06 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 43 | 16828 | 48 |
SMPD3,TRPM3,GABRA6,ASTN1,KCNT1,LRRC7,PPP2R5B,NRXN1,GRIN2A,UNC13C,ZFPM2,CELF4,GABRA1,KCNMA1,PTPRG,PCLO,HCN1,CELF5,STXBP5L,CR2,KSR2,RBFOX1,OPRL1,CELF6,TTC9B,SLC24A4,GABBR2,ZNF804A,DLG3,NRXN3,RYR2,GRID2,MYT1L,OLFM1,GABRD,AK5,RIMS4,CACNA1C,RGS7,RIMS2,ST8SIA5,GABRB2,R3HDM1 |
1.576e-05 | -11.06 | calcium channel activity | molecular function | GO:0005262 | 117 | 5 | 18094 | 49 |
CACNA1C,TRPM3,GRIN2A,SLC24A4,RYR2 |
1.661e-05 | -11.01 | establishment of localization | biological process | GO:0051234 | 3887 | 24 | 18204 | 49 |
SLC24A4,RIMS4,RYR2,GABRA1,KCNIP4,SMPD3,GABRA6,LRRC7,RBFOX1,RIMS2,GABRD,TRPM3,PCLO,KCNMA1,KCNT1,GRIN2A,GRID2,STXBP5L,CACNA1C,UNC13C,CPLX1,HCN1,GABRB2,NRXN1 |
1.674e-05 | -11.00 | postsynaptic specialization membrane | cellular component | GO:0099634 | 125 | 5 | 19108 | 49 |
CACNA1C,GABRB2,DLG3,GRID2,GRIN2A |
1.891e-05 | -10.88 | protein localization to synapse | biological process | GO:0035418 | 59 | 4 | 18204 | 49 |
LRRC7,PCLO,GRIN2A,NRXN1 |
1.897e-05 | -10.87 | NLGN2 (neuroligin 2) | protein interactions | 57555 | 63 | 4 | 19454 | 49 |
ST8SIA5,NRXN1,DLG3,NRXN3 |
1.921e-05 | -10.86 | Morphine addiction | KEGG pathways | hsa05032 | 91 | 5 | 7161 | 27 |
GABRA1,GABRA6,GABRB2,GABRD,GABBR2 |
1.921e-05 | -10.86 | Morphine addiction | KEGG pathways | ko05032 | 91 | 5 | 7161 | 27 |
GABRD,GABRB2,GABRA6,GABRA1,GABBR2 |
2.100e-05 | -10.77 | asymmetric synapse | cellular component | GO:0032279 | 333 | 7 | 19108 | 49 |
INSYN1,LRRC7,CACNA1C,PCLO,DLG3,GRIN2A,GRID2 |
2.126e-05 | -10.76 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 33 | 16828 | 48 |
CACNA1C,OLFM1,MYT1L,AK5,RBFOX3,RGS7,RIMS2,ST8SIA5,GABRB2,OPRL1,SLC24A4,ZNF804A,GABBR2,CR2,STXBP5L,KSR2,GRID2,RYR2,NRXN3,GRIN2A,UNC13C,ZFPM2,CELF4,LRRC7,NRXN1,PTPRG,PCLO,HCN1,GABRA1,KCNMA1,TRPM3,KCNT1,ASTN1 |
2.139e-05 | -10.75 | RBFOX1-like | interpro domains | IPR047131 | 3 | 2 | 18521 | 50 |
RBFOX1,RBFOX3 |
2.139e-05 | -10.75 | Fox-1_C_dom | interpro domains | IPR025670 | 3 | 2 | 18521 | 50 |
RBFOX3,RBFOX1 |
2.139e-05 | -10.75 | FOX1_RRM | interpro domains | IPR034237 | 3 | 2 | 18521 | 50 |
RBFOX3,RBFOX1 |
2.139e-05 | -10.75 | RBFOX1-3 | interpro domains | IPR017325 | 3 | 2 | 18521 | 50 |
RBFOX1,RBFOX3 |
2.224e-05 | -10.71 | Fox-1_C | pfam domains | PF12414 | 3 | 2 | 17795 | 49 |
RBFOX3,RBFOX1 |
2.402e-05 | -10.64 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 37 | 16828 | 48 |
IL1RAPL2,GABRA1,KCNMA1,PCLO,CELF5,HCN1,PTPRG,PPP2R5B,NRXN1,LRRC7,CELF4,GRIN2A,UNC13C,ZFPM2,ASTN1,GALNT9,KCNT1,TRPM3,GABRA6,GABRB2,RIMS2,AK5,GABRD,MYT1L,CACNA1C,NRXN3,GRID2,RYR2,RBFOX1,KSR2,STXBP5L,CR2,ZNF804A,GABBR2,KCNIP4,SLC24A4,OPRL1 |
2.421e-05 | -10.63 | dendrite | cellular component | GO:0030425 | 620 | 9 | 19108 | 49 |
GABRA1,ZNF804A,KCNIP4,GABRD,CACNA1C,GRIN2A,GRID2,GABRA6,HCN1 |
2.422e-05 | -10.63 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 18 | 16828 | 48 |
NRXN3,RYR2,TRPM3,STXBP5L,SLC24A4,RGS7,IL1RAPL2,GABRA1,HCN1,PCLO,PTPRG,PPP2R5B,MYT1L,OLFM1,CACNA1C,RIMS4,GRIN2A,UNC13C |
2.478e-05 | -10.61 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 9 | 18094 | 49 |
CACNA1C,GRIN2A,SLC24A4,RYR2,KCNT1,TRPM3,KCNIP4,KCNMA1,HCN1 |
2.483e-05 | -10.60 | dendritic tree | cellular component | GO:0097447 | 622 | 9 | 19108 | 49 |
GRID2,GRIN2A,HCN1,GABRA6,GABRA1,KCNIP4,ZNF804A,CACNA1C,GABRD |
2.743e-05 | -10.50 | regulation of mRNA processing | biological process | GO:0050684 | 132 | 5 | 18204 | 49 |
CELF4,RBFOX3,CELF6,RBFOX1,CELF5 |
2.938e-05 | -10.44 | Protein-protein interactions at synapses | REACTOME pathways | R-HSA-6794362 | 72 | 4 | 10285 | 26 |
DLG3,GRIN2A,NRXN3,NRXN1 |
3.048e-05 | -10.40 | DNAJC18 (DnaJ heat shock protein family (Hsp40) member C18) | protein interactions | 202052 | 71 | 4 | 19454 | 49 |
MARCHF4,GABRA6,GRIN2A,GABRD |
3.115e-05 | -10.38 | neuronal cell body | cellular component | GO:0043025 | 489 | 8 | 19108 | 49 |
ZNF804A,KCNIP4,CACNA1C,GABRD,NRXN1,OLFM1,ASTN1,CPLX1 |
3.125e-05 | -10.37 | inhibitory synapse assembly | biological process | GO:1904862 | 23 | 3 | 18204 | 49 |
GABRA1,GABRA6,GABRB2 |
3.145e-05 | -10.37 | ligand-gated monoatomic cation channel activity | molecular function | GO:0099094 | 135 | 5 | 18094 | 49 |
GRIN2A,RYR2,HCN1,KCNT1,KCNMA1 |
3.188e-05 | -10.35 | Retrograde endocannabinoid signaling | KEGG pathways | ko04723 | 101 | 5 | 7161 | 27 |
GABRD,GABRB2,GABRA6,CACNA1C,GABRA1 |
3.188e-05 | -10.35 | Retrograde endocannabinoid signaling | KEGG pathways | hsa04723 | 101 | 5 | 7161 | 27 |
GABRA6,CACNA1C,GABRA1,GABRD,GABRB2 |
3.258e-05 | -10.33 | calcium ion transmembrane transporter activity | molecular function | GO:0015085 | 136 | 5 | 18094 | 49 |
GRIN2A,SLC24A4,RYR2,CACNA1C,TRPM3 |
3.445e-05 | -10.28 | inorganic cation transmembrane transport | biological process | GO:0098662 | 618 | 9 | 18204 | 49 |
HCN1,CACNA1C,KCNMA1,GRIN2A,KCNIP4,KCNT1,RYR2,SLC24A4,TRPM3 |
3.588e-05 | -10.24 | Ligand-gated ion channel transport | REACTOME pathways | R-HSA-975298 | 26 | 3 | 10285 | 26 |
GABRA6,GABRA1,GABRB2 |
3.773e-05 | -10.19 | neuron to neuron synapse | cellular component | GO:0098984 | 365 | 7 | 19108 | 49 |
GRIN2A,GRID2,DLG3,PCLO,CACNA1C,INSYN1,LRRC7 |
3.942e-05 | -10.14 | peptide hormone secretion | biological process | GO:0030072 | 71 | 4 | 18204 | 49 |
PCLO,RIMS2,CPLX1,SMPD3 |
3.946e-05 | -10.14 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 25 | 16828 | 48 |
ASTN1,PCLO,CELF5,HCN1,PTPRG,IL1RAPL2,GABRA1,KCNMA1,CELF4,UNC13C,GRIN2A,ZFPM2,LRRC7,GRID2,RYR2,NRXN3,ZNF804A,GABBR2,KSR2,STXBP5L,R3HDM1,ST8SIA5,RIMS2,CACNA1C,AK5 |
4.003e-05 | -10.13 | metal ion transport | biological process | GO:0030001 | 630 | 9 | 18204 | 49 |
GRIN2A,KCNT1,KCNIP4,RYR2,HCN1,CACNA1C,KCNMA1,TRPM3,SLC24A4 |
4.145e-05 | -10.09 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 23 | 16828 | 48 |
R3HDM1,ST8SIA5,CACNA1C,AK5,GRID2,RYR2,NRXN3,ZNF804A,GABBR2,STXBP5L,KSR2,PTPRG,PCLO,HCN1,CELF5,GABRA1,IL1RAPL2,UNC13C,GRIN2A,ZFPM2,CELF4,LRRC7,ASTN1 |
4.163e-05 | -10.09 | synaptic vesicle cycle | biological process | GO:0099504 | 144 | 5 | 18204 | 49 |
RIMS2,PCLO,RIMS4,CPLX1,UNC13C |
4.163e-05 | -10.09 | regulated exocytosis | biological process | GO:0045055 | 144 | 5 | 18204 | 49 |
CPLX1,UNC13C,RIMS2,PCLO,RIMS4 |
4.195e-05 | -10.08 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 9 | 18094 | 49 |
HCN1,KCNMA1,KCNIP4,TRPM3,RYR2,KCNT1,SLC24A4,GRIN2A,CACNA1C |
4.271e-05 | -10.06 | K_chnl_Slo-like | interpro domains | IPR047871 | 4 | 2 | 18521 | 50 |
KCNT1,KCNMA1 |
4.271e-05 | -10.06 | Rim-like | interpro domains | IPR039032 | 4 | 2 | 18521 | 50 |
RIMS2,RIMS4 |
4.271e-05 | -10.06 | K_chnl_BK_asu | interpro domains | IPR003929 | 4 | 2 | 18521 | 50 |
KCNT1,KCNMA1 |
4.309e-05 | -10.05 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 9 | 18204 | 49 |
TRPM3,SLC24A4,KCNIP4,KCNT1,GRIN2A,RYR2,CACNA1C,HCN1,KCNMA1 |
4.394e-05 | -10.03 | exocytosis | biological process | GO:0006887 | 241 | 6 | 18204 | 49 |
RIMS2,STXBP5L,UNC13C,CPLX1,RIMS4,PCLO |
4.399e-05 | -10.03 | chemical synaptic transmission, postsynaptic | biological process | GO:0099565 | 73 | 4 | 18204 | 49 |
GRIN2A,INSYN1,CELF4,GRID2 |
4.441e-05 | -10.02 | BK_channel_a | pfam domains | PF03493 | 4 | 2 | 17795 | 49 |
KCNT1,KCNMA1 |
4.527e-05 | -10.00 | large_intestine-caecum-adenoma | COSMIC cancer mutations | large_intestine-caecum-adenoma | 229 | 6 | 16828 | 48 |
PCLO,HCN1,RIMS2,CACNA1C,MYT1L,OLFM1 |
4.711e-05 | -9.96 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 8 | 18204 | 49 |
CELF4,GRIN2A,RIMS2,NRXN1,UNC13C,CPLX1,RIMS4,GRID2 |
4.735e-05 | -9.96 | GABA-ergic synapse | cellular component | GO:0098982 | 78 | 4 | 19108 | 49 |
GABRA1,GABRB2,PCLO,GABRD |
4.778e-05 | -9.95 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 8 | 18204 | 49 |
RIMS4,GRID2,RIMS2,NRXN1,CELF4,GRIN2A,UNC13C,CPLX1 |
4.893e-05 | -9.93 | peptide secretion | biological process | GO:0002790 | 75 | 4 | 18204 | 49 |
CPLX1,SMPD3,PCLO,RIMS2 |
5.734e-05 | -9.77 | calcium-mediated signaling | biological process | GO:0019722 | 154 | 5 | 18204 | 49 |
CACNA1C,KSR2,RYR2,OPRL1,GRIN2A |
5.734e-05 | -9.77 | vesicle-mediated transport in synapse | biological process | GO:0099003 | 154 | 5 | 18204 | 49 |
CPLX1,UNC13C,RIMS2,PCLO,RIMS4 |
5.800e-05 | -9.76 | localization | biological process | GO:0051179 | 4474 | 25 | 18204 | 49 |
SMPD3,GABRA6,LRRC7,RBFOX1,RIMS2,GABRD,SLC24A4,RIMS4,GABRA1,RYR2,KCNIP4,GRID2,HCN1,CPLX1,GABRB2,UNC13C,STXBP5L,CACNA1C,NRXN1,PCLO,TRPM3,KCNMA1,DLG3,GRIN2A,KCNT1 |
5.891e-05 | -9.74 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 14 | 16828 | 48 |
STXBP5L,AK5,KSR2,ZFPM2,UNC13C,GRIN2A,CELF4,IL1RAPL2,ASTN1,NRXN3,PTPRG,HCN1,GRID2,RYR2 |
5.891e-05 | -9.74 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 14 | 16828 | 48 |
HCN1,PTPRG,IL1RAPL2,CELF4,GRIN2A,UNC13C,ZFPM2,AK5,GRID2,RYR2,NRXN3,ASTN1,KSR2,STXBP5L |
6.028e-05 | -9.72 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 41 | 16828 | 48 |
ASTN1,GALNT9,KCNT1,TRPM3,SMPD3,GABRA6,GABRA1,KCNMA1,PCLO,CELF5,HCN1,PTPRG,NRXN1,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,NRXN3,DLG3,GRID2,RYR2,KSR2,RBFOX1,STXBP5L,CR2,GABBR2,KCNIP4,ZNF804A,OPRL1,CELF6,TTC9B,ST8SIA5,RBFOX3,RIMS2,R3HDM1,MYT1L,OLFM1,GABRD,CACNA1C,RIMS4 |
6.082e-05 | -9.71 | alveolar | COSMIC cancer mutations | alveolar | 2414 | 18 | 16828 | 48 |
ZFPM2,GRIN2A,MYT1L,LRRC7,HCN1,PCLO,R3HDM1,PTPRG,GABBR2,ZNF804A,GABRA6,RBFOX1,TRPM3,STXBP5L,RYR2,GRID2,KCNT1,ASTN1 |
6.082e-05 | -9.71 | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | 2414 | 18 | 16828 | 48 |
LRRC7,MYT1L,ZFPM2,GRIN2A,PTPRG,HCN1,R3HDM1,PCLO,STXBP5L,RBFOX1,TRPM3,GABRA6,ZNF804A,GABBR2,ASTN1,KCNT1,RYR2,GRID2 |
6.664e-05 | -9.62 | potassium ion transmembrane transporter activity | molecular function | GO:0015079 | 158 | 5 | 18094 | 49 |
KCNIP4,KCNMA1,HCN1,SLC24A4,KCNT1 |
6.774e-05 | -9.60 | chloride channel activity | molecular function | GO:0005254 | 81 | 4 | 18094 | 49 |
GABRD,GABRA6,GABRB2,GABRA1 |
7.147e-05 | -9.55 | neuroligin family protein binding | molecular function | GO:0097109 | 5 | 2 | 18094 | 49 |
NRXN3,NRXN1 |
7.281e-05 | -9.53 | peptide transport | biological process | GO:0015833 | 83 | 4 | 18204 | 49 |
PCLO,RIMS2,CPLX1,SMPD3 |
7.700e-05 | -9.47 | cell body | cellular component | GO:0044297 | 556 | 8 | 19108 | 49 |
CPLX1,ASTN1,OLFM1,NRXN1,CACNA1C,GABRD,ZNF804A,KCNIP4 |
7.827e-05 | -9.46 | multicellular organism development | biological process | GO:0007275 | 3957 | 23 | 18204 | 49 |
IL1RAPL2,RBFOX1,LRRC7,SMPD3,GABRA6,RYR2,GABRA1,RBFOX3,SLC24A4,NRXN1,CACNA1C,HCN1,GABRB2,OLFM1,GRID2,NRXN3,DLG3,GRIN2A,CELF4,ZFPM2,ASTN1,MYT1L,PCLO |
7.954e-05 | -9.44 | potassium ion transmembrane transport | biological process | GO:0071805 | 165 | 5 | 18204 | 49 |
KCNIP4,KCNT1,KCNMA1,SLC24A4,HCN1 |
8.097e-05 | -9.42 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 7 | 19108 | 49 |
IL1RAPL2,PCLO,DLG3,GRID2,GRIN2A,CPLX1,HCN1 |
8.332e-05 | -9.39 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 12 | 16828 | 48 |
GABBR2,ZNF804A,CELF4,ZFPM2,GRIN2A,KSR2,STXBP5L,HCN1,GRID2,PTPRG,GALNT9,IL1RAPL2 |
8.332e-05 | -9.39 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 12 | 16828 | 48 |
GALNT9,IL1RAPL2,PTPRG,HCN1,GRID2,STXBP5L,KSR2,ZFPM2,GRIN2A,ZNF804A,GABBR2,CELF4 |
8.347e-05 | -9.39 | secretion | biological process | GO:0046903 | 536 | 8 | 18204 | 49 |
RIMS4,PCLO,SMPD3,RIMS2,NRXN1,STXBP5L,UNC13C,CPLX1 |
8.364e-05 | -9.39 | protein localization to cell junction | biological process | GO:1902414 | 86 | 4 | 18204 | 49 |
LRRC7,PCLO,GRIN2A,NRXN1 |
8.604e-05 | -9.36 | positive regulation of excitatory postsynaptic potential | biological process | GO:2000463 | 32 | 3 | 18204 | 49 |
RIMS2,NRXN1,GRIN2A |
9.415e-05 | -9.27 | regulation of exocytosis | biological process | GO:0017157 | 171 | 5 | 18204 | 49 |
SMPD3,CPLX1,RIMS2,RIMS4,PCLO |
9.685e-05 | -9.24 | voltage-gated monoatomic ion channel activity | molecular function | GO:0005244 | 171 | 5 | 18094 | 49 |
CACNA1C,GRIN2A,KCNMA1,KCNT1,HCN1 |
1.004e-04 | -9.21 | femur | COSMIC cancer mutations | femur | 1197 | 12 | 16828 | 48 |
LRRC7,GABRD,GRIN2A,PTPRG,HCN1,STXBP5L,SMPD3,GABRA6,GABBR2,ZNF804A,NRXN3,GRID2 |
1.023e-04 | -9.19 | voltage-gated channel activity | molecular function | GO:0022832 | 173 | 5 | 18094 | 49 |
CACNA1C,KCNT1,HCN1,KCNMA1,GRIN2A |
1.064e-04 | -9.15 | Syndecan/Neurexin_dom | interpro domains | IPR027789 | 6 | 2 | 18521 | 50 |
NRXN3,NRXN1 |
1.064e-04 | -9.15 | Gabra-1-6_TM | interpro domains | IPR047024 | 6 | 2 | 18521 | 50 |
GABRA6,GABRA1 |
1.064e-04 | -9.15 | GABAAa_rcpt | interpro domains | IPR001390 | 6 | 2 | 18521 | 50 |
GABRA1,GABRA6 |
1.073e-04 | -9.14 | molecular transducer activity | molecular function | GO:0060089 | 1474 | 13 | 18094 | 49 |
GRID2,NRXN1,CR2,OPRL1,GABRD,GABRA6,GABRA1,GRIN2A,IL1RAPL2,NRXN3,GABBR2,GABRB2,PTPRG |
1.073e-04 | -9.14 | signaling receptor activity | molecular function | GO:0038023 | 1474 | 13 | 18094 | 49 |
IL1RAPL2,GABBR2,PTPRG,GRID2,CR2,NRXN3,GABRB2,NRXN1,OPRL1,GABRD,GRIN2A,GABRA6,GABRA1 |
1.078e-04 | -9.13 | potassium ion transport | biological process | GO:0006813 | 176 | 5 | 18204 | 49 |
KCNMA1,HCN1,SLC24A4,KCNT1,KCNIP4 |
1.088e-04 | -9.13 | hormone secretion | biological process | GO:0046879 | 92 | 4 | 18204 | 49 |
CPLX1,SMPD3,PCLO,RIMS2 |
1.104e-04 | -9.11 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 12 | 16828 | 48 |
GABRA6,GRID2,RYR2,NRXN3,ZFPM2,UNC13C,PCLO,PTPRG,GABRB2,RIMS2,IL1RAPL2,RGS7 |
1.106e-04 | -9.11 | Syndecan | pfam domains | PF01034 | 6 | 2 | 17795 | 49 |
NRXN1,NRXN3 |
1.110e-04 | -9.11 | cell junction assembly | biological process | GO:0034329 | 285 | 6 | 18204 | 49 |
GRID2,GABRA6,GABRB2,NRXN1,GABRA1,PCLO |
1.176e-04 | -9.05 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 24 | 16828 | 48 |
CACNA1C,MYT1L,RIMS2,KCNIP4,ZNF804A,OPRL1,TTC9B,KSR2,CR2,STXBP5L,RYR2,GRID2,NRXN3,GRIN2A,ZFPM2,NRXN1,LRRC7,PCLO,CELF5,HCN1,KCNMA1,GABRA6,TRPM3,ASTN1 |
1.191e-04 | -9.04 | ST7L (suppression of tumorigenicity 7 like) | protein interactions | 54879 | 38 | 3 | 19454 | 49 |
GABRD,GABRA6,MARCHF4 |
1.200e-04 | -9.03 | nervous system development | biological process | GO:0007399 | 2185 | 16 | 18204 | 49 |
ASTN1,GRIN2A,GABRA1,SLC24A4,PCLO,RBFOX3,MYT1L,GABRB2,HCN1,RBFOX1,IL1RAPL2,NRXN1,NRXN3,GABRA6,OLFM1,GRID2 |
1.232e-04 | -9.00 | calcium ion transmembrane import into cytosol | biological process | GO:0097553 | 95 | 4 | 18204 | 49 |
GRIN2A,RYR2,SLC24A4,CACNA1C |
1.298e-04 | -8.95 | postsynaptic density membrane | cellular component | GO:0098839 | 101 | 4 | 19108 | 49 |
GRIN2A,GRID2,CACNA1C,DLG3 |
1.306e-04 | -8.94 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 8 | 19108 | 49 |
HCN1,GRID2,GRIN2A,CACNA1C,DLG3,KCNIP4,KCNMA1,GABBR2 |
1.313e-04 | -8.94 | monoatomic anion channel activity | molecular function | GO:0005253 | 96 | 4 | 18094 | 49 |
GABRD,GABRA6,GABRB2,GABRA1 |
1.348e-04 | -8.91 | ANF_lig-bd_rcpt | interpro domains | IPR001828 | 37 | 3 | 18521 | 50 |
GRID2,GRIN2A,GABBR2 |
1.363e-04 | -8.90 | regulation of RNA splicing | biological process | GO:0043484 | 185 | 5 | 18204 | 49 |
CELF4,RBFOX3,CELF5,RBFOX1,CELF6 |
1.427e-04 | -8.85 | ANF_receptor | pfam domains | PF01094 | 37 | 3 | 17795 | 49 |
GABBR2,GRID2,GRIN2A |
1.447e-04 | -8.84 | mRNA splice site recognition | biological process | GO:0006376 | 38 | 3 | 18204 | 49 |
CELF5,CELF6,CELF4 |
1.534e-04 | -8.78 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 5 | 10285 | 26 |
TRPM3,GABRB2,GABRA6,GABRA1,RYR2 |
1.577e-04 | -8.75 | ionotropic glutamate receptor complex | cellular component | GO:0008328 | 41 | 3 | 19108 | 49 |
GRID2,GRIN2A,DLG3 |
1.580e-04 | -8.75 | Peripla_BP_I | interpro domains | IPR028082 | 39 | 3 | 18521 | 50 |
GABBR2,GRIN2A,GRID2 |
1.684e-04 | -8.69 | hormone transport | biological process | GO:0009914 | 103 | 4 | 18204 | 49 |
SMPD3,CPLX1,RIMS2,PCLO |
1.759e-04 | -8.65 | cation channel complex | cellular component | GO:0034703 | 205 | 5 | 19108 | 49 |
KCNMA1,RYR2,CACNA1C,HCN1,KCNIP4 |
1.785e-04 | -8.63 | monoatomic cation transport | biological process | GO:0006812 | 766 | 9 | 18204 | 49 |
HCN1,CACNA1C,KCNMA1,GRIN2A,KCNIP4,KCNT1,RYR2,SLC24A4,TRPM3 |
1.805e-04 | -8.62 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 19 | 16828 | 48 |
GABRB2,KCNMA1,RIMS2,HCN1,PCLO,OLFM1,MYT1L,LRRC7,CACNA1C,UNC13C,ASTN1,NRXN3,GRID2,RBFOX1,TRPM3,CR2,GABBR2,GABRA6,OPRL1 |
1.862e-04 | -8.59 | GABAARALPHA | prints domains | PR01079 | 6 | 2 | 5227 | 19 |
GABRA6,GABRA1 |
1.865e-04 | -8.59 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 18 | 16828 | 48 |
STXBP5L,TRPM3,SLC24A4,NRXN3,RYR2,OLFM1,MYT1L,PPP2R5B,RIMS4,GRIN2A,UNC13C,CACNA1C,IL1RAPL2,GABRA1,RGS7,PTPRG,HCN1,PCLO |
1.989e-04 | -8.52 | ligand-gated monoatomic anion channel activity | molecular function | GO:0099095 | 42 | 3 | 18094 | 49 |
GABRB2,GABRA1,GABRA6 |
2.047e-04 | -8.49 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 18 | 16828 | 48 |
GRID2,RYR2,KCNT1,NRXN3,ZNF804A,KSR2,RBFOX1,CR2,STXBP5L,HCN1,R3HDM1,PTPRG,RIMS2,RBFOX3,CACNA1C,ZFPM2,NRXN1,MYT1L |
2.053e-04 | -8.49 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 12 | 16828 | 48 |
KCNT1,CELF5,HCN1,GRID2,GABRA1,RGS7,ASTN1,GABRA6,GRIN2A,GABBR2,CR2,RBFOX1 |
2.127e-04 | -8.46 | RRM_1 | pfam domains | PF00076 | 199 | 5 | 17795 | 49 |
CELF4,RBFOX1,CELF6,CELF5,RBFOX3 |
2.169e-04 | -8.44 | chloride transmembrane transport | biological process | GO:1902476 | 110 | 4 | 18204 | 49 |
GABRA1,GABRD,GABRA6,GABRB2 |
2.199e-04 | -8.42 | calcium ion transmembrane transport | biological process | GO:0070588 | 205 | 5 | 18204 | 49 |
CACNA1C,SLC24A4,RYR2,GRIN2A,TRPM3 |
2.215e-04 | -8.42 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 15 | 16828 | 48 |
NRXN3,RYR2,GRID2,CR2,STXBP5L,KSR2,KCNMA1,RIMS2,HCN1,PCLO,LRRC7,NRXN1,GRIN2A,UNC13C,CACNA1C |
2.226e-04 | -8.41 | neurotransmitter receptor complex | cellular component | GO:0098878 | 46 | 3 | 19108 | 49 |
GRID2,GRIN2A,DLG3 |
2.241e-04 | -8.40 | larynx | COSMIC cancer mutations | larynx | 1948 | 15 | 16828 | 48 |
KSR2,CR2,STXBP5L,NRXN3,GRID2,RYR2,NRXN1,LRRC7,CACNA1C,GRIN2A,UNC13C,KCNMA1,RIMS2,PCLO,HCN1 |
2.246e-04 | -8.40 | synaptic transmission, glutamatergic | biological process | GO:0035249 | 44 | 3 | 18204 | 49 |
UNC13C,GRID2,GRIN2A |
2.257e-04 | -8.40 | axon | cellular component | GO:0030424 | 650 | 8 | 19108 | 49 |
UNC13C,ZNF804A,PCLO,GABRD,LRRC7,HCN1,OLFM1,CPLX1 |
2.292e-04 | -8.38 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 29 | 16828 | 48 |
RYR2,GRID2,NRXN3,GABBR2,ZNF804A,STXBP5L,CR2,RBFOX1,KSR2,R3HDM1,RBFOX3,RIMS2,GABRB2,CACNA1C,MYT1L,AK5,KCNT1,ASTN1,GABRA6,TRPM3,PTPRG,PCLO,HCN1,IL1RAPL2,GRIN2A,UNC13C,ZFPM2,CELF4,LRRC7 |
2.294e-04 | -8.38 | Taste transduction | KEGG pathways | ko04742 | 82 | 4 | 7161 | 27 |
GABBR2,CACNA1C,GABRA1,GABRA6 |
2.294e-04 | -8.38 | Taste transduction | KEGG pathways | hsa04742 | 82 | 4 | 7161 | 27 |
GABBR2,GABRA1,CACNA1C,GABRA6 |
2.320e-04 | -8.37 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 12 | 16828 | 48 |
GRIN2A,OLFM1,RGS7,GABRA6,OPRL1,SLC24A4,ZNF804A,CR2,SMPD3,TRPM3,GRID2,NRXN3 |
2.565e-04 | -8.27 | receptor clustering | biological process | GO:0043113 | 46 | 3 | 18204 | 49 |
NRXN1,DLG3,LRRC7 |
2.582e-04 | -8.26 | synapse organization | biological process | GO:0050808 | 333 | 6 | 18204 | 49 |
NRXN1,GABRA1,PCLO,GRID2,GABRA6,GABRB2 |
2.728e-04 | -8.21 | arm | COSMIC cancer mutations | arm | 1331 | 12 | 16828 | 48 |
TRPM3,CR2,SMPD3,ZNF804A,SLC24A4,GABRA6,OPRL1,NRXN3,GRID2,OLFM1,GRIN2A,RGS7 |
2.788e-04 | -8.19 | RRM_dom | interpro domains | IPR000504 | 215 | 5 | 18521 | 50 |
RBFOX1,CELF5,CELF6,CELF4,RBFOX3 |
2.875e-04 | -8.15 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 21 | 16828 | 48 |
CACNA1C,CELF4,GRIN2A,UNC13C,AK5,LRRC7,MYT1L,CELF5,HCN1,PCLO,PTPRG,RIMS2,GABRA1,ZNF804A,OPRL1,TRPM3,KSR2,GRID2,RYR2,ASTN1,NRXN3 |
2.904e-04 | -8.14 | membrane | cellular component | GO:0016020 | 9220 | 36 | 19108 | 49 |
RYR2,ASTN1,GABRA6,SMPD3,PTPRG,KSR2,NRXN1,LRRC7,NRXN3,GRIN2A,MARCHF4,TRPM3,STXBP5L,RIMS2,KCNMA1,ZNF804A,UNC13C,KCNIP4,GABRB2,ST8SIA5,CACNA1C,GRID2,CR2,CPLX1,RIMS4,GABBR2,IL1RAPL2,KCNT1,GALNT9,HCN1,GABRA1,RGS7,DLG3,OPRL1,GABRD,SLC24A4 |
2.911e-04 | -8.14 | insulin secretion | biological process | GO:0030073 | 48 | 3 | 18204 | 49 |
CPLX1,RIMS2,PCLO |
2.911e-04 | -8.14 | calcium-ion regulated exocytosis | biological process | GO:0017156 | 48 | 3 | 18204 | 49 |
RIMS2,RIMS4,UNC13C |
2.984e-04 | -8.12 | regulation of synaptic plasticity | biological process | GO:0048167 | 219 | 5 | 18204 | 49 |
GRIN2A,RIMS4,RIMS2,UNC13C,GRID2 |
2.998e-04 | -8.11 | chloride transmembrane transporter activity | molecular function | GO:0015108 | 119 | 4 | 18094 | 49 |
GABRD,GABRA6,GABRB2,GABRA1 |
3.026e-04 | -8.10 | regulation of nervous system process | biological process | GO:0031644 | 120 | 4 | 18204 | 49 |
GRIN2A,CELF4,NRXN1,RIMS2 |
3.032e-04 | -8.10 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 44 | 16828 | 48 |
TRPM3,SMPD3,GABRA6,ASTN1,KCNT1,NRXN1,PPP2R5B,LRRC7,CELF4,ZFPM2,GRIN2A,UNC13C,KCNMA1,GABRA1,IL1RAPL2,HCN1,CELF5,PCLO,PTPRG,KSR2,RBFOX1,STXBP5L,CR2,ZNF804A,SLC24A4,GABBR2,TTC9B,CELF6,OPRL1,NRXN3,DLG3,GRID2,RYR2,AK5,MYT1L,GABRD,CPLX1,CACNA1C,RIMS4,GABRB2,ST8SIA5,RIMS2,RGS7,R3HDM1 |
3.056e-04 | -8.09 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-follicular_lymphoma | 208 | 5 | 16828 | 48 |
RIMS2,RGS7,GRID2,PCLO,UNC13C |
3.069e-04 | -8.09 | cervix | COSMIC cancer mutations | cervix | 11793 | 44 | 16828 | 48 |
R3HDM1,RIMS2,ST8SIA5,GABRB2,RIMS4,CPLX1,GABRD,MYT1L,AK5,DLG3,NRXN3,CELF6,TTC9B,GABBR2,STXBP5L,RBFOX1,CELF5,GABRA1,IL1RAPL2,GRIN2A,UNC13C,ZFPM2,CELF4,LRRC7,TRPM3,RGS7,CACNA1C,RYR2,GRID2,OPRL1,ZNF804A,SLC24A4,CR2,KSR2,PTPRG,PCLO,HCN1,KCNMA1,PPP2R5B,NRXN1,KCNT1,ASTN1,GABRA6,SMPD3 |
3.123e-04 | -8.07 | chloride transport | biological process | GO:0006821 | 121 | 4 | 18204 | 49 |
GABRB2,GABRA6,GABRA1,GABRD |
3.297e-04 | -8.02 | potassium channel activity | molecular function | GO:0005267 | 122 | 4 | 18094 | 49 |
KCNMA1,KCNT1,HCN1,KCNIP4 |
3.369e-04 | -8.00 | CELF3 (CUGBP Elav-like family member 3) | protein interactions | 11189 | 11 | 2 | 19454 | 49 |
RBFOX1,CELF5 |
3.510e-04 | -7.95 | PDZ | pfam domains | PF00595 | 122 | 4 | 17795 | 49 |
DLG3,PCLO,LRRC7,RIMS2 |
3.569e-04 | -7.94 | functioning | COSMIC cancer mutations | functioning | 1803 | 14 | 16828 | 48 |
RIMS4,UNC13C,GRIN2A,MYT1L,OLFM1,PTPRG,HCN1,PCLO,IL1RAPL2,SLC24A4,STXBP5L,TRPM3,RYR2,NRXN3 |
3.569e-04 | -7.94 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 14 | 16828 | 48 |
RYR2,NRXN3,SLC24A4,TRPM3,STXBP5L,PCLO,HCN1,PTPRG,IL1RAPL2,GRIN2A,UNC13C,RIMS4,MYT1L,OLFM1 |
3.621e-04 | -7.92 | C2 | pfam domains | PF00168 | 123 | 4 | 17795 | 49 |
PCLO,RIMS4,UNC13C,RIMS2 |
3.890e-04 | -7.85 | benzodiazepine receptor activity | molecular function | GO:0008503 | 11 | 2 | 18094 | 49 |
GABRA6,GABRA1 |
3.944e-04 | -7.84 | RRM | prosite domains | PS50102 | 209 | 5 | 12186 | 37 |
RBFOX3,CELF5,RBFOX1,CELF6,CELF4 |
4.186e-04 | -7.78 | transmembrane signaling receptor activity | molecular function | GO:0004888 | 1251 | 11 | 18094 | 49 |
CR2,GRID2,PTPRG,GABBR2,IL1RAPL2,GABRA6,GABRA1,GRIN2A,GABRD,OPRL1,GABRB2 |
4.347e-04 | -7.74 | inorganic anion transmembrane transport | biological process | GO:0098661 | 132 | 4 | 18204 | 49 |
GABRA1,GABRD,GABRA6,GABRB2 |
4.462e-04 | -7.71 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 13 | 16828 | 48 |
KSR2,ZNF804A,CELF6,GABRA6,NRXN3,DLG3,RYR2,GRID2,KCNT1,LRRC7,ZFPM2,IL1RAPL2,RIMS2 |
4.462e-04 | -7.71 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 13 | 16828 | 48 |
NRXN3,DLG3,GRID2,RYR2,KCNT1,KSR2,ZNF804A,GABRA6,CELF6,RIMS2,IL1RAPL2,LRRC7,ZFPM2 |
4.504e-04 | -7.71 | system development | biological process | GO:0048731 | 3533 | 20 | 18204 | 49 |
NRXN1,IL1RAPL2,CACNA1C,RBFOX1,HCN1,GABRB2,GRID2,OLFM1,SMPD3,GABRA6,NRXN3,RYR2,GABRA1,GRIN2A,ZFPM2,ASTN1,MYT1L,RBFOX3,PCLO,SLC24A4 |
4.605e-04 | -7.68 | regulation of ventricular cardiac muscle cell action potential | biological process | GO:0098911 | 12 | 2 | 18204 | 49 |
RYR2,CACNA1C |
4.794e-04 | -7.64 | RBD_domain_sf | interpro domains | IPR035979 | 242 | 5 | 18521 | 50 |
CELF6,RBFOX3,CELF4,RBFOX1,CELF5 |
5.070e-04 | -7.59 | Nucleotide-bd_a/b_plait_sf | interpro domains | IPR012677 | 245 | 5 | 18521 | 50 |
RBFOX1,CELF5,CELF6,CELF4,RBFOX3 |
5.116e-04 | -7.58 | DLG2 (discs large MAGUK scaffold protein 2) | protein interactions | 1740 | 62 | 3 | 19454 | 49 |
GRIN2A,GRID2,DLG3 |
5.271e-04 | -7.55 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 23 | 16828 | 48 |
KCNT1,ASTN1,GABRA6,TRPM3,PTPRG,PCLO,HCN1,UNC13C,GRIN2A,ZFPM2,LRRC7,RYR2,GRID2,ZNF804A,GABBR2,CR2,STXBP5L,RBFOX1,R3HDM1,RIMS2,GABRB2,CACNA1C,MYT1L |
5.286e-04 | -7.55 | skin-neck-malignant_melanoma | COSMIC cancer mutations | skin-neck-malignant_melanoma | 1223 | 11 | 16828 | 48 |
ASTN1,RIMS2,IL1RAPL2,GRID2,AK5,TRPM3,SMPD3,CR2,ZNF804A,GABRA6,GRIN2A |
5.368e-04 | -7.53 | scalp | COSMIC cancer mutations | scalp | 2110 | 15 | 16828 | 48 |
GRID2,KCNT1,ASTN1,NRXN3,GABBR2,GABRA6,OPRL1,CR2,SMPD3,STXBP5L,RIMS2,GRIN2A,NRXN1,LRRC7,OLFM1 |
5.432e-04 | -7.52 | calcium ion transport into cytosol | biological process | GO:0060402 | 13 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
5.459e-04 | -7.51 | RRM | smart domains | SM00360 | 202 | 5 | 9717 | 33 |
CELF6,CELF4,CELF5,RBFOX3,RBFOX1 |
5.566e-04 | -7.49 | calcium ion transport | biological process | GO:0006816 | 251 | 5 | 18204 | 49 |
CACNA1C,SLC24A4,RYR2,TRPM3,GRIN2A |
5.586e-04 | -7.49 | neck | COSMIC cancer mutations | neck | 1231 | 11 | 16828 | 48 |
GRID2,ASTN1,IL1RAPL2,RIMS2,ZNF804A,GRIN2A,GABRA6,TRPM3,AK5,SMPD3,CR2 |
5.656e-04 | -7.48 | - | gene3d domains | 3.40.50.2300 | 50 | 3 | 14470 | 47 |
GRIN2A,GRID2,GABBR2 |
5.676e-04 | -7.47 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 12 | 16828 | 48 |
LRRC7,MYT1L,NRXN1,UNC13C,CACNA1C,GABRA1,PCLO,STXBP5L,TRPM3,GABRA6,ASTN1,RYR2 |
5.726e-04 | -7.47 | monoatomic anion transmembrane transport | biological process | GO:0098656 | 142 | 4 | 18204 | 49 |
GABRB2,GABRA6,GABRA1,GABRD |
5.730e-04 | -7.46 | syntaxin binding | molecular function | GO:0019905 | 60 | 3 | 18094 | 49 |
UNC13C,CPLX1,STXBP5L |
5.857e-04 | -7.44 | monoatomic anion transmembrane transporter activity | molecular function | GO:0008509 | 142 | 4 | 18094 | 49 |
GABRA6,GABRA1,GABRB2,GABRD |
5.957e-04 | -7.43 | C2_dom | interpro domains | IPR000008 | 143 | 4 | 18521 | 50 |
UNC13C,RIMS2,RIMS4,PCLO |
6.014e-04 | -7.42 | voltage-gated monoatomic cation channel activity | molecular function | GO:0022843 | 143 | 4 | 18094 | 49 |
HCN1,KCNT1,KCNMA1,CACNA1C |
6.023e-04 | -7.41 | perikaryon | cellular component | GO:0043204 | 151 | 4 | 19108 | 49 |
OLFM1,ASTN1,CACNA1C,CPLX1 |
6.035e-04 | -7.41 | amide transport | biological process | GO:0042886 | 144 | 4 | 18204 | 49 |
PCLO,RIMS2,CPLX1,SMPD3 |
6.327e-04 | -7.37 | response to redox state | biological process | GO:0051775 | 14 | 2 | 18204 | 49 |
SMPD3,RYR2 |
6.366e-04 | -7.36 | Neurexin-like | interpro domains | IPR003585 | 14 | 2 | 18521 | 50 |
NRXN3,NRXN1 |
6.440e-04 | -7.35 | PDZ | interpro domains | IPR001478 | 146 | 4 | 18521 | 50 |
RIMS2,PCLO,LRRC7,DLG3 |
6.532e-04 | -7.33 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 46 | 16828 | 48 |
RBFOX1,STXBP5L,KCNIP4,GABBR2,CELF6,NRXN3,AK5,MYT1L,OLFM1,GABRD,CPLX1,RIMS4,ST8SIA5,GABRB2,RIMS2,R3HDM1,TRPM3,GALNT9,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,IL1RAPL2,GABRA1,CELF5,KSR2,CR2,SLC24A4,ZNF804A,OPRL1,RYR2,GRID2,CACNA1C,RGS7,RBFOX3,SMPD3,GABRA6,ASTN1,KCNT1,PPP2R5B,NRXN1,KCNMA1,PCLO,HCN1,PTPRG |
6.950e-04 | -7.27 | PDZ_sf | interpro domains | IPR036034 | 149 | 4 | 18521 | 50 |
PCLO,RIMS2,DLG3,LRRC7 |
7.292e-04 | -7.22 | GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3) | protein interactions | 2562 | 16 | 2 | 19454 | 49 |
GABRA6,GABRB2 |
7.303e-04 | -7.22 | C2 | smart domains | SM00239 | 122 | 4 | 9717 | 33 |
PCLO,RIMS2,RIMS4,UNC13C |
7.504e-04 | -7.19 | DLG4 (discs large MAGUK scaffold protein 4) | protein interactions | 1742 | 163 | 4 | 19454 | 49 |
GRIN2A,DLG3,PTPRG,LRRC7 |
7.565e-04 | -7.19 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 41 | 16828 | 48 |
KSR2,RBFOX1,STXBP5L,CR2,SLC24A4,GABBR2,ZNF804A,OPRL1,CELF6,NRXN3,DLG3,GRID2,RYR2,AK5,MYT1L,OLFM1,GABRD,CACNA1C,RIMS4,ST8SIA5,RGS7,RIMS2,TRPM3,SMPD3,GABRA6,ASTN1,KCNT1,PPP2R5B,NRXN1,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,GABRA1,IL1RAPL2,KCNMA1,PCLO,CELF5,HCN1,PTPRG |
7.762e-04 | -7.16 | learning | biological process | GO:0007612 | 154 | 4 | 18204 | 49 |
NRXN3,OPRL1,GRIN2A,NRXN1 |
7.778e-04 | -7.16 | excitatory postsynaptic potential | biological process | GO:0060079 | 67 | 3 | 18204 | 49 |
GRIN2A,CELF4,GRID2 |
7.926e-04 | -7.14 | GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A) | protein interactions | 2903 | 72 | 3 | 19454 | 49 |
PPP2R5B,DLG3,GRIN2A |
8.322e-04 | -7.09 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 11 | 16828 | 48 |
ST8SIA5,RIMS2,PTPRG,MYT1L,ZFPM2,NRXN3,RYR2,KCNT1,RBFOX1,KSR2,SMPD3 |
8.342e-04 | -7.09 | positive regulation of synaptic transmission | biological process | GO:0050806 | 157 | 4 | 18204 | 49 |
GRIN2A,RIMS4,RIMS2,NRXN1 |
8.659e-04 | -7.05 | C2 | prosite domains | PS50004 | 142 | 4 | 12186 | 37 |
RIMS4,UNC13C,RIMS2,PCLO |
8.745e-04 | -7.04 | monoatomic anion transport | biological process | GO:0006820 | 159 | 4 | 18204 | 49 |
GABRA1,GABRD,GABRB2,GABRA6 |
8.826e-04 | -7.03 | nodular | COSMIC cancer mutations | nodular | 1515 | 12 | 16828 | 48 |
GABRA1,RGS7,ASTN1,KCNT1,GRID2,CELF5,HCN1,CR2,RBFOX1,GRIN2A,GABRA6,GABBR2 |
8.889e-04 | -7.03 | PDZ | prosite domains | PS50106 | 143 | 4 | 12186 | 37 |
DLG3,PCLO,LRRC7,RIMS2 |
8.943e-04 | -7.02 | inorganic anion transmembrane transporter activity | molecular function | GO:0015103 | 159 | 4 | 18094 | 49 |
GABRB2,GABRA1,GABRA6,GABRD |
9.162e-04 | -7.00 | inorganic anion transport | biological process | GO:0015698 | 161 | 4 | 18204 | 49 |
GABRD,GABRA1,GABRA6,GABRB2 |
9.267e-04 | -6.98 | GRIK5 (glutamate ionotropic receptor kainate type subunit 5) | protein interactions | 2901 | 18 | 2 | 19454 | 49 |
GRID2,DLG3 |
9.407e-04 | -6.97 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
9.601e-04 | -6.95 | calyx of Held | cellular component | GO:0044305 | 18 | 2 | 19108 | 49 |
CPLX1,UNC13C |
9.636e-04 | -6.94 | LITAF (lipopolysaccharide induced TNF factor) | protein interactions | 9516 | 77 | 3 | 19454 | 49 |
KCNIP4,CACNA1C,R3HDM1 |
9.687e-04 | -6.94 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 32 | 16828 | 48 |
RIMS4,CACNA1C,CPLX1,MYT1L,OLFM1,AK5,R3HDM1,RBFOX3,ST8SIA5,ZNF804A,KCNIP4,GABBR2,STXBP5L,KSR2,GRID2,RYR2,NRXN3,UNC13C,GRIN2A,ZFPM2,CELF4,LRRC7,PTPRG,PCLO,HCN1,CELF5,IL1RAPL2,GABRA1,GABRA6,KCNT1,GALNT9,ASTN1 |
9.910e-04 | -6.92 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 21 | 16828 | 48 |
PTPRG,PCLO,HCN1,IL1RAPL2,RIMS2,GRIN2A,CELF4,CACNA1C,LRRC7,OLFM1,AK5,NRXN1,KCNT1,GRID2,RYR2,NRXN3,ASTN1,GABRA6,ZNF804A,GABBR2,KSR2 |
9.910e-04 | -6.92 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 21 | 16828 | 48 |
ZNF804A,GABBR2,GABRA6,KSR2,RYR2,GRID2,KCNT1,ASTN1,NRXN3,CACNA1C,CELF4,GRIN2A,NRXN1,AK5,OLFM1,LRRC7,HCN1,PCLO,PTPRG,RIMS2,IL1RAPL2 |
9.922e-04 | -6.92 | 4.1m | smart domains | SM00294 | 14 | 2 | 9717 | 33 |
NRXN3,NRXN1 |
1.048e-03 | -6.86 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 9 | 16828 | 48 |
ZNF804A,GRID2,GABRA6,GRIN2A,ASTN1,NRXN3,RBFOX1,GABRD,GABRA1 |
1.063e-03 | -6.85 | Iono_Glu_rcpt_met | interpro domains | IPR001508 | 18 | 2 | 18521 | 50 |
GRID2,GRIN2A |
1.063e-03 | -6.85 | Ionotropic_Glu_rcpt | interpro domains | IPR015683 | 18 | 2 | 18521 | 50 |
GRID2,GRIN2A |
1.063e-03 | -6.85 | Glu/Gly-bd | interpro domains | IPR019594 | 18 | 2 | 18521 | 50 |
GRIN2A,GRID2 |
1.063e-03 | -6.85 | Iontro_rcpt_C | interpro domains | IPR001320 | 18 | 2 | 18521 | 50 |
GRID2,GRIN2A |
1.071e-03 | -6.84 | parallel fiber to Purkinje cell synapse | cellular component | GO:0098688 | 19 | 2 | 19108 | 49 |
UNC13C,GRID2 |
1.105e-03 | -6.81 | Lig_chan | pfam domains | PF00060 | 18 | 2 | 17795 | 49 |
GRID2,GRIN2A |
1.105e-03 | -6.81 | Lig_chan-Glu_bd | pfam domains | PF10613 | 18 | 2 | 17795 | 49 |
GRIN2A,GRID2 |
1.117e-03 | -6.80 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 22 | 16828 | 48 |
R3HDM1,PCLO,HCN1,PTPRG,RIMS2,CACNA1C,UNC13C,GRIN2A,ZFPM2,MYT1L,LRRC7,GRID2,RYR2,KCNT1,ASTN1,ZNF804A,GABBR2,GABRA6,RBFOX1,TRPM3,STXBP5L,CR2 |
1.147e-03 | -6.77 | - | gene3d domains | 3.30.70.330 | 245 | 5 | 14470 | 47 |
RBFOX3,CELF4,RBFOX1,CELF5,CELF6 |
1.160e-03 | -6.76 | C2_domain_sf | interpro domains | IPR035892 | 171 | 4 | 18521 | 50 |
UNC13C,PCLO,RIMS4,RIMS2 |
1.179e-03 | -6.74 | excitatory synapse assembly | biological process | GO:1904861 | 19 | 2 | 18204 | 49 |
NRXN1,GRID2 |
1.179e-03 | -6.74 | vocalization behavior | biological process | GO:0071625 | 19 | 2 | 18204 | 49 |
NRXN3,NRXN1 |
1.245e-03 | -6.69 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 33 | 16828 | 48 |
GABBR2,ZNF804A,CR2,STXBP5L,KSR2,RYR2,GRID2,DLG3,NRXN3,CACNA1C,OLFM1,AK5,R3HDM1,RBFOX3,ST8SIA5,GABRB2,GABRA6,SMPD3,TRPM3,KCNT1,GALNT9,ASTN1,UNC13C,GRIN2A,ZFPM2,CELF4,LRRC7,PTPRG,PCLO,HCN1,CELF5,IL1RAPL2,GABRA1 |
1.253e-03 | -6.68 | SALM protein interactions at the synapses | REACTOME pathways | R-HSA-8849932 | 21 | 2 | 10285 | 26 |
GRIN2A,DLG3 |
1.261e-03 | -6.68 | behavior | biological process | GO:0007610 | 619 | 7 | 18204 | 49 |
GRIN2A,NRXN1,ASTN1,HCN1,OPRL1,SLC24A4,NRXN3 |
1.321e-03 | -6.63 | PDZ | smart domains | SM00228 | 143 | 4 | 9717 | 33 |
PCLO,RIMS2,DLG3,LRRC7 |
1.366e-03 | -6.60 | - | gene3d domains | 2.30.42.10 | 149 | 4 | 14470 | 47 |
LRRC7,DLG3,RIMS2,PCLO |
1.398e-03 | -6.57 | regulation of neurotransmitter secretion | biological process | GO:0046928 | 82 | 3 | 18204 | 49 |
CPLX1,RIMS2,RIMS4 |
1.412e-03 | -6.56 | regulation of monoatomic cation transmembrane transport | biological process | GO:1904062 | 309 | 5 | 18204 | 49 |
CACNA1C,RYR2,GRIN2A,RGS7,KCNIP4 |
1.418e-03 | -6.56 | NLGN3 (neuroligin 3) | protein interactions | 54413 | 88 | 3 | 19454 | 49 |
DLG3,NRXN1,NRXN3 |
1.443e-03 | -6.54 | plasma membrane signaling receptor complex | cellular component | GO:0098802 | 191 | 4 | 19108 | 49 |
GABBR2,GRIN2A,GRID2,DLG3 |
1.448e-03 | -6.54 | spliceosomal complex assembly | biological process | GO:0000245 | 83 | 3 | 18204 | 49 |
CELF4,CELF6,CELF5 |
1.567e-03 | -6.46 | chondrosarcoma | COSMIC cancer mutations | chondrosarcoma | 1181 | 10 | 16828 | 48 |
HCN1,GRID2,PCLO,R3HDM1,RYR2,GABRA6,CR2,GABRD,STXBP5L,LRRC7 |
1.584e-03 | -6.45 | cell communication by electrical coupling | biological process | GO:0010644 | 22 | 2 | 18204 | 49 |
RYR2,CACNA1C |
1.584e-03 | -6.45 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | biological process | GO:0010881 | 22 | 2 | 18204 | 49 |
RYR2,CACNA1C |
1.592e-03 | -6.44 | voltage-gated potassium channel complex | cellular component | GO:0008076 | 90 | 3 | 19108 | 49 |
KCNMA1,HCN1,KCNIP4 |
1.603e-03 | -6.44 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 41 | 16828 | 48 |
TRPM3,SMPD3,GABRA6,ASTN1,KCNT1,PPP2R5B,NRXN1,LRRC7,CELF4,GRIN2A,UNC13C,ZFPM2,GABRA1,IL1RAPL2,KCNMA1,PCLO,CELF5,HCN1,PTPRG,RBFOX1,KSR2,CR2,STXBP5L,GABBR2,ZNF804A,SLC24A4,OPRL1,CELF6,NRXN3,DLG3,RYR2,GRID2,AK5,OLFM1,MYT1L,GABRD,CACNA1C,RIMS4,ST8SIA5,RGS7,RIMS2 |
1.617e-03 | -6.43 | C2 domain | gene3d domains | 2.60.40.150 | 156 | 4 | 14470 | 47 |
RIMS4,PCLO,RIMS2,UNC13C |
1.625e-03 | -6.42 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 21 | 16828 | 48 |
UNC13C,GRIN2A,CACNA1C,MYT1L,LRRC7,AK5,PPP2R5B,PTPRG,PCLO,R3HDM1,HCN1,GABRA1,RIMS2,GABRB2,GABRA6,CR2,STXBP5L,KSR2,KCNT1,GRID2,RYR2 |
1.631e-03 | -6.42 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 21 | 16828 | 48 |
LRRC7,MYT1L,PPP2R5B,AK5,UNC13C,GRIN2A,CACNA1C,RIMS2,GABRA1,GABRB2,PTPRG,HCN1,R3HDM1,PCLO,CR2,STXBP5L,KSR2,GABRA6,KCNT1,RYR2,GRID2 |
1.654e-03 | -6.40 | PBPe | smart domains | SM00079 | 18 | 2 | 9717 | 33 |
GRID2,GRIN2A |
1.654e-03 | -6.40 | Lig_chan-Glu_bd | smart domains | SM00918 | 18 | 2 | 9717 | 33 |
GRID2,GRIN2A |
1.656e-03 | -6.40 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 44 | 16828 | 48 |
CPLX1,RIMS4,AK5,OLFM1,GABRD,MYT1L,R3HDM1,GABRB2,ST8SIA5,GABBR2,KCNIP4,CELF6,RBFOX1,STXBP5L,NRXN3,CELF4,ZFPM2,UNC13C,GRIN2A,LRRC7,CELF5,IL1RAPL2,GABRA1,TRPM3,GALNT9,CACNA1C,RGS7,RBFOX3,ZNF804A,OPRL1,KSR2,CR2,RYR2,GRID2,NRXN1,PPP2R5B,HCN1,PCLO,PTPRG,KCNMA1,GABRA6,SMPD3,KCNT1,ASTN1 |
1.656e-03 | -6.40 | CNKSR2 (connector enhancer of kinase suppressor of Ras 2) | protein interactions | 22866 | 24 | 2 | 19454 | 49 |
LRRC7,DLG3 |
1.720e-03 | -6.37 | CASK (calcium/calmodulin dependent serine protein kinase) | protein interactions | 8573 | 204 | 4 | 19454 | 49 |
NRXN3,DLG3,NRXN1,GRIN2A |
1.775e-03 | -6.33 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 13 | 16828 | 48 |
CR2,CELF6,ASTN1,NRXN3,RYR2,GRID2,MYT1L,ZFPM2,GRIN2A,CACNA1C,KCNMA1,PTPRG,HCN1 |
1.784e-03 | -6.33 | extremity | COSMIC cancer mutations | extremity | 1876 | 13 | 16828 | 48 |
GRID2,RYR2,NRXN3,ASTN1,CELF6,CR2,PTPRG,HCN1,KCNMA1,GRIN2A,ZFPM2,CACNA1C,MYT1L |
1.828e-03 | -6.30 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 21 | 16828 | 48 |
PTPRG,PCLO,R3HDM1,HCN1,GABRA1,RIMS2,GABRB2,GRIN2A,UNC13C,CACNA1C,MYT1L,LRRC7,AK5,PPP2R5B,KCNT1,GRID2,RYR2,GABRA6,STXBP5L,CR2,KSR2 |
1.850e-03 | -6.29 | NMDARECEPTOR | prints domains | PR00177 | 18 | 2 | 5227 | 19 |
GRIN2A,GRID2 |
1.856e-03 | -6.29 | multicellular organismal process | biological process | GO:0032501 | 6177 | 27 | 18204 | 49 |
IL1RAPL2,RBFOX1,OPRL1,LRRC7,CR2,SMPD3,GABRA6,INSYN1,RYR2,GABRA1,RBFOX3,SLC24A4,NRXN1,GABRB2,HCN1,CACNA1C,NRXN3,OLFM1,GRID2,GRIN2A,DLG3,CELF4,ASTN1,KCNMA1,ZFPM2,PCLO,MYT1L |
1.863e-03 | -6.29 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 11 | 16828 | 48 |
SLC24A4,ZFPM2,RBFOX1,GABRD,CR2,MYT1L,RYR2,PCLO,PTPRG,ASTN1,RGS7 |
1.863e-03 | -6.29 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 11 | 16828 | 48 |
ZFPM2,GABRD,MYT1L,PCLO,PTPRG,RGS7,SLC24A4,RBFOX1,CR2,RYR2,ASTN1 |
1.913e-03 | -6.26 | human chr4q22.1-q22.2 | chromosome location | human chr4q22.1-q22.2 | 1 | 1 | 26134 | 50 |
GRID2 |
1.913e-03 | -6.26 | human chr12q24.22-q24.23 | chromosome location | human chr12q24.22-q24.23 | 1 | 1 | 26134 | 50 |
KSR2 |
1.913e-03 | -6.26 | human chr4p15.31-p15.2 | chromosome location | human chr4p15.31-p15.2 | 1 | 1 | 26134 | 50 |
KCNIP4 |
1.913e-03 | -6.26 | human chr9q21.12-q21.13 | chromosome location | human chr9q21.12-q21.13 | 1 | 1 | 26134 | 50 |
TRPM3 |
1.913e-03 | -6.26 | human chr14q24.3-q31.1 | chromosome location | human chr14q24.3-q31.1 | 1 | 1 | 26134 | 50 |
NRXN3 |
1.913e-03 | -6.26 | human chr1q43|1q23.1 | chromosome location | human chr1q43|1q23.1 | 1 | 1 | 26134 | 50 |
RGS7 |
1.931e-03 | -6.25 | SERPINA12 (serpin family A member 12) | protein interactions | 145264 | 98 | 3 | 19454 | 49 |
PTPRG,GALNT9,RBFOX1 |
1.971e-03 | -6.23 | Potassium Channels | REACTOME pathways | R-HSA-1296071 | 100 | 3 | 10285 | 26 |
HCN1,GABBR2,KCNMA1 |
2.000e-03 | -6.21 | anatomical structure development | biological process | GO:0048856 | 5207 | 24 | 18204 | 49 |
PCLO,MYT1L,CELF4,GRIN2A,DLG3,ASTN1,ZFPM2,NRXN3,OLFM1,GRID2,NRXN1,CACNA1C,HCN1,GABRB2,RBFOX3,SLC24A4,RYR2,GABRA1,LRRC7,CR2,GABRA6,SMPD3,IL1RAPL2,RBFOX1 |
2.046e-03 | -6.19 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 40 | 16828 | 48 |
CELF4,UNC13C,GRIN2A,ZFPM2,PPP2R5B,NRXN1,LRRC7,PCLO,CELF5,HCN1,PTPRG,GABRA1,IL1RAPL2,GABRA6,TRPM3,KCNT1,ASTN1,CACNA1C,CPLX1,RIMS4,AK5,OLFM1,GABRD,MYT1L,R3HDM1,ST8SIA5,GABRB2,RBFOX3,RIMS2,ZNF804A,GABBR2,OPRL1,CELF6,KSR2,RBFOX1,STXBP5L,CR2,RYR2,GRID2,NRXN3 |
2.083e-03 | -6.17 | pancreas-other-cystic_tumour | COSMIC cancer mutations | pancreas-other-cystic_tumour | 89 | 3 | 16828 | 48 |
R3HDM1,KCNT1,AK5 |
2.083e-03 | -6.17 | cystic_tumour | COSMIC cancer mutations | cystic_tumour | 89 | 3 | 16828 | 48 |
AK5,R3HDM1,KCNT1 |
2.085e-03 | -6.17 | liver-carcinoma-hepatocellular_carcinoma | COSMIC cancer mutations | liver-carcinoma-hepatocellular_carcinoma | 14800 | 48 | 16828 | 48 |
ST8SIA5,GABRB2,RIMS2,R3HDM1,AK5,OLFM1,MYT1L,GABRD,CPLX1,RIMS4,NRXN3,DLG3,RBFOX1,STXBP5L,KCNIP4,GABBR2,TTC9B,CELF6,IL1RAPL2,GABRA1,CELF5,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,GALNT9,TRPM3,RBFOX3,RGS7,CACNA1C,GRID2,RYR2,KSR2,CR2,ZNF804A,SLC24A4,OPRL1,KCNMA1,PCLO,HCN1,PTPRG,PPP2R5B,NRXN1,ASTN1,KCNT1,SMPD3,GABRA6 |
2.085e-03 | -6.17 | hepatocellular_carcinoma | COSMIC cancer mutations | hepatocellular_carcinoma | 14800 | 48 | 16828 | 48 |
RBFOX1,STXBP5L,GABBR2,KCNIP4,TTC9B,CELF6,NRXN3,DLG3,AK5,MYT1L,GABRD,OLFM1,CPLX1,RIMS4,GABRB2,ST8SIA5,RIMS2,R3HDM1,TRPM3,GALNT9,LRRC7,CELF4,ZFPM2,UNC13C,GRIN2A,GABRA1,IL1RAPL2,CELF5,KSR2,CR2,SLC24A4,ZNF804A,OPRL1,RYR2,GRID2,CACNA1C,RGS7,RBFOX3,SMPD3,GABRA6,ASTN1,KCNT1,NRXN1,PPP2R5B,KCNMA1,HCN1,PCLO,PTPRG |
2.095e-03 | -6.17 | DLGAP1 (DLG associated protein 1) | protein interactions | 9229 | 27 | 2 | 19454 | 49 |
DLG3,GRIN2A |
2.214e-03 | -6.11 | potassium channel complex | cellular component | GO:0034705 | 101 | 3 | 19108 | 49 |
KCNIP4,HCN1,KCNMA1 |
2.240e-03 | -6.10 | glutamate receptor activity | molecular function | GO:0008066 | 26 | 2 | 18094 | 49 |
GRID2,GRIN2A |
2.253e-03 | -6.10 | GRIK2 (glutamate ionotropic receptor kainate type subunit 2) | protein interactions | 2898 | 28 | 2 | 19454 | 49 |
GRID2,DLG3 |
2.312e-03 | -6.07 | tibia | COSMIC cancer mutations | tibia | 836 | 8 | 16828 | 48 |
LRRC7,KSR2,TRPM3,ZFPM2,ZNF804A,NRXN3,ASTN1,R3HDM1 |
2.316e-03 | -6.07 | calmodulin binding | molecular function | GO:0005516 | 206 | 4 | 18094 | 49 |
UNC13C,SLC24A4,RYR2,CACNA1C |
2.344e-03 | -6.06 | regulation of monoatomic ion transmembrane transport | biological process | GO:0034765 | 347 | 5 | 18204 | 49 |
RGS7,KCNIP4,GRIN2A,RYR2,CACNA1C |
2.370e-03 | -6.04 | thyroid-other-neoplasm | COSMIC cancer mutations | thyroid-other-neoplasm | 7637 | 32 | 16828 | 48 |
RBFOX1,KSR2,CR2,STXBP5L,ZNF804A,GABBR2,CELF6,NRXN3,RYR2,OLFM1,MYT1L,GABRD,CACNA1C,ST8SIA5,RBFOX3,RIMS2,R3HDM1,TRPM3,SMPD3,GABRA6,ASTN1,GALNT9,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,GABRA1,KCNMA1,PCLO,CELF5,PTPRG |
2.387e-03 | -6.04 | cell-cell signaling involved in cardiac conduction | biological process | GO:0086019 | 27 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
2.387e-03 | -6.04 | regulation of cardiac muscle contraction by calcium ion signaling | biological process | GO:0010882 | 27 | 2 | 18204 | 49 |
RYR2,CACNA1C |
2.398e-03 | -6.03 | regulation of neurotransmitter transport | biological process | GO:0051588 | 99 | 3 | 18204 | 49 |
RIMS2,RIMS4,CPLX1 |
2.439e-03 | -6.02 | voltage-gated potassium channel activity | molecular function | GO:0005249 | 99 | 3 | 18094 | 49 |
KCNT1,HCN1,KCNMA1 |
2.501e-03 | -5.99 | Periplasmic binding protein-like II | gene3d domains | 3.40.190.10 | 23 | 2 | 14470 | 47 |
GRIN2A,GRID2 |
2.519e-03 | -5.98 | Akap7 (A-kinase anchoring protein 7) | protein interactions | 361458 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Zmpste24 (zinc metallopeptidase STE24) | protein interactions | 313564 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Itln1 (intelectin 1) | protein interactions | 498284 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Dync1i2 (dynein cytoplasmic 1 intermediate chain 2) | protein interactions | 116659 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ndufs1 (NADH:ubiquinone oxidoreductase core subunit S1) | protein interactions | 301458 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ndufb8 (NADH:ubiquinone oxidoreductase subunit B8) | protein interactions | 293991 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Iapp (islet amyloid polypeptide) | protein interactions | 24476 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Snrpa (small nuclear ribonucleoprotein polypeptide A) | protein interactions | 292729 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Rab5c (RAB5C, member RAS oncogene family) | protein interactions | 287709 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Nomo1 (Nodal modulator 1) | protein interactions | 361578 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tardbp (TAR DNA binding protein) | protein interactions | 298648 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Stoml2 (stomatin like 2) | protein interactions | 298203 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | LOC100361008 (Cytochrome c oxidase subunit 5A, mitochondrial-like) | protein interactions | 100361008 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hmgn5b (high mobility group nucleosome binding domain 5B) | protein interactions | 120097335 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ina (internexin neuronal intermediate filament protein, alpha) | protein interactions | 24503 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Gpd2 (glycerol-3-phosphate dehydrogenase 2) | protein interactions | 25062 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Pgk2 (phosphoglycerate kinase 2) | protein interactions | 316265 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | LOC102554637 (anionic trypsin-2-like) | protein interactions | 102554637 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Phb1l1 (prohibitin 1 like 1) | protein interactions | 302688 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Copb1 (COPI coat complex subunit beta 1) | protein interactions | 114023 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Bst2 (bone marrow stromal cell antigen 2) | protein interactions | 378947 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Syvn1 (synoviolin 1) | protein interactions | 361712 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Usp15 (ubiquitin specific peptidase 15) | protein interactions | 171329 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tpd52l2 (TPD52 like 2) | protein interactions | 296480 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Purb (purine rich element binding protein B) | protein interactions | 498407 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cct3 (chaperonin containing TCP1 subunit 3) | protein interactions | 295230 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tor1aip2 (torsin 1A interacting protein 2) | protein interactions | 304881 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tmed2 (transmembrane p24 trafficking protein 2) | protein interactions | 65165 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Dnajb11 (DnaJ heat shock protein family (Hsp40) member B11) | protein interactions | 360734 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Camk2b (calcium/calmodulin-dependent protein kinase II beta) | protein interactions | 24245 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Fstl4 (follistatin-like 4) | protein interactions | 303130 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cyp2c55 (cytochrome P450, family 2, subfamily c, polypeptide 55) | protein interactions | 100361492 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Pgrmc1 (progesterone receptor membrane component 1) | protein interactions | 291948 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Zc3h13 (zinc finger CCCH type containing 13) | protein interactions | 305955 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Myef2 (myelin expression factor 2) | protein interactions | 679712 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Timm44 (translocase of inner mitochondrial membrane 44) | protein interactions | 29635 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Krt83 (keratin 83) | protein interactions | 407759 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Actg2 (actin gamma 2, smooth muscle) | protein interactions | 25365 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Pcsk1n (proprotein convertase subtilisin/kexin type 1 inhibitor) | protein interactions | 246333 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Actr1a (actin related protein 1A) | protein interactions | 294010 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Kiaa0232 (KIAA0232 homolog) | protein interactions | 680039 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sphkap (SPHK1 interactor, AKAP domain containing) | protein interactions | 316561 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Gorasp2 (golgi reassembly stacking protein 2) | protein interactions | 113961 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Copg1 (COPI coat complex subunit gamma 1) | protein interactions | 297428 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sel1l (SEL1L adaptor subunit of SYVN1 ubiquitin ligase) | protein interactions | 314352 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cox5b (cytochrome c oxidase subunit 5B) | protein interactions | 94194 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Eif3b (eukaryotic translation initiation factor 3, subunit B) | protein interactions | 288516 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cd81 (Cd81 molecule) | protein interactions | 25621 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Gaa (alpha glucosidase) | protein interactions | 367562 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Kcnd2 (potassium voltage-gated channel subfamily D member 2) | protein interactions | 65180 | 1 | 1 | 19454 | 49 |
KCNIP4 |
2.519e-03 | -5.98 | Rnf13 (ring finger protein 13) | protein interactions | 681578 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ptma (prothymosin alpha) | protein interactions | 29222 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Copb2 (COPI coat complex subunit beta 2) | protein interactions | 60384 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Pgam1 (phosphoglycerate mutase 1) | protein interactions | 24642 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Kpna2l1 (karyopherin subunit alpha 2 like 1) | protein interactions | 100359600 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cep135 (centrosomal protein 135) | protein interactions | 305288 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tceal3 (transcription elongation factor A like 3) | protein interactions | 501628 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cep162 (centrosomal protein 162) | protein interactions | 300880 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Stxbp5l (syntaxin binding protein 5L) | protein interactions | 288080 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ppard (peroxisome proliferator-activated receptor delta) | protein interactions | 25682 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hnrnpul2 (heterogeneous nuclear ribonucleoprotein U-like 2) | protein interactions | 309197 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Rps26-ps11 (ribosomal protein S26, pseudogene 11) | protein interactions | 100360508 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hmgn3 (high mobility group nucleosomal binding domain 3) | protein interactions | 113990 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Nnt (nicotinamide nucleotide transhydrogenase) | protein interactions | 310378 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hnrnph3 (heterogeneous nuclear ribonucleoprotein H3) | protein interactions | 361838 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Rpl31-ps10 (ribosomal protein L31, pseudogene 10) | protein interactions | 502887 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Atp6v0d1 (ATPase H+ transporting V0 subunit D1) | protein interactions | 291969 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Pdia6 (protein disulfide isomerase family A, member 6) | protein interactions | 286906 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Srprb (SRP receptor subunit beta) | protein interactions | 300965 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Krt8 (keratin 8) | protein interactions | 25626 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Fam114a1 (family with sequence similarity 114, member A1) | protein interactions | 498366 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tgoln2 (trans-golgi network protein 2) | protein interactions | 192152 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Copa (COPI coat complex subunit alpha) | protein interactions | 304978 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Atp5f1d (ATP synthase F1 subunit delta) | protein interactions | 245965 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Vil1 (villin 1) | protein interactions | 316521 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tmem263 (transmembrane protein 263) | protein interactions | 362857 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ttc22 (tetratricopeptide repeat domain 22) | protein interactions | 298300 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | LOC286987 (hemiferrin, transferrin-like protein) | protein interactions | 286987 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ranbp1 (RAN binding protein 1) | protein interactions | 360739 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Acad10 (acyl-CoA dehydrogenase family, member 10) | protein interactions | 304500 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Atxn2 (ataxin 2) | protein interactions | 288663 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Chmp4b (charged multivesicular body protein 4B) | protein interactions | 100359642 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Gcn1 (GCN1 activator of EIF2AK4) | protein interactions | 690632 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cope (COPI coat complex subunit epsilon) | protein interactions | 290659 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Vgf (VGF nerve growth factor inducible) | protein interactions | 29461 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Dnah17 (dynein, axonemal, heavy chain 17) | protein interactions | 287845 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tuba1c (tubulin, alpha 1C) | protein interactions | 300218 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Snrnp27 (small nuclear ribonucleoprotein U4/U6.U5 subunit 27) | protein interactions | 362392 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Atp6v0a1 (ATPase H+ transporting V0 subunit a1) | protein interactions | 29757 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hnrnpr (heterogeneous nuclear ribonucleoprotein R) | protein interactions | 319110 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Stip1 (stress-induced phosphoprotein 1) | protein interactions | 192277 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ndufv3-ps1 (NADH:ubiquinone oxidoreductase subunit V3, pseudogene 1) | protein interactions | 685005 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Rps27-ps8 (ribosomal protein S27, pseudogene 8) | protein interactions | 100359517 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Psap (prosaposin) | protein interactions | 25524 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Nbas (NBAS subunit of NRZ tethering complex) | protein interactions | 690073 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hdgfl3 (HDGF like 3) | protein interactions | 252941 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | LOC100360522 (ribosomal protein P1-like) | protein interactions | 100360522 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Mlec (malectin) | protein interactions | 304543 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hspa4 (heat shock protein family A (Hsp70) member 4) | protein interactions | 266759 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | LOC100365839 (40S ribosomal protein S3a-like) | protein interactions | 100365839 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Dynll2 (dynein light chain LC8-type 2) | protein interactions | 140734 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Dynll1 (dynein light chain LC8-type 1) | protein interactions | 58945 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Nolc1 (nucleolar and coiled-body phosphoprotein 1) | protein interactions | 64896 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Grpel1 (GrpE-like 1, mitochondrial) | protein interactions | 79563 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Gfpt1 (glutamine fructose-6-phosphate transaminase 1) | protein interactions | 297417 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | LOC297756 (ribosomal protein S8-like) | protein interactions | 297756 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Atp5mc2 (ATP synthase membrane subunit c locus 2) | protein interactions | 171082 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Qpct (glutaminyl-peptide cyclotransferase) | protein interactions | 313837 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ciao2b (cytosolic iron-sulfur assembly component 2B) | protein interactions | 680987 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Fam114a2 (family with sequence similarity 114, member A2) | protein interactions | 303155 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Atp1a2 (ATPase Na+/K+ transporting subunit alpha 2) | protein interactions | 24212 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Scg5 (secretogranin V) | protein interactions | 25719 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Kif5b (kinesin family member 5B) | protein interactions | 117550 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Trim28 (tripartite motif-containing 28) | protein interactions | 116698 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | U2af2 (U2 small nuclear RNA auxiliary factor 2) | protein interactions | 308335 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cnbp (CCHC-type zinc finger, nucleic acid binding protein) | protein interactions | 64530 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hba-a2 (hemoglobin alpha, adult chain 2) | protein interactions | 360504 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Phb2 (prohibitin 2) | protein interactions | 114766 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Anxa5 (annexin A5) | protein interactions | 25673 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Abca4 (ATP binding cassette subfamily A member 4) | protein interactions | 310836 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sec11a (SEC11 homolog A, signal peptidase complex subunit) | protein interactions | 65166 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cul3 (cullin 3) | protein interactions | 301555 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ranbp2 (RAN binding protein 2) | protein interactions | 294429 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Rps12l1 (ribosomal protein S12 like 1) | protein interactions | 100360573 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cep192 (centrosomal protein 192) | protein interactions | 307347 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Marcksl1 (MARCKS-like 1) | protein interactions | 81520 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sec16a (SEC16 homolog A, endoplasmic reticulum export factor) | protein interactions | 100360302 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Npm1-ps9 (nucleophosmin 1, pseudogene 9) | protein interactions | 300303 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Arsb (arylsulfatase B) | protein interactions | 25227 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sel1l2 (SEL1L2 adaptor subunit of SYVN1 ubiquitin ligase) | protein interactions | 311470 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cse1l (chromosome segregation 1 like) | protein interactions | 362273 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ccar2 (cell cycle and apoptosis regulator 2) | protein interactions | 306007 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sh3glb1 (SH3 domain -containing GRB2-like endophilin B1) | protein interactions | 292156 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tuba4a (tubulin, alpha 4A) | protein interactions | 316531 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cdc37 (cell division cycle 37, HSP90 cochaperone) | protein interactions | 114562 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Os9 (OS9, endoplasmic reticulum lectin) | protein interactions | 362891 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Amz2 (archaelysin family metallopeptidase 2) | protein interactions | 360650 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Srsf4 (serine and arginine rich splicing factor 4) | protein interactions | 362612 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Pgam5 (PGAM family member 5, mitochondrial serine/threonine protein phosphatase) | protein interactions | 288731 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Slc7a5 (solute carrier family 7 member 5) | protein interactions | 50719 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tnpo1 (transportin 1) | protein interactions | 309126 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Scgn (secretagogin, EF-hand calcium binding protein) | protein interactions | 306942 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Vwa5b2 (von Willebrand factor A domain containing 5B2) | protein interactions | 303812 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Psma3l (proteasome subunit alpha type 3-like) | protein interactions | 408248 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hmgn2 (high mobility group nucleosomal binding domain 2) | protein interactions | 114637 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Rpl17-ps1 (ribosomal protein L17, pseudogene 1) | protein interactions | 499485 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Glg1 (golgi glycoprotein 1) | protein interactions | 29476 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ermp1 (endoplasmic reticulum metallopeptidase 1) | protein interactions | 373544 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Jpt1 (Jupiter microtubule associated homolog 1) | protein interactions | 287828 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Gps1 (G protein pathway suppressor 1) | protein interactions | 117039 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sod1 (superoxide dismutase 1) | protein interactions | 24786 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ganab (glucosidase II alpha subunit) | protein interactions | 293721 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Dnaaf3 (dynein, axonemal, assembly factor 3) | protein interactions | 100359753 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Kifc2 (kinesin family member C2) | protein interactions | 300053 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sncb (synuclein, beta) | protein interactions | 113893 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Spcs2 (signal peptidase complex subunit 2) | protein interactions | 293142 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Taf15 (TATA-box binding protein associated factor 15) | protein interactions | 287571 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Trip11 (thyroid hormone receptor interactor 11) | protein interactions | 314393 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ins2 (insulin 2) | protein interactions | 24506 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | C1qbp (complement C1q binding protein) | protein interactions | 29681 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hmga1 (high mobility group AT-hook 1) | protein interactions | 117062 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Sytl1 (synaptotagmin-like 1) | protein interactions | 269589 | 1 | 1 | 19454 | 49 |
NRXN1 |
2.519e-03 | -5.98 | Ptmal5 (prothymosin alpha like 5) | protein interactions | 100359583 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Tmem109 (transmembrane protein 109) | protein interactions | 361732 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Babam1 (BRISC and BRCA1 A complex member 1) | protein interactions | 290631 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Pdhb (pyruvate dehydrogenase E1 subunit beta) | protein interactions | 289950 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Cplx2 (complexin 2) | protein interactions | 116657 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Nudc (nuclear distribution C, dynein complex regulator) | protein interactions | 29648 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Ptms (parathymosin) | protein interactions | 83801 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Mroh6 (maestro heat-like repeat family member 6) | protein interactions | 100359562 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Lmnb2 (lamin B2) | protein interactions | 299625 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Mcm3 (minichromosome maintenance complex component 3) | protein interactions | 316273 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Hm13 (histocompatibility minor 13) | protein interactions | 311545 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.519e-03 | -5.98 | Scfd1 (sec1 family domain containing 1) | protein interactions | 54350 | 1 | 1 | 19454 | 49 |
STXBP5L |
2.563e-03 | -5.97 | skin-upper_leg-malignant_melanoma | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma | 850 | 8 | 16828 | 48 |
GRID2,GABRB2,ASTN1,RIMS2,GRIN2A,RBFOX1,GABRD,STXBP5L |
2.564e-03 | -5.97 | cerebellar Golgi cell to granule cell synapse | cellular component | GO:0099192 | 1 | 1 | 19108 | 49 |
GABRA6 |
2.566e-03 | -5.97 | startle response | biological process | GO:0001964 | 28 | 2 | 18204 | 49 |
GRID2,GRIN2A |
2.566e-03 | -5.97 | calcium ion import across plasma membrane | biological process | GO:0098703 | 28 | 2 | 18204 | 49 |
SLC24A4,CACNA1C |
2.580e-03 | -5.96 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 10 | 16828 | 48 |
ZNF804A,KCNIP4,CACNA1C,LRRC7,OLFM1,PTPRG,HCN1,RYR2,PCLO,RIMS2 |
2.580e-03 | -5.96 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 10 | 16828 | 48 |
PTPRG,PCLO,RYR2,HCN1,RIMS2,CACNA1C,KCNIP4,ZNF804A,LRRC7,OLFM1 |
2.614e-03 | -5.95 | PRR20A (proline rich 20A) | protein interactions | 122183 | 109 | 3 | 19454 | 49 |
TRPM3,RBFOX1,CELF4 |
2.692e-03 | -5.92 | polysaccharide transport | biological process | GO:0015774 | 1 | 1 | 18204 | 49 |
SMPD3 |
2.692e-03 | -5.92 | regulation of exocytic insertion of neurotransmitter receptor to postsynaptic membrane | biological process | GO:0099145 | 1 | 1 | 18204 | 49 |
CPLX1 |
2.692e-03 | -5.92 | cone photoresponse recovery | biological process | GO:0036368 | 1 | 1 | 18204 | 49 |
SLC24A4 |
2.692e-03 | -5.92 | regulation of retina development in camera-type eye | biological process | GO:1902866 | 1 | 1 | 18204 | 49 |
CELF4 |
2.692e-03 | -5.92 | dADP biosynthetic process | biological process | GO:0006173 | 1 | 1 | 18204 | 49 |
AK5 |
2.700e-03 | -5.91 | GBR2_CC | interpro domains | IPR041689 | 1 | 1 | 18521 | 50 |
GABBR2 |
2.700e-03 | -5.91 | X_opioid_rcpt | interpro domains | IPR001420 | 1 | 1 | 18521 | 50 |
OPRL1 |
2.700e-03 | -5.91 | Sphingomyelinase/PLipase_C | interpro domains | IPR017766 | 1 | 1 | 18521 | 50 |
SMPD3 |
2.700e-03 | -5.91 | GPCR_3_GABA_rcpt_B2 | interpro domains | IPR002457 | 1 | 1 | 18521 | 50 |
GABBR2 |
2.700e-03 | -5.91 | GABBAa6_rcpt | interpro domains | IPR005436 | 1 | 1 | 18521 | 50 |
GABRA6 |
2.700e-03 | -5.91 | DLG3_SH3 | interpro domains | IPR035763 | 1 | 1 | 18521 | 50 |
DLG3 |
2.700e-03 | -5.91 | VDCC_L_a1csu | interpro domains | IPR005451 | 1 | 1 | 18521 | 50 |
CACNA1C |
2.700e-03 | -5.91 | MARCHF4_RING_CH-C4HC3 | interpro domains | IPR047905 | 1 | 1 | 18521 | 50 |
MARCHF4 |
2.700e-03 | -5.91 | GABAAd_rcpt | interpro domains | IPR008098 | 1 | 1 | 18521 | 50 |
GABRD |
2.700e-03 | -5.91 | PCLO_FYVE1 | interpro domains | IPR042720 | 1 | 1 | 18521 | 50 |
PCLO |
2.700e-03 | -5.91 | GABRA1_ECD | interpro domains | IPR047079 | 1 | 1 | 18521 | 50 |
GABRA1 |
2.700e-03 | -5.91 | GABBAa1_rcpt | interpro domains | IPR005431 | 1 | 1 | 18521 | 50 |
GABRA1 |
2.700e-03 | -5.91 | KSR_SAM-like_dom | interpro domains | IPR025561 | 1 | 1 | 18521 | 50 |
KSR2 |
2.708e-03 | -5.91 | neutral sphingomyelin phosphodiesterase activity | molecular function | GO:0061751 | 1 | 1 | 18094 | 49 |
SMPD3 |
2.708e-03 | -5.91 | nociceptin receptor activity | molecular function | GO:0001626 | 1 | 1 | 18094 | 49 |
OPRL1 |
2.708e-03 | -5.91 | intracellular cAMP-activated cation channel activity involved in regulation of presynaptic membrane potential | molecular function | GO:0140232 | 1 | 1 | 18094 | 49 |
HCN1 |
2.740e-03 | -5.90 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 3 | 16828 | 48 |
ZNF804A,NRXN3,KSR2 |
2.749e-03 | -5.90 | cortical cytoskeleton | cellular component | GO:0030863 | 109 | 3 | 19108 | 49 |
RIMS4,PCLO,RIMS2 |
2.751e-03 | -5.90 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 47 | 16828 | 48 |
LRRC7,UNC13C,GRIN2A,ZFPM2,CELF4,GABRA1,IL1RAPL2,CELF5,TRPM3,GALNT9,MYT1L,OLFM1,GABRD,AK5,RIMS4,CPLX1,RIMS2,ST8SIA5,GABRB2,R3HDM1,STXBP5L,RBFOX1,CELF6,GABBR2,KCNIP4,DLG3,NRXN3,PPP2R5B,NRXN1,KCNMA1,PTPRG,PCLO,HCN1,SMPD3,GABRA6,ASTN1,KCNT1,CACNA1C,RGS7,RBFOX3,CR2,KSR2,OPRL1,ZNF804A,SLC24A4,GRID2,RYR2 |
2.751e-03 | -5.90 | calcium ion import into cytosol | biological process | GO:1902656 | 29 | 2 | 18204 | 49 |
SLC24A4,CACNA1C |
2.751e-03 | -5.90 | regulation of cardiac muscle cell action potential | biological process | GO:0098901 | 29 | 2 | 18204 | 49 |
RYR2,CACNA1C |
2.754e-03 | -5.89 | GBR2_CC | pfam domains | PF18455 | 1 | 1 | 17795 | 49 |
GABBR2 |
2.754e-03 | -5.89 | SAM_KSR1 | pfam domains | PF13543 | 1 | 1 | 17795 | 49 |
KSR2 |
2.758e-03 | -5.89 | ABCB9 (ATP binding cassette subfamily B member 9) | protein interactions | 23457 | 31 | 2 | 19454 | 49 |
MARCHF4,GRIN2A |
2.784e-03 | -5.88 | ligand-gated calcium channel activity | molecular function | GO:0099604 | 29 | 2 | 18094 | 49 |
GRIN2A,RYR2 |
2.801e-03 | -5.88 | pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 7 | 16828 | 48 |
RYR2,ASTN1,KCNMA1,GALNT9,RBFOX1,LRRC7,CR2 |
2.801e-03 | -5.88 | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 7 | 16828 | 48 |
RYR2,LRRC7,CR2,KCNMA1,GALNT9,RBFOX1,ASTN1 |
2.916e-03 | -5.84 | cell junction organization | biological process | GO:0034330 | 532 | 6 | 18204 | 49 |
GRID2,GABRA6,GABRB2,NRXN1,GABRA1,PCLO |
2.978e-03 | -5.82 | monoatomic ion-gated channel activity | molecular function | GO:0022839 | 30 | 2 | 18094 | 49 |
KCNMA1,KCNT1 |
3.040e-03 | -5.80 | SNARE binding | molecular function | GO:0000149 | 107 | 3 | 18094 | 49 |
CPLX1,UNC13C,STXBP5L |
3.041e-03 | -5.80 | primary_central_nervous_system_lymphoma | COSMIC cancer mutations | primary_central_nervous_system_lymphoma | 683 | 7 | 16828 | 48 |
KCNIP4,NRXN1,STXBP5L,RYR2,PTPRG,KCNT1,GALNT9 |
3.041e-03 | -5.80 | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | 683 | 7 | 16828 | 48 |
STXBP5L,NRXN1,KCNIP4,GALNT9,PTPRG,KCNT1,RYR2 |
3.127e-03 | -5.77 | macromolecule localization | biological process | GO:0033036 | 2376 | 14 | 18204 | 49 |
RYR2,DLG3,GRIN2A,KCNIP4,PCLO,RIMS2,NRXN1,CPLX1,HCN1,STXBP5L,RBFOX1,LRRC7,SMPD3,GRID2 |
3.140e-03 | -5.76 | protein localization to postsynaptic membrane | biological process | GO:1903539 | 31 | 2 | 18204 | 49 |
LRRC7,GRIN2A |
3.140e-03 | -5.76 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0010880 | 31 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
3.175e-03 | -5.75 | upper_leg | COSMIC cancer mutations | upper_leg | 880 | 8 | 16828 | 48 |
GRID2,RIMS2,ASTN1,GABRB2,GRIN2A,GABRD,STXBP5L,RBFOX1 |
3.177e-03 | -5.75 | intracellularly ligand-gated monoatomic ion channel activity | molecular function | GO:0005217 | 31 | 2 | 18094 | 49 |
HCN1,RYR2 |
3.220e-03 | -5.74 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 39 | 16828 | 48 |
NRXN3,GRID2,RYR2,KSR2,STXBP5L,CR2,GABBR2,KCNIP4,SLC24A4,ZNF804A,OPRL1,ST8SIA5,RGS7,RIMS2,R3HDM1,AK5,MYT1L,GABRD,CACNA1C,CPLX1,RIMS4,ASTN1,GALNT9,KCNT1,TRPM3,GABRA6,IL1RAPL2,GABRA1,KCNMA1,PCLO,CELF5,HCN1,PTPRG,NRXN1,LRRC7,CELF4,GRIN2A,UNC13C,ZFPM2 |
3.220e-03 | -5.74 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 39 | 16828 | 48 |
GABRA6,TRPM3,KCNT1,GALNT9,ASTN1,UNC13C,GRIN2A,ZFPM2,CELF4,LRRC7,NRXN1,PTPRG,PCLO,CELF5,HCN1,IL1RAPL2,GABRA1,KCNMA1,OPRL1,KCNIP4,GABBR2,SLC24A4,ZNF804A,STXBP5L,CR2,KSR2,RYR2,GRID2,NRXN3,RIMS4,CACNA1C,CPLX1,MYT1L,GABRD,AK5,R3HDM1,RGS7,RIMS2,ST8SIA5 |
3.270e-03 | -5.72 | developmental process | biological process | GO:0032502 | 5716 | 25 | 18204 | 49 |
RBFOX3,SLC24A4,GABRA1,RYR2,LRRC7,CR2,GABRA6,SMPD3,RIMS2,IL1RAPL2,RBFOX1,PCLO,MYT1L,CELF4,GRIN2A,DLG3,ASTN1,ZFPM2,NRXN3,OLFM1,GRID2,NRXN1,CACNA1C,GABRB2,HCN1 |
3.312e-03 | -5.71 | ABCC10 (ATP binding cassette subfamily C member 10) | protein interactions | 89845 | 34 | 2 | 19454 | 49 |
MARCHF4,OPRL1 |
3.315e-03 | -5.71 | cell-cell adhesion | biological process | GO:0098609 | 546 | 6 | 18204 | 49 |
NRXN3,ASTN1,GRID2,DLG3,LRRC7,NRXN1 |
3.326e-03 | -5.71 | adenosine ribonucleotides de novo biosynthesis | BIOCYC pathways | META_PWY-7219 | 1 | 1 | 902 | 3 |
AK5 |
3.344e-03 | -5.70 | protein localization to postsynapse | biological process | GO:0062237 | 32 | 2 | 18204 | 49 |
LRRC7,GRIN2A |
3.406e-03 | -5.68 | localization within membrane | biological process | GO:0051668 | 549 | 6 | 18204 | 49 |
STXBP5L,KCNIP4,LRRC7,GRIN2A,DLG3,NRXN1 |
3.430e-03 | -5.68 | ZDHHC15 (zinc finger DHHC-type palmitoyltransferase 15) | protein interactions | 158866 | 120 | 3 | 19454 | 49 |
RIMS2,NRXN1,STXBP5L |
3.475e-03 | -5.66 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 36 | 16828 | 48 |
RYR2,GRID2,NRXN3,DLG3,ZNF804A,GABBR2,OPRL1,KSR2,STXBP5L,CR2,R3HDM1,GABRB2,ST8SIA5,RIMS2,RGS7,RBFOX3,CACNA1C,RIMS4,AK5,OLFM1,KCNT1,ASTN1,GABRA6,TRPM3,SMPD3,HCN1,PCLO,PTPRG,KCNMA1,IL1RAPL2,CELF4,ZFPM2,GRIN2A,UNC13C,PPP2R5B,LRRC7 |
3.543e-03 | -5.64 | RNA splicing | biological process | GO:0008380 | 382 | 5 | 18204 | 49 |
CELF6,RBFOX1,CELF5,RBFOX3,CELF4 |
3.635e-03 | -5.62 | LVDCCALPHA1C | prints domains | PR01635 | 1 | 1 | 5227 | 19 |
CACNA1C |
3.635e-03 | -5.62 | GABAARALPHA6 | prints domains | PR01619 | 1 | 1 | 5227 | 19 |
GABRA6 |
3.635e-03 | -5.62 | GABAARALPHA1 | prints domains | PR01614 | 1 | 1 | 5227 | 19 |
GABRA1 |
3.635e-03 | -5.62 | GABAB2RECPTR | prints domains | PR01178 | 1 | 1 | 5227 | 19 |
GABBR2 |
3.635e-03 | -5.62 | GABAARDELTA | prints domains | PR01722 | 1 | 1 | 5227 | 19 |
GABRD |
3.635e-03 | -5.62 | XOPIOIDR | prints domains | PR00547 | 1 | 1 | 5227 | 19 |
OPRL1 |
3.714e-03 | -5.60 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 9 | 16828 | 48 |
GRIN2A,GABRA6,GRID2,ZNF804A,GABRA1,GABRD,RBFOX1,NRXN3,ASTN1 |
3.742e-03 | -5.59 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 45 | 16828 | 48 |
CELF5,IL1RAPL2,GABRA1,ZFPM2,GRIN2A,UNC13C,CELF4,LRRC7,GALNT9,TRPM3,R3HDM1,RIMS2,GABRB2,ST8SIA5,RIMS4,MYT1L,GABRD,OLFM1,AK5,DLG3,NRXN3,KCNIP4,GABBR2,STXBP5L,RBFOX1,PTPRG,HCN1,PCLO,KCNMA1,NRXN1,PPP2R5B,KCNT1,ASTN1,GABRA6,SMPD3,RGS7,RBFOX3,CACNA1C,RYR2,GRID2,OPRL1,ZNF804A,SLC24A4,CR2,KSR2 |
3.844e-03 | -5.56 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 3 | 18204 | 49 |
GRID2,IL1RAPL2,NRXN1 |
3.898e-03 | -5.55 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-polycythaemia_vera | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-polycythaemia_vera | 369 | 5 | 16828 | 48 |
GRIN2A,RYR2,KCNMA1,KSR2,ST8SIA5 |
3.898e-03 | -5.55 | polycythaemia_vera | COSMIC cancer mutations | polycythaemia_vera | 369 | 5 | 16828 | 48 |
KSR2,ST8SIA5,KCNMA1,RYR2,GRIN2A |
3.976e-03 | -5.53 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-cortisol_and_virilizing_syndrome-producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-cortisol_and_virilizing_syndrome-producing | 33 | 2 | 16828 | 48 |
GRIN2A,CACNA1C |
3.990e-03 | -5.52 | regulation of presynapse organization | biological process | GO:0099174 | 35 | 2 | 18204 | 49 |
IL1RAPL2,GRID2 |
3.990e-03 | -5.52 | regulation of presynapse assembly | biological process | GO:1905606 | 35 | 2 | 18204 | 49 |
IL1RAPL2,GRID2 |
3.990e-03 | -5.52 | regulation of cardiac muscle cell contraction | biological process | GO:0086004 | 35 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
4.012e-03 | -5.52 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 9 | 16828 | 48 |
LRRC7,KSR2,CACNA1C,ZNF804A,GABRA1,DLG3,ASTN1,PTPRG,RYR2 |
4.128e-03 | -5.49 | regulation of system process | biological process | GO:0044057 | 571 | 6 | 18204 | 49 |
CACNA1C,RIMS2,NRXN1,RYR2,CELF4,GRIN2A |
4.218e-03 | -5.47 | response to amphetamine | biological process | GO:0001975 | 36 | 2 | 18204 | 49 |
RGS7,GRIN2A |
4.218e-03 | -5.47 | positive regulation of synaptic transmission, glutamatergic | biological process | GO:0051968 | 36 | 2 | 18204 | 49 |
GRIN2A,NRXN1 |
4.269e-03 | -5.46 | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 377 | 5 | 16828 | 48 |
ZFPM2,LRRC7,TRPM3,NRXN1,ASTN1 |
4.281e-03 | -5.45 | regulation of synapse organization | biological process | GO:0050807 | 246 | 4 | 18204 | 49 |
NRXN1,IL1RAPL2,GRID2,ZNF804A |
4.339e-03 | -5.44 | ABCD4 (ATP binding cassette subfamily D member 4) | protein interactions | 5826 | 39 | 2 | 19454 | 49 |
MARCHF4,GRIN2A |
4.339e-03 | -5.44 | E (envelope protein) | protein interactions | 14254599 | 39 | 2 | 19454 | 49 |
LRRC7,RIMS2 |
4.404e-03 | -5.43 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 9 | 16828 | 48 |
CACNA1C,ZNF804A,LRRC7,KSR2,PTPRG,RYR2,GABRA1,DLG3,ASTN1 |
4.408e-03 | -5.42 | Laminin_G_2 | pfam domains | PF02210 | 36 | 2 | 17795 | 49 |
NRXN1,NRXN3 |
4.492e-03 | -5.41 | regulation of mRNA metabolic process | biological process | GO:1903311 | 404 | 5 | 18204 | 49 |
RBFOX1,CELF6,CELF5,CELF4,RBFOX3 |
4.519e-03 | -5.40 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 11 | 16828 | 48 |
STXBP5L,CR2,SMPD3,OPRL1,GABRA6,NRXN3,KCNT1,OLFM1,LRRC7,NRXN1,RIMS2 |
4.523e-03 | -5.40 | action potential | biological process | GO:0001508 | 124 | 3 | 18204 | 49 |
RYR2,CACNA1C,HCN1 |
4.660e-03 | -5.37 | skin-upper_arm-malignant_melanoma | COSMIC cancer mutations | skin-upper_arm-malignant_melanoma | 553 | 6 | 16828 | 48 |
ASTN1,STXBP5L,CR2,R3HDM1,GRIN2A,GABRA6 |
4.662e-03 | -5.37 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 4 | 18204 | 49 |
IL1RAPL2,NRXN1,ZNF804A,GRID2 |
4.722e-03 | -5.36 | dendrite membrane | cellular component | GO:0032590 | 40 | 2 | 19108 | 49 |
GABRA1,GABRA6 |
4.751e-03 | -5.35 | protein localization | biological process | GO:0008104 | 1954 | 12 | 18204 | 49 |
PCLO,RYR2,DLG3,GRIN2A,KCNIP4,LRRC7,GRID2,NRXN1,RIMS2,CPLX1,HCN1,STXBP5L |
4.761e-03 | -5.35 | NCAM signaling for neurite out-growth | REACTOME pathways | R-HSA-375165 | 276 | 4 | 10285 | 26 |
KSR2,GRIN2A,PPP2R5B,CACNA1C |
4.767e-03 | -5.35 | fibula | COSMIC cancer mutations | fibula | 387 | 5 | 16828 | 48 |
LRRC7,TRPM3,ASTN1,NRXN1,ZFPM2 |
4.783e-03 | -5.34 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 6 | 16828 | 48 |
ASTN1,PCLO,RYR2,ZFPM2,GABRA6,GRIN2A |
4.867e-03 | -5.33 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 6 | 16828 | 48 |
ASTN1,RYR2,PCLO,GRIN2A,ZFPM2,GABRA6 |
4.910e-03 | -5.32 | cellular macromolecule localization | biological process | GO:0070727 | 1962 | 12 | 18204 | 49 |
PCLO,RYR2,DLG3,GRIN2A,KCNIP4,GRID2,LRRC7,HCN1,CPLX1,STXBP5L,NRXN1,RIMS2 |
5.011e-03 | -5.30 | LAM_G_DOMAIN | prosite domains | PS50025 | 35 | 2 | 12186 | 37 |
NRXN1,NRXN3 |
5.018e-03 | -5.29 | RYR2 (ryanodine receptor 2) | protein interactions | 6262 | 42 | 2 | 19454 | 49 |
RYR2,CACNA1C |
5.031e-03 | -5.29 | Dnaja2 (DnaJ heat shock protein family (Hsp40) member A2) | protein interactions | 84026 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Cox4i1 (cytochrome c oxidase subunit 4i1) | protein interactions | 29445 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Ubap2l (ubiquitin associated protein 2-like) | protein interactions | 361984 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Atp5pf (ATP synthase peripheral stalk subunit F6) | protein interactions | 94271 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Rpsa (ribosomal protein SA) | protein interactions | 29236 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Tnpo2 (transportin 2) | protein interactions | 304670 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Plec (plectin) | protein interactions | 64204 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Prdx2 (peroxiredoxin 2) | protein interactions | 29338 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Tmod3 (tropomodulin 3) | protein interactions | 300838 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Ndufv2 (NADH:ubiquinone oxidoreductase core subunit V2) | protein interactions | 81728 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Ndufv3 (NADH:ubiquinone oxidoreductase subunit V3) | protein interactions | 64539 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Chchd3 (coiled-coil-helix-coiled-coil-helix domain containing 3) | protein interactions | 296966 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Atp5pd (ATP synthase peripheral stalk subunit d) | protein interactions | 641434 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Psma3 (proteasome 20S subunit alpha 3) | protein interactions | 29670 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Gsn (gelsolin) | protein interactions | 296654 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Tpm4 (tropomyosin 4) | protein interactions | 24852 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Mycbp (Myc binding protein) | protein interactions | 100361133 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Psmd3 (proteasome 26S subunit, non-ATPase 3) | protein interactions | 287670 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Lrrfip2 (LRR binding FLII interacting protein 2) | protein interactions | 301035 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Ckap4 (cytoskeleton-associated protein 4) | protein interactions | 362859 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Dnaja1 (DnaJ heat shock protein family (Hsp40) member A1) | protein interactions | 65028 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Sec31a (SEC31 homolog A, COPII coat complex component) | protein interactions | 93646 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Lmo7 (LIM domain 7) | protein interactions | 361084 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Hadha (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha) | protein interactions | 170670 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Tcp1 (t-complex 1) | protein interactions | 24818 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Rplp1 (ribosomal protein lateral stalk subunit P1) | protein interactions | 140661 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Dbn1 (drebrin 1) | protein interactions | 81653 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Rab5b (RAB5B, member RAS oncogene family) | protein interactions | 288779 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Rcn1 (reticulocalbin 1) | protein interactions | 362182 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Gnb1 (G protein subunit beta 1) | protein interactions | 24400 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Mfap1a (microfibrillar-associated protein 1A) | protein interactions | 499878 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Nucb1 (nucleobindin 1) | protein interactions | 84595 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | AOAH (acyloxyacyl hydrolase) | protein interactions | 313 | 2 | 1 | 19454 | 49 |
DLG3 |
5.031e-03 | -5.29 | Ncl (nucleolin) | protein interactions | 25135 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Thy1 (Thy-1 cell surface antigen) | protein interactions | 24832 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Myl12b (myosin light chain 12B) | protein interactions | 50685 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Eef1b2 (eukaryotic translation elongation factor 1 beta 2) | protein interactions | 363241 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Rab3a (RAB3A, member RAS oncogene family) | protein interactions | 25531 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Myo18a (myosin XVIIIa) | protein interactions | 360570 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Sytl4 (synaptotagmin-like 4) | protein interactions | 140594 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Tufm (Tu translation elongation factor, mitochondrial) | protein interactions | 293481 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.031e-03 | -5.29 | Eif4b (eukaryotic translation initiation factor 4B) | protein interactions | 300253 | 2 | 1 | 19454 | 49 |
STXBP5L |
5.085e-03 | -5.28 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-essential_thrombocythaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-essential_thrombocythaemia | 393 | 5 | 16828 | 48 |
CR2,STXBP5L,ASTN1,CELF4,CELF5 |
5.085e-03 | -5.28 | essential_thrombocythaemia | COSMIC cancer mutations | essential_thrombocythaemia | 393 | 5 | 16828 | 48 |
ASTN1,CR2,STXBP5L,CELF5,CELF4 |
5.122e-03 | -5.27 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex | cellular component | GO:0070554 | 2 | 1 | 19108 | 49 |
CPLX1 |
5.122e-03 | -5.27 | G protein-coupled GABA receptor complex | cellular component | GO:1902712 | 2 | 1 | 19108 | 49 |
GABBR2 |
5.173e-03 | -5.26 | PTPRA (protein tyrosine phosphatase receptor type A) | protein interactions | 5786 | 139 | 3 | 19454 | 49 |
MARCHF4,KCNMA1,PTPRG |
5.173e-03 | -5.26 | SH3GL3 (SH3 domain containing GRB2 like 3, endophilin A3) | protein interactions | 6457 | 139 | 3 | 19454 | 49 |
RBFOX1,RBFOX3,GABBR2 |
5.187e-03 | -5.26 | calcium ion import | biological process | GO:0070509 | 40 | 2 | 18204 | 49 |
CACNA1C,SLC24A4 |
5.187e-03 | -5.26 | bone-humerus-chondrosarcoma | COSMIC cancer mutations | bone-humerus-chondrosarcoma | 123 | 3 | 16828 | 48 |
RYR2,PCLO,R3HDM1 |
5.203e-03 | -5.26 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 30 | 16828 | 48 |
ZNF804A,GABBR2,STXBP5L,CR2,KSR2,GRID2,RYR2,NRXN3,CACNA1C,OLFM1,AK5,R3HDM1,RBFOX3,ST8SIA5,GABRB2,GABRA6,KCNT1,GALNT9,ASTN1,UNC13C,GRIN2A,ZFPM2,CELF4,LRRC7,PTPRG,PCLO,HCN1,CELF5,GABRA1,IL1RAPL2 |
5.215e-03 | -5.26 | distal axon | cellular component | GO:0150034 | 273 | 4 | 19108 | 49 |
CPLX1,UNC13C,OLFM1,ZNF804A |
5.309e-03 | -5.24 | Cardiac conduction | REACTOME pathways | R-HSA-5576891 | 142 | 3 | 10285 | 26 |
RYR2,CACNA1C,KCNIP4 |
5.376e-03 | -5.23 | cellular response to high light intensity | biological process | GO:0071486 | 2 | 1 | 18204 | 49 |
SLC24A4 |
5.376e-03 | -5.23 | neurotransmitter receptor transport postsynaptic membrane to endosome | biological process | GO:0098968 | 2 | 1 | 18204 | 49 |
LRRC7 |
5.376e-03 | -5.23 | dADP metabolic process | biological process | GO:0046056 | 2 | 1 | 18204 | 49 |
AK5 |
5.376e-03 | -5.23 | presynapse to nucleus signaling pathway | biological process | GO:0099526 | 2 | 1 | 18204 | 49 |
PCLO |
5.376e-03 | -5.23 | olfactory nerve maturation | biological process | GO:0021630 | 2 | 1 | 18204 | 49 |
SLC24A4 |
5.376e-03 | -5.23 | purine deoxyribonucleoside diphosphate biosynthetic process | biological process | GO:0009183 | 2 | 1 | 18204 | 49 |
AK5 |
5.376e-03 | -5.23 | polysaccharide localization | biological process | GO:0033037 | 2 | 1 | 18204 | 49 |
SMPD3 |
5.376e-03 | -5.23 | presynaptic signal transduction | biological process | GO:0098928 | 2 | 1 | 18204 | 49 |
PCLO |
5.376e-03 | -5.23 | response to carbon monoxide | biological process | GO:0034465 | 2 | 1 | 18204 | 49 |
KCNMA1 |
5.383e-03 | -5.22 | protein secretion | biological process | GO:0009306 | 132 | 3 | 18204 | 49 |
CPLX1,PCLO,RIMS2 |
5.392e-03 | -5.22 | SAM_KSR1_N_sf | interpro domains | IPR046933 | 2 | 1 | 18521 | 50 |
KSR2 |
5.392e-03 | -5.22 | SAM_KSR1_N | interpro domains | IPR046861 | 2 | 1 | 18521 | 50 |
KSR2 |
5.392e-03 | -5.22 | Largen/INSYN1 | interpro domains | IPR027997 | 2 | 1 | 18521 | 50 |
INSYN1 |
5.392e-03 | -5.22 | Astrotactin | interpro domains | IPR026995 | 2 | 1 | 18521 | 50 |
ASTN1 |
5.392e-03 | -5.22 | FOG | interpro domains | IPR039746 | 2 | 1 | 18521 | 50 |
ZFPM2 |
5.392e-03 | -5.22 | Sph/SMPD2-like | interpro domains | IPR038772 | 2 | 1 | 18521 | 50 |
SMPD3 |
5.392e-03 | -5.22 | Alpha_CARP_receptor-type | interpro domains | IPR041887 | 2 | 1 | 18521 | 50 |
PTPRG |
5.392e-03 | -5.22 | ASTN1_2_Fn3 | interpro domains | IPR045574 | 2 | 1 | 18521 | 50 |
ASTN1 |
5.392e-03 | -5.22 | ZF_CCHC_FOG | interpro domains | IPR034731 | 2 | 1 | 18521 | 50 |
ZFPM2 |
5.392e-03 | -5.22 | ZFPM1/2_PR | interpro domains | IPR049361 | 2 | 1 | 18521 | 50 |
ZFPM2 |
5.392e-03 | -5.22 | Slowpoke-like_C | interpro domains | IPR048735 | 2 | 1 | 18521 | 50 |
KCNMA1 |
5.392e-03 | -5.22 | IL-1_rcpt_II-typ | interpro domains | IPR004077 | 2 | 1 | 18521 | 50 |
IL1RAPL2 |
5.392e-03 | -5.22 | AK1/5 | interpro domains | IPR006267 | 2 | 1 | 18521 | 50 |
AK5 |
5.392e-03 | -5.22 | Znf_piccolo | interpro domains | IPR008899 | 2 | 1 | 18521 | 50 |
PCLO |
5.392e-03 | -5.22 | Annexin-like | interpro domains | IPR040685 | 2 | 1 | 18521 | 50 |
ASTN1 |
5.392e-03 | -5.22 | Lgl_C_dom | interpro domains | IPR013905 | 2 | 1 | 18521 | 50 |
STXBP5L |
5.392e-03 | -5.22 | ASTN_1_2_N | interpro domains | IPR045575 | 2 | 1 | 18521 | 50 |
ASTN1 |
5.409e-03 | -5.22 | Circadian entrainment | KEGG pathways | ko04713 | 96 | 3 | 7161 | 27 |
CACNA1C,GRIN2A,RYR2 |
5.409e-03 | -5.22 | Circadian entrainment | KEGG pathways | hsa04713 | 96 | 3 | 7161 | 27 |
RYR2,GRIN2A,CACNA1C |
5.409e-03 | -5.22 | interleukin-1, type II, blocking receptor activity | molecular function | GO:0004910 | 2 | 1 | 18094 | 49 |
IL1RAPL2 |
5.409e-03 | -5.22 | suramin binding | molecular function | GO:0043924 | 2 | 1 | 18094 | 49 |
RYR2 |
5.409e-03 | -5.22 | intracellular sodium-activated potassium channel activity | molecular function | GO:0005228 | 2 | 1 | 18094 | 49 |
KCNT1 |
5.409e-03 | -5.22 | BRE binding | molecular function | GO:0042835 | 2 | 1 | 18094 | 49 |
CELF4 |
5.409e-03 | -5.22 | large conductance calcium-activated potassium channel activity | molecular function | GO:0060072 | 2 | 1 | 18094 | 49 |
KCNMA1 |
5.443e-03 | -5.21 | regulation of actin filament-based movement | biological process | GO:1903115 | 41 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
5.476e-03 | -5.21 | Laminin_G | interpro domains | IPR001791 | 41 | 2 | 18521 | 50 |
NRXN3,NRXN1 |
5.497e-03 | -5.20 | establishment of protein localization to extracellular region | biological process | GO:0035592 | 133 | 3 | 18204 | 49 |
RIMS2,PCLO,CPLX1 |
5.500e-03 | -5.20 | Slowpoke_C | pfam domains | PF21014 | 2 | 1 | 17795 | 49 |
KCNMA1 |
5.500e-03 | -5.20 | Lgl_C | pfam domains | PF08596 | 2 | 1 | 17795 | 49 |
STXBP5L |
5.500e-03 | -5.20 | DUF4589 | pfam domains | PF15252 | 2 | 1 | 17795 | 49 |
INSYN1 |
5.500e-03 | -5.20 | FOG1-like_PR | pfam domains | PF21182 | 2 | 1 | 17795 | 49 |
ZFPM2 |
5.500e-03 | -5.20 | zf-piccolo | pfam domains | PF05715 | 2 | 1 | 17795 | 49 |
PCLO |
5.500e-03 | -5.20 | ASTN1_2_fn3 | pfam domains | PF19743 | 2 | 1 | 17795 | 49 |
ASTN1 |
5.500e-03 | -5.20 | Annexin_2 | pfam domains | PF18411 | 2 | 1 | 17795 | 49 |
ASTN1 |
5.500e-03 | -5.20 | SAM_KSR1_N | pfam domains | PF20406 | 2 | 1 | 17795 | 49 |
KSR2 |
5.500e-03 | -5.20 | ASTN_1_2_N | pfam domains | PF19441 | 2 | 1 | 17795 | 49 |
ASTN1 |
5.707e-03 | -5.17 | skin-abdomen-malignant_melanoma | COSMIC cancer mutations | skin-abdomen-malignant_melanoma | 404 | 5 | 16828 | 48 |
GABBR2,GRIN2A,ASTN1,RBFOX1,NRXN3 |
5.800e-03 | -5.15 | cortisol_and_virilizing_syndrome-producing | COSMIC cancer mutations | cortisol_and_virilizing_syndrome-producing | 40 | 2 | 16828 | 48 |
CACNA1C,GRIN2A |
5.880e-03 | -5.14 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 6 | 10285 | 26 |
GABRA1,GABRA6,SLC24A4,RYR2,TRPM3,GABRB2 |
5.885e-03 | -5.14 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 40 | 16828 | 48 |
KCNT1,ASTN1,GALNT9,GABRA6,TRPM3,PCLO,CELF5,HCN1,PTPRG,GABRA1,IL1RAPL2,KCNMA1,CELF4,GRIN2A,UNC13C,ZFPM2,NRXN1,LRRC7,GRID2,RYR2,NRXN3,SLC24A4,GABBR2,ZNF804A,KCNIP4,OPRL1,KSR2,CR2,STXBP5L,R3HDM1,ST8SIA5,RGS7,RIMS2,CACNA1C,CPLX1,RIMS4,AK5,OLFM1,MYT1L,GABRD |
5.959e-03 | -5.12 | upper_arm | COSMIC cancer mutations | upper_arm | 582 | 6 | 16828 | 48 |
R3HDM1,GRIN2A,GABRA6,ASTN1,CR2,STXBP5L |
5.974e-03 | -5.12 | regulation of synaptic vesicle exocytosis | biological process | GO:2000300 | 43 | 2 | 18204 | 49 |
RIMS4,RIMS2 |
5.997e-03 | -5.12 | prostate | COSMIC cancer mutations | prostate | 13883 | 46 | 16828 | 48 |
R3HDM1,ST8SIA5,GABRB2,RIMS2,CPLX1,RIMS4,AK5,GABRD,MYT1L,OLFM1,NRXN3,KCNIP4,GABBR2,CELF6,RBFOX1,STXBP5L,CELF5,GABRA1,IL1RAPL2,CELF4,GRIN2A,UNC13C,ZFPM2,LRRC7,GALNT9,TRPM3,RBFOX3,RGS7,CACNA1C,GRID2,RYR2,ZNF804A,SLC24A4,OPRL1,KSR2,CR2,PCLO,HCN1,PTPRG,KCNMA1,PPP2R5B,NRXN1,KCNT1,ASTN1,GABRA6,SMPD3 |
6.043e-03 | -5.11 | cAMP signaling pathway | KEGG pathways | ko04024 | 198 | 4 | 7161 | 27 |
CACNA1C,GABBR2,RYR2,GRIN2A |
6.043e-03 | -5.11 | cAMP signaling pathway | KEGG pathways | hsa04024 | 198 | 4 | 7161 | 27 |
GABBR2,GRIN2A,RYR2,CACNA1C |
6.064e-03 | -5.11 | ZF_CCHC_FOG | prosite domains | PS51810 | 2 | 1 | 12186 | 37 |
ZFPM2 |
6.081e-03 | -5.10 | system process | biological process | GO:0003008 | 2015 | 12 | 18204 | 49 |
OPRL1,GRID2,SLC24A4,NRXN3,RYR2,NRXN1,CELF4,INSYN1,GRIN2A,KCNMA1,HCN1,CACNA1C |
6.110e-03 | -5.10 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 8 | 16828 | 48 |
IL1RAPL2,NRXN3,GABRB2,PTPRG,PCLO,RYR2,GRID2,ZFPM2 |
6.205e-03 | -5.08 | terminal bouton | cellular component | GO:0043195 | 46 | 2 | 19108 | 49 |
CPLX1,UNC13C |
6.247e-03 | -5.08 | receptor localization to synapse | biological process | GO:0097120 | 44 | 2 | 18204 | 49 |
DLG3,LRRC7 |
6.391e-03 | -5.05 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 18 | 16828 | 48 |
GABBR2,GABRA6,TRPM3,SMPD3,CR2,GRID2,RYR2,KCNT1,ASTN1,NRXN3,CACNA1C,UNC13C,GRIN2A,OLFM1,LRRC7,HCN1,PCLO,RIMS2 |
6.398e-03 | -5.05 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 37 | 16828 | 48 |
ASTN1,KCNT1,TRPM3,GABRA6,GABRA1,IL1RAPL2,PCLO,HCN1,CELF5,PTPRG,PPP2R5B,NRXN1,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,NRXN3,DLG3,GRID2,RYR2,KSR2,STXBP5L,CR2,GABBR2,ZNF804A,SLC24A4,OPRL1,RGS7,RIMS2,R3HDM1,AK5,MYT1L,GABRD,OLFM1,CACNA1C,CPLX1 |
6.414e-03 | -5.05 | learning or memory | biological process | GO:0007611 | 276 | 4 | 18204 | 49 |
NRXN3,GRIN2A,OPRL1,NRXN1 |
6.430e-03 | -5.05 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 18 | 16828 | 48 |
HCN1,PCLO,RIMS2,CACNA1C,GRIN2A,UNC13C,OLFM1,LRRC7,GRID2,RYR2,KCNT1,ASTN1,NRXN3,GABBR2,GABRA6,TRPM3,CR2,SMPD3 |
6.461e-03 | -5.04 | protein localization to extracellular region | biological process | GO:0071692 | 141 | 3 | 18204 | 49 |
PCLO,RIMS2,CPLX1 |
6.472e-03 | -5.04 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 37 | 16828 | 48 |
GABRA1,IL1RAPL2,CELF5,HCN1,PCLO,PTPRG,NRXN1,PPP2R5B,LRRC7,CELF4,ZFPM2,UNC13C,GRIN2A,ASTN1,KCNT1,TRPM3,GABRA6,RIMS2,RGS7,R3HDM1,AK5,MYT1L,OLFM1,GABRD,CPLX1,CACNA1C,NRXN3,DLG3,RYR2,GRID2,KSR2,CR2,STXBP5L,GABBR2,SLC24A4,ZNF804A,OPRL1 |
6.486e-03 | -5.04 | L1 transposable element, RRM domain | gene3d domains | 3.30.70.1820 | 2 | 1 | 14470 | 47 |
UNC13C |
6.486e-03 | -5.04 | - | gene3d domains | 6.10.140.1120 | 2 | 1 | 14470 | 47 |
KSR2 |
6.503e-03 | -5.04 | human chr1p31.1 | chromosome location | human chr1p31.1 | 63 | 2 | 26134 | 50 |
LRRC7,AK5 |
6.505e-03 | -5.04 | PPP3CA (protein phosphatase 3 catalytic subunit alpha) | protein interactions | 5530 | 151 | 3 | 19454 | 49 |
GABRB2,GABRA1,SMPD3 |
6.511e-03 | -5.03 | PIGA (phosphatidylinositol glycan anchor biosynthesis class A) | protein interactions | 5277 | 48 | 2 | 19454 | 49 |
MARCHF4,GRIN2A |
6.527e-03 | -5.03 | glutamate receptor signaling pathway | biological process | GO:0007215 | 45 | 2 | 18204 | 49 |
GRIN2A,GRID2 |
6.527e-03 | -5.03 | regulation of adenylate cyclase activity | biological process | GO:0045761 | 45 | 2 | 18204 | 49 |
GABBR2,CACNA1C |
6.527e-03 | -5.03 | cell communication involved in cardiac conduction | biological process | GO:0086065 | 45 | 2 | 18204 | 49 |
RYR2,CACNA1C |
6.527e-03 | -5.03 | cardiac muscle cell action potential involved in contraction | biological process | GO:0086002 | 45 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
6.568e-03 | -5.03 | soft_tissue-striated_muscle-rhabdomyosarcoma | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma | 594 | 6 | 16828 | 48 |
PTPRG,RYR2,ZFPM2,CACNA1C,STXBP5L,MYT1L |
6.601e-03 | -5.02 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 5 | 18204 | 49 |
LRRC7,PPP2R5B,ZNF804A,GRID2,PTPRG |
6.626e-03 | -5.02 | GnRH Signaling Pathway | SMPDB pathways | SMP0063811 | 47 | 2 | 1369 | 4 |
CACNA1C,LRRC7 |
6.640e-03 | -5.01 | bone-femur-chondrosarcoma | COSMIC cancer mutations | bone-femur-chondrosarcoma | 419 | 5 | 16828 | 48 |
GABRA6,HCN1,LRRC7,GABRD,STXBP5L |
6.663e-03 | -5.01 | mRNA processing | biological process | GO:0006397 | 444 | 5 | 18204 | 49 |
CELF6,RBFOX1,CELF5,RBFOX3,CELF4 |
6.884e-03 | -4.98 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 4 | 16828 | 48 |
PCLO,GABRA6,UNC13C,RBFOX1 |
6.892e-03 | -4.98 | pre-mRNA binding | molecular function | GO:0036002 | 46 | 2 | 18094 | 49 |
CELF4,CELF5 |
7.049e-03 | -4.95 | PTPN4 (protein tyrosine phosphatase non-receptor type 4) | protein interactions | 5775 | 50 | 2 | 19454 | 49 |
GRID2,GRIN2A |
7.053e-03 | -4.95 | abdomen | COSMIC cancer mutations | abdomen | 603 | 6 | 16828 | 48 |
RBFOX1,GRIN2A,GABBR2,KCNMA1,ASTN1,NRXN3 |
7.103e-03 | -4.95 | ventricular cardiac muscle tissue morphogenesis | biological process | GO:0055010 | 47 | 2 | 18204 | 49 |
ZFPM2,RYR2 |
7.221e-03 | -4.93 | eye | COSMIC cancer mutations | eye | 606 | 6 | 16828 | 48 |
KCNMA1,PCLO,PTPRG,TRPM3,MYT1L,GRIN2A |
7.257e-03 | -4.93 | BKCHANNELA | prints domains | PR01449 | 2 | 1 | 5227 | 19 |
KCNMA1 |
7.257e-03 | -4.93 | INTRLEUKN1R2 | prints domains | PR01539 | 2 | 1 | 5227 | 19 |
IL1RAPL2 |
7.296e-03 | -4.92 | SNARE complex | cellular component | GO:0031201 | 50 | 2 | 19108 | 49 |
STXBP5L,CPLX1 |
7.519e-03 | -4.89 | neuromuscular process | biological process | GO:0050905 | 149 | 3 | 18204 | 49 |
GRIN2A,NRXN1,GRID2 |
7.538e-03 | -4.89 | Vcp (valosin-containing protein) | protein interactions | 116643 | 3 | 1 | 19454 | 49 |
STXBP5L |
7.538e-03 | -4.89 | SLAMF9 (SLAM family member 9) | protein interactions | 89886 | 3 | 1 | 19454 | 49 |
INSYN1 |
7.538e-03 | -4.89 | Tpm1 (tropomyosin 1) | protein interactions | 24851 | 3 | 1 | 19454 | 49 |
STXBP5L |
7.538e-03 | -4.89 | TULP1 (TUB like protein 1) | protein interactions | 7287 | 3 | 1 | 19454 | 49 |
NRXN1 |
7.538e-03 | -4.89 | Rps26 (ribosomal protein S26) | protein interactions | 27139 | 3 | 1 | 19454 | 49 |
STXBP5L |
7.538e-03 | -4.89 | Dlgap2 (DLG associated protein 2) | protein interactions | 116681 | 3 | 1 | 19454 | 49 |
GRIN2A |
7.538e-03 | -4.89 | Baiap2 (brain-specific angiogenesis inhibitor 1-associated protein 2) | protein interactions | 108100 | 3 | 1 | 19454 | 49 |
DLG3 |
7.605e-03 | -4.88 | ABCA1 (ATP binding cassette subfamily A member 1) | protein interactions | 19 | 52 | 2 | 19454 | 49 |
DLG3,RIMS2 |
7.605e-03 | -4.88 | PKD1 (polycystin 1, transient receptor potential channel interacting) | protein interactions | 5310 | 52 | 2 | 19454 | 49 |
RGS7,PTPRG |
7.674e-03 | -4.87 | G protein-coupled receptor heterodimeric complex | cellular component | GO:0038039 | 3 | 1 | 19108 | 49 |
GABBR2 |
7.674e-03 | -4.87 | dendritic microtubule | cellular component | GO:1901588 | 3 | 1 | 19108 | 49 |
ZNF804A |
7.847e-03 | -4.85 | cytoplasmic region | cellular component | GO:0099568 | 307 | 4 | 19108 | 49 |
RIMS2,PCLO,UNC13C,RIMS4 |
7.847e-03 | -4.85 | protein localization to membrane | biological process | GO:0072657 | 462 | 5 | 18204 | 49 |
KCNIP4,LRRC7,DLG3,GRIN2A,NRXN1 |
8.030e-03 | -4.82 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 30 | 16828 | 48 |
GALNT9,ASTN1,KCNT1,SMPD3,TRPM3,PTPRG,PCLO,LRRC7,PPP2R5B,NRXN1,UNC13C,GRIN2A,ZFPM2,CELF4,NRXN3,GRID2,RYR2,CELF6,GABBR2,ZNF804A,SLC24A4,KCNIP4,RGS7,ST8SIA5,GABRB2,R3HDM1,MYT1L,OLFM1,AK5,CACNA1C |
8.049e-03 | -4.82 | LamG | smart domains | SM00282 | 40 | 2 | 9717 | 33 |
NRXN1,NRXN3 |
8.054e-03 | -4.82 | smooth muscle contraction involved in micturition | biological process | GO:0060083 | 3 | 1 | 18204 | 49 |
KCNMA1 |
8.054e-03 | -4.82 | regulation of SA node cell action potential | biological process | GO:0098907 | 3 | 1 | 18204 | 49 |
RYR2 |
8.054e-03 | -4.82 | membrane depolarization during atrial cardiac muscle cell action potential | biological process | GO:0098912 | 3 | 1 | 18204 | 49 |
CACNA1C |
8.054e-03 | -4.82 | protein localization to early endosome | biological process | GO:1902946 | 3 | 1 | 18204 | 49 |
LRRC7 |
8.054e-03 | -4.82 | type B pancreatic cell apoptotic process | biological process | GO:0097050 | 3 | 1 | 18204 | 49 |
RYR2 |
8.054e-03 | -4.82 | directional locomotion | biological process | GO:0033058 | 3 | 1 | 18204 | 49 |
GRIN2A |
8.054e-03 | -4.82 | cellular response to redox state | biological process | GO:0071461 | 3 | 1 | 18204 | 49 |
SMPD3 |
8.054e-03 | -4.82 | response to melanocyte-stimulating hormone | biological process | GO:1990680 | 3 | 1 | 18204 | 49 |
SLC24A4 |
8.054e-03 | -4.82 | negative regulation of female gonad development | biological process | GO:2000195 | 3 | 1 | 18204 | 49 |
ZFPM2 |
8.054e-03 | -4.82 | regulation of locomotor rhythm | biological process | GO:1904059 | 3 | 1 | 18204 | 49 |
OPRL1 |
8.054e-03 | -4.82 | calcium ion transmembrane transport via high voltage-gated calcium channel | biological process | GO:0061577 | 3 | 1 | 18204 | 49 |
CACNA1C |
8.054e-03 | -4.82 | right ventricular cardiac muscle tissue morphogenesis | biological process | GO:0003221 | 3 | 1 | 18204 | 49 |
ZFPM2 |
8.054e-03 | -4.82 | presynaptic active zone assembly | biological process | GO:1904071 | 3 | 1 | 18204 | 49 |
PCLO |
8.054e-03 | -4.82 | negative regulation of synaptic plasticity | biological process | GO:0031914 | 3 | 1 | 18204 | 49 |
UNC13C |
8.054e-03 | -4.82 | cranial nerve maturation | biological process | GO:0021605 | 3 | 1 | 18204 | 49 |
SLC24A4 |
8.054e-03 | -4.82 | purine deoxyribonucleoside diphosphate metabolic process | biological process | GO:0009182 | 3 | 1 | 18204 | 49 |
AK5 |
8.054e-03 | -4.82 | positive regulation of ATPase-coupled calcium transmembrane transporter activity | biological process | GO:1901896 | 3 | 1 | 18204 | 49 |
RYR2 |
8.054e-03 | -4.82 | neuroligin clustering involved in postsynaptic membrane assembly | biological process | GO:0097118 | 3 | 1 | 18204 | 49 |
NRXN1 |
8.054e-03 | -4.82 | dense core granule priming | biological process | GO:0061789 | 3 | 1 | 18204 | 49 |
UNC13C |
8.078e-03 | -4.82 | SPRY2_RyR | interpro domains | IPR035764 | 3 | 1 | 18521 | 50 |
RYR2 |
8.078e-03 | -4.82 | MARCHF4/9/11 | interpro domains | IPR046356 | 3 | 1 | 18521 | 50 |
MARCHF4 |
8.078e-03 | -4.82 | Myelin_TF | interpro domains | IPR013681 | 3 | 1 | 18521 | 50 |
MYT1L |
8.078e-03 | -4.82 | RYDR_Jsol | interpro domains | IPR048581 | 3 | 1 | 18521 | 50 |
RYR2 |
8.078e-03 | -4.82 | AIP/AIPL1/TTC9 | interpro domains | IPR039663 | 3 | 1 | 18521 | 50 |
TTC9B |
8.078e-03 | -4.82 | NMDAR2_C | interpro domains | IPR018884 | 3 | 1 | 18521 | 50 |
GRIN2A |
8.078e-03 | -4.82 | CAC1F_C | interpro domains | IPR031688 | 3 | 1 | 18521 | 50 |
CACNA1C |
8.078e-03 | -4.82 | Ryanodine_rcpt | interpro domains | IPR003032 | 3 | 1 | 18521 | 50 |
RYR2 |
8.078e-03 | -4.82 | Ryanrecept_TM4-6 | interpro domains | IPR009460 | 3 | 1 | 18521 | 50 |
RYR2 |
8.078e-03 | -4.82 | SPRY1_RyR | interpro domains | IPR035761 | 3 | 1 | 18521 | 50 |
RYR2 |
8.078e-03 | -4.82 | Noelin_dom | interpro domains | IPR022082 | 3 | 1 | 18521 | 50 |
OLFM1 |
8.078e-03 | -4.82 | Ryan_recept | interpro domains | IPR013333 | 3 | 1 | 18521 | 50 |
RYR2 |
8.078e-03 | -4.82 | GABAAb_rcpt | interpro domains | IPR002289 | 3 | 1 | 18521 | 50 |
GABRB2 |
8.078e-03 | -4.82 | GPCR3_GABA-B | interpro domains | IPR002455 | 3 | 1 | 18521 | 50 |
GABBR2 |
8.078e-03 | -4.82 | Unc-13_C2B | interpro domains | IPR037302 | 3 | 1 | 18521 | 50 |
UNC13C |
8.078e-03 | -4.82 | SPRY3_RyR | interpro domains | IPR035762 | 3 | 1 | 18521 | 50 |
RYR2 |
8.078e-03 | -4.82 | Unc-13 | interpro domains | IPR027080 | 3 | 1 | 18521 | 50 |
UNC13C |
8.103e-03 | -4.82 | voltage-gated calcium channel activity involved in AV node cell action potential | molecular function | GO:0086056 | 3 | 1 | 18094 | 49 |
CACNA1C |
8.103e-03 | -4.82 | G protein-coupled GABA receptor activity | molecular function | GO:0004965 | 3 | 1 | 18094 | 49 |
GABBR2 |
8.129e-03 | -4.81 | regulation of monoatomic ion transport | biological process | GO:0043269 | 466 | 5 | 18204 | 49 |
CACNA1C,RYR2,GRIN2A,KCNIP4,RGS7 |
8.238e-03 | -4.80 | MYT1 | pfam domains | PF08474 | 3 | 1 | 17795 | 49 |
MYT1L |
8.238e-03 | -4.80 | RYDR_Jsol | pfam domains | PF21119 | 3 | 1 | 17795 | 49 |
RYR2 |
8.238e-03 | -4.80 | RR_TM4-6 | pfam domains | PF06459 | 3 | 1 | 17795 | 49 |
RYR2 |
8.238e-03 | -4.80 | CAC1F_C | pfam domains | PF16885 | 3 | 1 | 17795 | 49 |
CACNA1C |
8.238e-03 | -4.80 | NMDAR2_C | pfam domains | PF10565 | 3 | 1 | 17795 | 49 |
GRIN2A |
8.238e-03 | -4.80 | RyR | pfam domains | PF02026 | 3 | 1 | 17795 | 49 |
RYR2 |
8.238e-03 | -4.80 | SUZ | pfam domains | PF12752 | 3 | 1 | 17795 | 49 |
R3HDM1 |
8.238e-03 | -4.80 | Noelin-1 | pfam domains | PF12308 | 3 | 1 | 17795 | 49 |
OLFM1 |
8.320e-03 | -4.79 | cardiac muscle cell contraction | biological process | GO:0086003 | 51 | 2 | 18204 | 49 |
RYR2,CACNA1C |
8.377e-03 | -4.78 | regulation of G protein-coupled receptor signaling pathway | biological process | GO:0008277 | 155 | 3 | 18204 | 49 |
OPRL1,RGS7,SLC24A4 |
8.387e-03 | -4.78 | cell cortex | cellular component | GO:0005938 | 313 | 4 | 19108 | 49 |
RIMS4,RIMS2,PCLO,UNC13C |
8.477e-03 | -4.77 | AP4M1 (adaptor related protein complex 4 subunit mu 1) | protein interactions | 9179 | 55 | 2 | 19454 | 49 |
GRID2,GRIN2A |
8.638e-03 | -4.75 | response to amine | biological process | GO:0014075 | 52 | 2 | 18204 | 49 |
GRIN2A,RGS7 |
8.663e-03 | -4.75 | cellular localization | biological process | GO:0051641 | 2660 | 14 | 18204 | 49 |
DLG3,GRIN2A,KCNIP4,RYR2,RIMS4,PCLO,HCN1,CPLX1,STXBP5L,UNC13C,RIMS2,NRXN1,GRID2,LRRC7 |
8.746e-03 | -4.74 | Felodipine Metabolism Pathway | SMPDB pathways | SMP0000619 | 3 | 1 | 1369 | 4 |
CACNA1C |
8.962e-03 | -4.71 | biological process involved in intraspecies interaction between organisms | biological process | GO:0051703 | 53 | 2 | 18204 | 49 |
NRXN3,NRXN1 |
8.962e-03 | -4.71 | social behavior | biological process | GO:0035176 | 53 | 2 | 18204 | 49 |
NRXN1,NRXN3 |
9.290e-03 | -4.68 | positive regulation of neuron projection development | biological process | GO:0010976 | 161 | 3 | 18204 | 49 |
PPP2R5B,ZNF804A,LRRC7 |
9.290e-03 | -4.68 | regulation of cyclase activity | biological process | GO:0031279 | 54 | 2 | 18204 | 49 |
CACNA1C,GABBR2 |
9.390e-03 | -4.67 | GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) | protein interactions | 2904 | 58 | 2 | 19454 | 49 |
GRIN2A,DLG3 |
9.391e-03 | -4.67 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 46 | 16828 | 48 |
AK5,MYT1L,GABRD,CPLX1,RIMS4,ST8SIA5,GABRB2,RIMS2,R3HDM1,RBFOX1,STXBP5L,GABBR2,KCNIP4,CELF6,TTC9B,NRXN3,DLG3,LRRC7,CELF4,UNC13C,GRIN2A,ZFPM2,IL1RAPL2,GABRA1,CELF5,TRPM3,GALNT9,CACNA1C,RGS7,KSR2,CR2,ZNF804A,SLC24A4,OPRL1,RYR2,GRID2,PPP2R5B,NRXN1,KCNMA1,PCLO,HCN1,PTPRG,SMPD3,GABRA6,ASTN1,KCNT1 |
9.565e-03 | -4.65 | regulation of transmembrane transport | biological process | GO:0034762 | 485 | 5 | 18204 | 49 |
RYR2,GRIN2A,RGS7,KCNIP4,CACNA1C |
9.625e-03 | -4.64 | establishment or maintenance of epithelial cell apical/basal polarity | biological process | GO:0045197 | 55 | 2 | 18204 | 49 |
LRRC7,DLG3 |
9.686e-03 | -4.64 | Penbutolol Action Pathway | SMPDB pathways | SMP0000305 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Fosphenytoin (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000326 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Dobutamine Action Pathway | SMPDB pathways | SMP0000662 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Bopindolol Action Pathway | SMPDB pathways | SMP0000657 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Oxprenolol Action Pathway | SMPDB pathways | SMP0000304 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Verapamil Action Pathway | SMPDB pathways | SMP0000375 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Ibutilide Action Pathway | SMPDB pathways | SMP0000332 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Metipranolol Action Pathway | SMPDB pathways | SMP0000667 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Amlodipine Action Pathway | SMPDB pathways | SMP0000376 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Procainamide (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000324 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Timolol Action Pathway | SMPDB pathways | SMP0000659 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Atenolol Action Pathway | SMPDB pathways | SMP0000298 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Diltiazem Action Pathway | SMPDB pathways | SMP0000359 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Disopyramide Action Pathway | SMPDB pathways | SMP0000325 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Isradipine Action Pathway | SMPDB pathways | SMP0000378 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Pindolol Action Pathway | SMPDB pathways | SMP0000306 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Acebutolol Action Pathway | SMPDB pathways | SMP0000296 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Isoprenaline Action Pathway | SMPDB pathways | SMP0000663 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Esmolol Action Pathway | SMPDB pathways | SMP0000301 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Bupranolol Action Pathway | SMPDB pathways | SMP0000670 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Bisoprolol Action Pathway | SMPDB pathways | SMP0000300 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Nitrendipine Action Pathway | SMPDB pathways | SMP0000382 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Practolol Action Pathway | SMPDB pathways | SMP0000669 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Nifedipine Action Pathway | SMPDB pathways | SMP0000379 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Flecainide Action Pathway | SMPDB pathways | SMP0000331 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Carteolol Action Pathway | SMPDB pathways | SMP0000658 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Sotalol Action Pathway | SMPDB pathways | SMP0000660 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Betaxolol Action Pathway | SMPDB pathways | SMP0000299 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Levobunolol Action Pathway | SMPDB pathways | SMP0000666 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Nadolol Action Pathway | SMPDB pathways | SMP0000303 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Epinephrine Action Pathway | SMPDB pathways | SMP0000661 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Tocainide Action Pathway | SMPDB pathways | SMP0000330 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Bevantolol Action Pathway | SMPDB pathways | SMP0000668 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Muscle/Heart Contraction | SMPDB pathways | SMP0000588 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Nebivolol Action Pathway | SMPDB pathways | SMP0000366 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Alprenolol Action Pathway | SMPDB pathways | SMP0000297 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Propranolol Action Pathway | SMPDB pathways | SMP0000307 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Mexiletine Action Pathway | SMPDB pathways | SMP0000329 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Nisoldipine Action Pathway | SMPDB pathways | SMP0000381 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Felodipine Action Pathway | SMPDB pathways | SMP0000377 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Metoprolol Action Pathway | SMPDB pathways | SMP0000302 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Nimodipine Action Pathway | SMPDB pathways | SMP0000380 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Arbutamine Action Pathway | SMPDB pathways | SMP0000664 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.686e-03 | -4.64 | Amiodarone Action Pathway | SMPDB pathways | SMP0000665 | 57 | 2 | 1369 | 4 |
RYR2,CACNA1C |
9.686e-03 | -4.64 | Quinidine Action Pathway | SMPDB pathways | SMP0000323 | 57 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
9.713e-03 | -4.63 | Single Helix bin | gene3d domains | 1.20.5.580 | 3 | 1 | 14470 | 47 |
CPLX1 |
9.713e-03 | -4.63 | - | gene3d domains | 1.10.490.160 | 3 | 1 | 14470 | 47 |
RYR2 |
9.751e-03 | -4.63 | dendritic spine | cellular component | GO:0043197 | 172 | 3 | 19108 | 49 |
GRIN2A,GRID2,ZNF804A |
9.964e-03 | -4.61 | cardiac muscle cell action potential | biological process | GO:0086001 | 56 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
1.001e-02 | -4.60 | central_nervous_system-posterior_fossa-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-posterior_fossa-glioma-astrocytoma_Grade_IV | 53 | 2 | 16828 | 48 |
STXBP5L,LRRC7 |
1.002e-02 | -4.60 | Carvedilol Action Pathway | SMPDB pathways | SMP0000367 | 58 | 2 | 1369 | 4 |
RYR2,CACNA1C |
1.002e-02 | -4.60 | Labetalol Action Pathway | SMPDB pathways | SMP0000368 | 58 | 2 | 1369 | 4 |
RYR2,CACNA1C |
1.003e-02 | -4.60 | regulation of transport | biological process | GO:0051049 | 1621 | 10 | 18204 | 49 |
CPLX1,CACNA1C,RYR2,RIMS2,GRIN2A,KCNIP4,SMPD3,RIMS4,PCLO,RGS7 |
1.004e-02 | -4.60 | Sstr2 (somatostatin receptor 2) | protein interactions | 54305 | 4 | 1 | 19454 | 49 |
DLG3 |
1.004e-02 | -4.60 | Clta (clathrin, light chain A) | protein interactions | 83800 | 4 | 1 | 19454 | 49 |
STXBP5L |
1.004e-02 | -4.60 | HCN4 (hyperpolarization activated cyclic nucleotide gated potassium channel 4) | protein interactions | 10021 | 4 | 1 | 19454 | 49 |
HCN1 |
1.004e-02 | -4.60 | Map1b (microtubule-associated protein 1B) | protein interactions | 29456 | 4 | 1 | 19454 | 49 |
STXBP5L |
1.004e-02 | -4.60 | Psmc5 (proteasome 26S subunit, ATPase 5) | protein interactions | 81827 | 4 | 1 | 19454 | 49 |
STXBP5L |
1.004e-02 | -4.60 | NUDT16L2P (nudix hydrolase 16 like 2, pseudogene) | protein interactions | 152195 | 4 | 1 | 19454 | 49 |
GRIN2A |
1.004e-02 | -4.60 | Ywhaq (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta) | protein interactions | 25577 | 4 | 1 | 19454 | 49 |
STXBP5L |
1.006e-02 | -4.60 | neuron spine | cellular component | GO:0044309 | 174 | 3 | 19108 | 49 |
ZNF804A,GRID2,GRIN2A |
1.007e-02 | -4.60 | HCN channels | REACTOME pathways | R-HSA-1296061 | 4 | 1 | 10285 | 26 |
HCN1 |
1.017e-02 | -4.59 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-virilizing_syndrome_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-virilizing_syndrome_producing | 298 | 4 | 16828 | 48 |
NRXN3,PPP2R5B,GABRA1,PCLO |
1.022e-02 | -4.58 | HCN channel complex | cellular component | GO:0098855 | 4 | 1 | 19108 | 49 |
HCN1 |
1.027e-02 | -4.58 | nervous system process | biological process | GO:0050877 | 1376 | 9 | 18204 | 49 |
OPRL1,NRXN3,SLC24A4,GRID2,INSYN1,CELF4,GRIN2A,NRXN1,HCN1 |
1.036e-02 | -4.57 | Lidocaine (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000328 | 59 | 2 | 1369 | 4 |
RYR2,CACNA1C |
1.037e-02 | -4.57 | neuron projection membrane | cellular component | GO:0032589 | 60 | 2 | 19108 | 49 |
GABRA1,GABRA6 |
1.055e-02 | -4.55 | cognition | biological process | GO:0050890 | 319 | 4 | 18204 | 49 |
NRXN3,NRXN1,OPRL1,GRIN2A |
1.066e-02 | -4.54 | regulation of lyase activity | biological process | GO:0051339 | 58 | 2 | 18204 | 49 |
CACNA1C,GABBR2 |
1.072e-02 | -4.54 | negative regulation of hyaluronan biosynthetic process | biological process | GO:1900126 | 4 | 1 | 18204 | 49 |
SMPD3 |
1.072e-02 | -4.54 | response to high light intensity | biological process | GO:0009644 | 4 | 1 | 18204 | 49 |
SLC24A4 |
1.072e-02 | -4.54 | cellular response to light intensity | biological process | GO:0071484 | 4 | 1 | 18204 | 49 |
SLC24A4 |
1.072e-02 | -4.54 | maintenance of presynaptic active zone structure | biological process | GO:0048790 | 4 | 1 | 18204 | 49 |
PCLO |
1.072e-02 | -4.54 | left ventricular cardiac muscle tissue morphogenesis | biological process | GO:0003220 | 4 | 1 | 18204 | 49 |
RYR2 |
1.072e-02 | -4.54 | deoxyribonucleoside diphosphate biosynthetic process | biological process | GO:0009189 | 4 | 1 | 18204 | 49 |
AK5 |
1.072e-02 | -4.54 | regulation of atrial cardiac muscle cell action potential | biological process | GO:0098910 | 4 | 1 | 18204 | 49 |
RYR2 |
1.072e-02 | -4.54 | nerve maturation | biological process | GO:0021682 | 4 | 1 | 18204 | 49 |
SLC24A4 |
1.072e-02 | -4.54 | negative regulation of gonad development | biological process | GO:1905940 | 4 | 1 | 18204 | 49 |
ZFPM2 |
1.072e-02 | -4.54 | regulation of AV node cell action potential | biological process | GO:0098904 | 4 | 1 | 18204 | 49 |
RYR2 |
1.076e-02 | -4.53 | VDCC_L_a1su | interpro domains | IPR005446 | 4 | 1 | 18521 | 50 |
CACNA1C |
1.076e-02 | -4.53 | DLG1-like | interpro domains | IPR016313 | 4 | 1 | 18521 | 50 |
DLG3 |
1.076e-02 | -4.53 | RGS6/7/9/11_DHEX_sf | interpro domains | IPR047017 | 4 | 1 | 18521 | 50 |
RGS7 |
1.076e-02 | -4.53 | TRPM_tetra | interpro domains | IPR032415 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | DLG1-4_PDZ_assoc | interpro domains | IPR019583 | 4 | 1 | 18521 | 50 |
DLG3 |
1.076e-02 | -4.53 | RGS6/7/9/11 | interpro domains | IPR047016 | 4 | 1 | 18521 | 50 |
RGS7 |
1.076e-02 | -4.53 | Lethal2_giant | interpro domains | IPR000664 | 4 | 1 | 18521 | 50 |
STXBP5L |
1.076e-02 | -4.53 | SUZ | interpro domains | IPR024771 | 4 | 1 | 18521 | 50 |
R3HDM1 |
1.076e-02 | -4.53 | LLGL2 | interpro domains | IPR013577 | 4 | 1 | 18521 | 50 |
STXBP5L |
1.076e-02 | -4.53 | RGS_DHEX | interpro domains | IPR040759 | 4 | 1 | 18521 | 50 |
RGS7 |
1.076e-02 | -4.53 | Synaphin | interpro domains | IPR008849 | 4 | 1 | 18521 | 50 |
CPLX1 |
1.076e-02 | -4.53 | Opioid_rcpt | interpro domains | IPR001418 | 4 | 1 | 18521 | 50 |
OPRL1 |
1.076e-02 | -4.53 | DLG1_PEST_dom | interpro domains | IPR019590 | 4 | 1 | 18521 | 50 |
DLG3 |
1.076e-02 | -4.53 | Ion_trans_N | interpro domains | IPR013621 | 4 | 1 | 18521 | 50 |
HCN1 |
1.076e-02 | -4.53 | TRPM_tetra_sf | interpro domains | IPR037162 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | response to organonitrogen compound | biological process | GO:0010243 | 915 | 7 | 18204 | 49 |
GABRB2,HCN1,RYR2,GRIN2A,SMPD3,SLC24A4,RGS7 |
1.079e-02 | -4.53 | ryanodine-sensitive calcium-release channel activity | molecular function | GO:0005219 | 4 | 1 | 18094 | 49 |
RYR2 |
1.079e-02 | -4.53 | structural constituent of presynaptic active zone | molecular function | GO:0098882 | 4 | 1 | 18094 | 49 |
PCLO |
1.084e-02 | -4.52 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 47 | 16828 | 48 |
NRXN3,DLG3,GABBR2,KCNIP4,TTC9B,CELF6,RBFOX1,STXBP5L,R3HDM1,GABRB2,ST8SIA5,RIMS2,RIMS4,AK5,MYT1L,GABRD,OLFM1,GALNT9,TRPM3,CELF5,GABRA1,IL1RAPL2,CELF4,ZFPM2,UNC13C,GRIN2A,LRRC7,GRID2,RYR2,SLC24A4,ZNF804A,OPRL1,KSR2,CR2,RBFOX3,RGS7,CACNA1C,KCNT1,ASTN1,GABRA6,SMPD3,HCN1,PCLO,PTPRG,KCNMA1,NRXN1,PPP2R5B |
1.087e-02 | -4.52 | GABABRECEPTR | prints domains | PR01176 | 3 | 1 | 5227 | 19 |
GABBR2 |
1.087e-02 | -4.52 | RYANODINER | prints domains | PR00795 | 3 | 1 | 5227 | 19 |
RYR2 |
1.087e-02 | -4.52 | GABAARBETA | prints domains | PR01160 | 3 | 1 | 5227 | 19 |
GABRB2 |
1.097e-02 | -4.51 | Synaphin | pfam domains | PF05835 | 4 | 1 | 17795 | 49 |
CPLX1 |
1.097e-02 | -4.51 | Ion_trans_N | pfam domains | PF08412 | 4 | 1 | 17795 | 49 |
HCN1 |
1.097e-02 | -4.51 | TRPM_tetra | pfam domains | PF16519 | 4 | 1 | 17795 | 49 |
TRPM3 |
1.097e-02 | -4.51 | LLGL | pfam domains | PF08366 | 4 | 1 | 17795 | 49 |
STXBP5L |
1.097e-02 | -4.51 | PDZ_assoc | pfam domains | PF10600 | 4 | 1 | 17795 | 49 |
DLG3 |
1.097e-02 | -4.51 | RGS_DHEX | pfam domains | PF18148 | 4 | 1 | 17795 | 49 |
RGS7 |
1.101e-02 | -4.51 | Axon guidance | REACTOME pathways | R-HSA-422475 | 549 | 5 | 10285 | 26 |
PPP2R5B,CACNA1C,DLG3,GRIN2A,KSR2 |
1.101e-02 | -4.51 | establishment or maintenance of apical/basal cell polarity | biological process | GO:0035088 | 59 | 2 | 18204 | 49 |
LRRC7,DLG3 |
1.101e-02 | -4.51 | establishment or maintenance of bipolar cell polarity | biological process | GO:0061245 | 59 | 2 | 18204 | 49 |
LRRC7,DLG3 |
1.106e-02 | -4.50 | bladder | COSMIC cancer mutations | bladder | 14112 | 46 | 16828 | 48 |
KCNIP4,GABBR2,CELF6,TTC9B,RBFOX1,STXBP5L,NRXN3,DLG3,CPLX1,RIMS4,AK5,MYT1L,GABRD,R3HDM1,ST8SIA5,GABRB2,RIMS2,TRPM3,GALNT9,CELF4,UNC13C,GRIN2A,ZFPM2,LRRC7,CELF5,GABRA1,IL1RAPL2,SLC24A4,ZNF804A,OPRL1,KSR2,CR2,RYR2,GRID2,CACNA1C,RGS7,GABRA6,SMPD3,KCNT1,ASTN1,PPP2R5B,NRXN1,PCLO,HCN1,PTPRG,KCNMA1 |
1.106e-02 | -4.50 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 46 | 16828 | 48 |
DLG3,NRXN3,CELF6,TTC9B,KCNIP4,GABBR2,STXBP5L,RBFOX1,R3HDM1,RIMS2,GABRB2,ST8SIA5,RIMS4,CPLX1,GABRD,MYT1L,AK5,GALNT9,TRPM3,CELF5,GABRA1,IL1RAPL2,ZFPM2,UNC13C,GRIN2A,CELF4,LRRC7,GRID2,RYR2,OPRL1,SLC24A4,ZNF804A,CR2,KSR2,RGS7,CACNA1C,KCNT1,ASTN1,GABRA6,SMPD3,PTPRG,HCN1,PCLO,KCNMA1,NRXN1,PPP2R5B |
1.127e-02 | -4.49 | Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 | KEGG pathways | M00069 | 3 | 1 | 7161 | 27 |
ST8SIA5 |
1.127e-02 | -4.49 | Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 | KEGG pathways | hsa_M00069 | 3 | 1 | 7161 | 27 |
ST8SIA5 |
1.137e-02 | -4.48 | regulation of action potential | biological process | GO:0098900 | 60 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
1.144e-02 | -4.47 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 3 | 5310 | 17 |
RGS7,CACNA1C,RYR2 |
1.156e-02 | -4.46 | liver-carcinoma | COSMIC cancer mutations | liver-carcinoma | 15337 | 48 | 16828 | 48 |
KCNT1,ASTN1,GABRA6,SMPD3,PCLO,HCN1,PTPRG,KCNMA1,PPP2R5B,NRXN1,RYR2,GRID2,ZNF804A,SLC24A4,OPRL1,KSR2,CR2,RGS7,RBFOX3,CACNA1C,GALNT9,TRPM3,CELF5,IL1RAPL2,GABRA1,CELF4,GRIN2A,UNC13C,ZFPM2,LRRC7,NRXN3,DLG3,GABBR2,KCNIP4,CELF6,TTC9B,RBFOX1,STXBP5L,R3HDM1,ST8SIA5,GABRB2,RIMS2,CPLX1,RIMS4,AK5,GABRD,MYT1L,OLFM1 |
1.165e-02 | -4.45 | Synaptic Vesicle Pathway | WikiPathways | WP2267 | 52 | 2 | 5310 | 17 |
CPLX1,UNC13C |
1.166e-02 | -4.45 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 42 | 16828 | 48 |
GALNT9,ASTN1,KCNT1,SMPD3,TRPM3,GABRA6,GABRA1,IL1RAPL2,KCNMA1,PTPRG,PCLO,CELF5,HCN1,LRRC7,NRXN1,UNC13C,GRIN2A,ZFPM2,CELF4,NRXN3,GRID2,RYR2,CR2,STXBP5L,KSR2,RBFOX1,TTC9B,KCNIP4,ZNF804A,GABBR2,RBFOX3,RGS7,RIMS2,ST8SIA5,GABRB2,R3HDM1,OLFM1,MYT1L,AK5,RIMS4,CACNA1C,CPLX1 |
1.174e-02 | -4.44 | cardiac muscle tissue morphogenesis | biological process | GO:0055008 | 61 | 2 | 18204 | 49 |
RYR2,ZFPM2 |
1.174e-02 | -4.44 | negative regulation of G protein-coupled receptor signaling pathway | biological process | GO:0045744 | 61 | 2 | 18204 | 49 |
RGS7,OPRL1 |
1.178e-02 | -4.44 | cellular component assembly | biological process | GO:0022607 | 2472 | 13 | 18204 | 49 |
GRID2,SMPD3,GABRA6,CELF6,NRXN1,UNC13C,GABRB2,HCN1,TRPM3,PCLO,GABRA1,CELF4,CELF5 |
1.181e-02 | -4.44 | C1-like_sf | interpro domains | IPR046349 | 61 | 2 | 18521 | 50 |
KSR2,UNC13C |
1.209e-02 | -4.42 | excitatory synapse | cellular component | GO:0060076 | 65 | 2 | 19108 | 49 |
UNC13C,GRID2 |
1.209e-02 | -4.42 | SUZ | prosite domains | PS51673 | 4 | 1 | 12186 | 37 |
R3HDM1 |
1.211e-02 | -4.41 | regulation of postsynaptic membrane neurotransmitter receptor levels | biological process | GO:0099072 | 62 | 2 | 18204 | 49 |
DLG3,LRRC7 |
1.227e-02 | -4.40 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 5 | 18204 | 49 |
CPLX1,SMPD3,RIMS4,PCLO,RIMS2 |
1.238e-02 | -4.39 | PCNX3 (pecanex 3) | protein interactions | 399909 | 67 | 2 | 19454 | 49 |
GABRA6,MARCHF4 |
1.244e-02 | -4.39 | Dopaminergic synapse | KEGG pathways | hsa04728 | 130 | 3 | 7161 | 27 |
CACNA1C,PPP2R5B,GRIN2A |
1.244e-02 | -4.39 | Dopaminergic synapse | KEGG pathways | ko04728 | 130 | 3 | 7161 | 27 |
GRIN2A,PPP2R5B,CACNA1C |
1.249e-02 | -4.38 | ventricular cardiac muscle tissue development | biological process | GO:0003229 | 63 | 2 | 18204 | 49 |
RYR2,ZFPM2 |
1.253e-02 | -4.38 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 49 |
TRPM3 |
1.253e-02 | -4.38 | TRH (thyrotropin releasing hormone) | protein interactions | 7200 | 5 | 1 | 19454 | 49 |
KCNIP4 |
1.253e-02 | -4.38 | Ncam1 (neural cell adhesion molecule 1) | protein interactions | 24586 | 5 | 1 | 19454 | 49 |
STXBP5L |
1.253e-02 | -4.38 | GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3) | protein interactions | 2567 | 5 | 1 | 19454 | 49 |
GABRA1 |
1.253e-02 | -4.38 | SYT13 (synaptotagmin 13) | protein interactions | 57586 | 5 | 1 | 19454 | 49 |
NRXN1 |
1.253e-02 | -4.38 | NXNL2 (nucleoredoxin like 2) | protein interactions | 158046 | 5 | 1 | 19454 | 49 |
GRIN2A |
1.253e-02 | -4.38 | CHRM1 (cholinergic receptor muscarinic 1) | protein interactions | 1128 | 5 | 1 | 19454 | 49 |
RGS7 |
1.253e-02 | -4.38 | HCN3 (hyperpolarization activated cyclic nucleotide gated potassium channel 3) | protein interactions | 57657 | 5 | 1 | 19454 | 49 |
HCN1 |
1.258e-02 | -4.38 | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 891 | 7 | 16828 | 48 |
GABBR2,CELF4,PTPRG,ASTN1,AK5,MYT1L,LRRC7 |
1.274e-02 | -4.36 | TMEM186 (transmembrane protein 186) | protein interactions | 25880 | 68 | 2 | 19454 | 49 |
MARCHF4,OPRL1 |
1.275e-02 | -4.36 | Nicotine Activity on Chromaffin Cells | WikiPathways | WP1603 | 4 | 1 | 5310 | 17 |
CACNA1C |
1.281e-02 | -4.36 | skin-upper_back-malignant_melanoma | COSMIC cancer mutations | skin-upper_back-malignant_melanoma | 319 | 4 | 16828 | 48 |
RGS7,KCNIP4,GRIN2A,GABRA6 |
1.293e-02 | -4.35 | - | gene3d domains | 1.20.58.1100 | 4 | 1 | 14470 | 47 |
UNC13C |
1.293e-02 | -4.35 | TRPM, tetramerisation domain | gene3d domains | 1.20.5.1010 | 4 | 1 | 14470 | 47 |
TRPM3 |
1.293e-02 | -4.35 | - | gene3d domains | 1.10.1240.60 | 4 | 1 | 14470 | 47 |
RGS7 |
1.308e-02 | -4.34 | virilizing_syndrome_producing | COSMIC cancer mutations | virilizing_syndrome_producing | 321 | 4 | 16828 | 48 |
PPP2R5B,NRXN3,GABRA1,PCLO |
1.325e-02 | -4.32 | positive regulation of synapse assembly | biological process | GO:0051965 | 65 | 2 | 18204 | 49 |
GRID2,NRXN1 |
1.325e-02 | -4.32 | sensory perception of pain | biological process | GO:0019233 | 65 | 2 | 18204 | 49 |
OPRL1,GRIN2A |
1.333e-02 | -4.32 | ZF_DAG_PE_1 | prosite domains | PS00479 | 58 | 2 | 12186 | 37 |
KSR2,UNC13C |
1.339e-02 | -4.31 | presynaptic dense core vesicle exocytosis | biological process | GO:0099525 | 5 | 1 | 18204 | 49 |
UNC13C |
1.339e-02 | -4.31 | calcium ion export across plasma membrane | biological process | GO:1990034 | 5 | 1 | 18204 | 49 |
SLC24A4 |
1.339e-02 | -4.31 | neuronal dense core vesicle exocytosis | biological process | GO:0099011 | 5 | 1 | 18204 | 49 |
UNC13C |
1.339e-02 | -4.31 | membrane depolarization during AV node cell action potential | biological process | GO:0086045 | 5 | 1 | 18204 | 49 |
CACNA1C |
1.339e-02 | -4.31 | conditioned place preference | biological process | GO:1990708 | 5 | 1 | 18204 | 49 |
OPRL1 |
1.339e-02 | -4.31 | neuron-glial cell signaling | biological process | GO:0150099 | 5 | 1 | 18204 | 49 |
GABBR2 |
1.339e-02 | -4.31 | Purkinje myocyte to ventricular cardiac muscle cell signaling | biological process | GO:0086029 | 5 | 1 | 18204 | 49 |
RYR2 |
1.339e-02 | -4.31 | deoxyribonucleoside diphosphate metabolic process | biological process | GO:0009186 | 5 | 1 | 18204 | 49 |
AK5 |
1.339e-02 | -4.31 | positive regulation of neurotrophin TRK receptor signaling pathway | biological process | GO:0051388 | 5 | 1 | 18204 | 49 |
PPP2R5B |
1.339e-02 | -4.31 | negative regulation of cell volume | biological process | GO:0045794 | 5 | 1 | 18204 | 49 |
KCNMA1 |
1.339e-02 | -4.31 | regulation of homophilic cell adhesion | biological process | GO:1903385 | 5 | 1 | 18204 | 49 |
PTPRG |
1.339e-02 | -4.31 | ADP biosynthetic process | biological process | GO:0006172 | 5 | 1 | 18204 | 49 |
AK5 |
1.339e-02 | -4.31 | response to odorant | biological process | GO:1990834 | 5 | 1 | 18204 | 49 |
SLC24A4 |
1.339e-02 | -4.31 | purine deoxyribonucleotide biosynthetic process | biological process | GO:0009153 | 5 | 1 | 18204 | 49 |
AK5 |
1.339e-02 | -4.31 | positive regulation of dendritic spine maintenance | biological process | GO:1902952 | 5 | 1 | 18204 | 49 |
ZNF804A |
1.339e-02 | -4.31 | positive regulation of the force of heart contraction | biological process | GO:0098735 | 5 | 1 | 18204 | 49 |
RYR2 |
1.339e-02 | -4.31 | gephyrin clustering involved in postsynaptic density assembly | biological process | GO:0097116 | 5 | 1 | 18204 | 49 |
NRXN1 |
1.339e-02 | -4.31 | general adaptation syndrome, behavioral process | biological process | GO:0051867 | 5 | 1 | 18204 | 49 |
HCN1 |
1.343e-02 | -4.31 | PP2A_B56 | interpro domains | IPR002554 | 5 | 1 | 18521 | 50 |
PPP2R5B |
1.343e-02 | -4.31 | Znf_C2H2C_sf | interpro domains | IPR036060 | 5 | 1 | 18521 | 50 |
MYT1L |
1.343e-02 | -4.31 | K/Na/Ca-exchanger | interpro domains | IPR004481 | 5 | 1 | 18521 | 50 |
SLC24A4 |
1.343e-02 | -4.31 | Munc13_dom-2 | interpro domains | IPR014772 | 5 | 1 | 18521 | 50 |
UNC13C |
1.347e-02 | -4.31 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | molecular function | GO:0086007 | 5 | 1 | 18094 | 49 |
CACNA1C |
1.347e-02 | -4.31 | calcium, potassium:sodium antiporter activity | molecular function | GO:0008273 | 5 | 1 | 18094 | 49 |
SLC24A4 |
1.347e-02 | -4.31 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 7 | 16828 | 48 |
ASTN1,PTPRG,LRRC7,MYT1L,AK5,CELF4,GABBR2 |
1.352e-02 | -4.30 | MAGUK_N_PEST | smart domains | SM01277 | 4 | 1 | 9717 | 33 |
DLG3 |
1.369e-02 | -4.29 | B56 | pfam domains | PF01603 | 5 | 1 | 17795 | 49 |
PPP2R5B |
1.372e-02 | -4.29 | PE/DAG-bd | interpro domains | IPR002219 | 66 | 2 | 18521 | 50 |
UNC13C,KSR2 |
1.392e-02 | -4.27 | calcium channel complex | cellular component | GO:0034704 | 70 | 2 | 19108 | 49 |
RYR2,CACNA1C |
1.406e-02 | -4.26 | upper_back | COSMIC cancer mutations | upper_back | 328 | 4 | 16828 | 48 |
RGS7,KCNIP4,GABRA6,GRIN2A |
1.429e-02 | -4.25 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 3 | 10285 | 26 |
KCNIP4,CACNA1C,RYR2 |
1.432e-02 | -4.25 | RBM47 (RNA binding motif protein 47) | protein interactions | 54502 | 202 | 3 | 19454 | 49 |
CELF5,RBFOX1,R3HDM1 |
1.446e-02 | -4.24 | LVDCCALPHA1 | prints domains | PR01630 | 4 | 1 | 5227 | 19 |
CACNA1C |
1.446e-02 | -4.24 | LETHAL2GIANT | prints domains | PR00962 | 4 | 1 | 5227 | 19 |
STXBP5L |
1.446e-02 | -4.24 | OPIOIDR | prints domains | PR00384 | 4 | 1 | 5227 | 19 |
OPRL1 |
1.458e-02 | -4.23 | pancreas-carcinoma | COSMIC cancer mutations | pancreas-carcinoma | 14770 | 47 | 16828 | 48 |
LRRC7,ZFPM2,GRIN2A,UNC13C,CELF4,GABRA1,IL1RAPL2,CELF5,TRPM3,GALNT9,OLFM1,GABRD,MYT1L,AK5,RIMS4,CPLX1,RIMS2,GABRB2,ST8SIA5,R3HDM1,STXBP5L,RBFOX1,CELF6,TTC9B,GABBR2,DLG3,NRXN3,NRXN1,PPP2R5B,KCNMA1,PTPRG,HCN1,PCLO,SMPD3,GABRA6,ASTN1,KCNT1,CACNA1C,RGS7,RBFOX3,CR2,KSR2,OPRL1,SLC24A4,ZNF804A,RYR2,GRID2 |
1.502e-02 | -4.20 | GRID2IP (Grid2 interacting protein) | protein interactions | 392862 | 6 | 1 | 19454 | 49 |
GRID2 |
1.502e-02 | -4.20 | SYTL3 (synaptotagmin like 3) | protein interactions | 94120 | 6 | 1 | 19454 | 49 |
NRXN1 |
1.502e-02 | -4.20 | Tubb4b (tubulin, beta 4B class IVb) | protein interactions | 296554 | 6 | 1 | 19454 | 49 |
STXBP5L |
1.508e-02 | -4.19 | TNFR1-mediated ceramide production | REACTOME pathways | R-HSA-5626978 | 6 | 1 | 10285 | 26 |
SMPD3 |
1.509e-02 | -4.19 | MHD2 | prosite domains | PS51259 | 5 | 1 | 12186 | 37 |
UNC13C |
1.516e-02 | -4.19 | meninges | COSMIC cancer mutations | meninges | 514 | 5 | 16828 | 48 |
CR2,RIMS2,GRIN2A,CACNA1C,PCLO |
1.516e-02 | -4.19 | meningioma | COSMIC cancer mutations | meningioma | 514 | 5 | 16828 | 48 |
GRIN2A,CACNA1C,PCLO,RIMS2,CR2 |
1.526e-02 | -4.18 | cardiac conduction | biological process | GO:0061337 | 70 | 2 | 18204 | 49 |
RYR2,CACNA1C |
1.526e-02 | -4.18 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 46 | 16828 | 48 |
KCNT1,ASTN1,GABRA6,SMPD3,PTPRG,HCN1,PCLO,KCNMA1,NRXN1,PPP2R5B,GRID2,RYR2,OPRL1,ZNF804A,SLC24A4,CR2,KSR2,RBFOX3,RGS7,CACNA1C,GALNT9,TRPM3,CELF5,IL1RAPL2,GABRA1,ZFPM2,UNC13C,GRIN2A,CELF4,LRRC7,DLG3,NRXN3,CELF6,TTC9B,GABBR2,STXBP5L,RBFOX1,R3HDM1,RIMS2,GABRB2,ST8SIA5,RIMS4,GABRD,MYT1L,OLFM1,AK5 |
1.529e-02 | -4.18 | nuclear stress granule | cellular component | GO:0097165 | 6 | 1 | 19108 | 49 |
RBFOX1 |
1.529e-02 | -4.18 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 3 | 16828 | 48 |
ZNF804A,GRID2,PTPRG |
1.554e-02 | -4.16 | central_nervous_system-brainstem-glioma | COSMIC cancer mutations | central_nervous_system-brainstem-glioma | 338 | 4 | 16828 | 48 |
IL1RAPL2,ASTN1,OPRL1,CELF4 |
1.560e-02 | -4.16 | ZF_DAG_PE_2 | prosite domains | PS50081 | 63 | 2 | 12186 | 37 |
KSR2,UNC13C |
1.562e-02 | -4.16 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 25 | 16828 | 48 |
RIMS4,RIMS2,GABRB2,OPRL1,TTC9B,SLC24A4,ZNF804A,KCNIP4,CR2,STXBP5L,RBFOX1,GRID2,NRXN3,CELF4,LRRC7,PPP2R5B,NRXN1,CELF5,HCN1,IL1RAPL2,KCNMA1,GABRA6,SMPD3,TRPM3,ASTN1 |
1.569e-02 | -4.16 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 25 | 16828 | 48 |
KCNMA1,IL1RAPL2,HCN1,CELF5,LRRC7,NRXN1,PPP2R5B,CELF4,ASTN1,SMPD3,TRPM3,GABRA6,RIMS2,GABRB2,RIMS4,NRXN3,GRID2,STXBP5L,CR2,RBFOX1,TTC9B,OPRL1,SLC24A4,ZNF804A,KCNIP4 |
1.569e-02 | -4.15 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 14 | 16828 | 48 |
RYR2,ASTN1,NRXN3,SLC24A4,RBFOX1,CR2,HCN1,PCLO,PTPRG,RGS7,ZFPM2,GRIN2A,GABRD,MYT1L |
1.573e-02 | -4.15 | SDR9C7 (short chain dehydrogenase/reductase family 9C member 7) | protein interactions | 121214 | 76 | 2 | 19454 | 49 |
RBFOX1,GALNT9 |
1.573e-02 | -4.15 | SRI (sorcin) | protein interactions | 6717 | 76 | 2 | 19454 | 49 |
RYR2,CACNA1C |
1.573e-02 | -4.15 | caecum | COSMIC cancer mutations | caecum | 14248 | 46 | 16828 | 48 |
CELF5,GABRA1,IL1RAPL2,ZFPM2,UNC13C,GRIN2A,CELF4,LRRC7,GALNT9,TRPM3,R3HDM1,RIMS2,GABRB2,ST8SIA5,RIMS4,OLFM1,GABRD,MYT1L,AK5,DLG3,NRXN3,TTC9B,CELF6,GABBR2,STXBP5L,RBFOX1,PTPRG,HCN1,PCLO,KCNMA1,NRXN1,PPP2R5B,KCNT1,ASTN1,GABRA6,SMPD3,RGS7,RBFOX3,CACNA1C,GRID2,RYR2,OPRL1,SLC24A4,ZNF804A,CR2,KSR2 |
1.587e-02 | -4.14 | neuromuscular junction | cellular component | GO:0031594 | 75 | 2 | 19108 | 49 |
DLG3,UNC13C |
1.591e-02 | -4.14 | regulation of secretion by cell | biological process | GO:1903530 | 551 | 5 | 18204 | 49 |
RIMS2,RIMS4,PCLO,SMPD3,CPLX1 |
1.604e-02 | -4.13 | positive regulation of inhibitory postsynaptic potential | biological process | GO:0097151 | 6 | 1 | 18204 | 49 |
RIMS2 |
1.604e-02 | -4.13 | vocal learning | biological process | GO:0042297 | 6 | 1 | 18204 | 49 |
NRXN1 |
1.604e-02 | -4.13 | neuronal signal transduction | biological process | GO:0023041 | 6 | 1 | 18204 | 49 |
OLFM1 |
1.604e-02 | -4.13 | postsynaptic density protein 95 clustering | biological process | GO:0097119 | 6 | 1 | 18204 | 49 |
NRXN1 |
1.604e-02 | -4.13 | Purkinje myocyte to ventricular cardiac muscle cell communication | biological process | GO:0086068 | 6 | 1 | 18204 | 49 |
RYR2 |
1.604e-02 | -4.13 | purine nucleoside diphosphate biosynthetic process | biological process | GO:0009136 | 6 | 1 | 18204 | 49 |
AK5 |
1.604e-02 | -4.13 | purine ribonucleoside diphosphate biosynthetic process | biological process | GO:0009180 | 6 | 1 | 18204 | 49 |
AK5 |
1.604e-02 | -4.13 | general adaptation syndrome | biological process | GO:0051866 | 6 | 1 | 18204 | 49 |
HCN1 |
1.604e-02 | -4.13 | imitative learning | biological process | GO:0098596 | 6 | 1 | 18204 | 49 |
NRXN1 |
1.604e-02 | -4.13 | dentinogenesis | biological process | GO:0097187 | 6 | 1 | 18204 | 49 |
SMPD3 |
1.604e-02 | -4.13 | cellular response to histamine | biological process | GO:0071420 | 6 | 1 | 18204 | 49 |
GABRB2 |
1.604e-02 | -4.13 | presynaptic active zone organization | biological process | GO:1990709 | 6 | 1 | 18204 | 49 |
PCLO |
1.604e-02 | -4.13 | sphingomyelin catabolic process | biological process | GO:0006685 | 6 | 1 | 18204 | 49 |
SMPD3 |
1.609e-02 | -4.13 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 1 | 18521 | 50 |
RYR2 |
1.609e-02 | -4.13 | RIH_dom | interpro domains | IPR000699 | 6 | 1 | 18521 | 50 |
RYR2 |
1.609e-02 | -4.13 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 1 | 18521 | 50 |
RYR2 |
1.609e-02 | -4.13 | Adenylat_kinase_CS | interpro domains | IPR033690 | 6 | 1 | 18521 | 50 |
AK5 |
1.609e-02 | -4.13 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 1 | 18521 | 50 |
RYR2 |
1.609e-02 | -4.13 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 1 | 18521 | 50 |
RYR2 |
1.609e-02 | -4.13 | cardiac ventricle morphogenesis | biological process | GO:0003208 | 72 | 2 | 18204 | 49 |
ZFPM2,RYR2 |
1.614e-02 | -4.13 | calcium-induced calcium release activity | molecular function | GO:0048763 | 6 | 1 | 18094 | 49 |
RYR2 |
1.614e-02 | -4.13 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity | molecular function | GO:0003828 | 6 | 1 | 18094 | 49 |
ST8SIA5 |
1.614e-02 | -4.13 | glutamate-gated calcium ion channel activity | molecular function | GO:0022849 | 6 | 1 | 18094 | 49 |
GRIN2A |
1.636e-02 | -4.11 | Adrenergic signaling in cardiomyocytes | KEGG pathways | ko04261 | 144 | 3 | 7161 | 27 |
PPP2R5B,RYR2,CACNA1C |
1.636e-02 | -4.11 | Adrenergic signaling in cardiomyocytes | KEGG pathways | hsa04261 | 144 | 3 | 7161 | 27 |
CACNA1C,PPP2R5B,RYR2 |
1.641e-02 | -4.11 | zf-C2HC | pfam domains | PF01530 | 6 | 1 | 17795 | 49 |
MYT1L |
1.641e-02 | -4.11 | RYDR_ITPR | pfam domains | PF01365 | 6 | 1 | 17795 | 49 |
RYR2 |
1.641e-02 | -4.11 | RIH_assoc | pfam domains | PF08454 | 6 | 1 | 17795 | 49 |
RYR2 |
1.641e-02 | -4.11 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 1 | 17795 | 49 |
RYR2 |
1.662e-02 | -4.10 | protein-RNA complex assembly | biological process | GO:0022618 | 200 | 3 | 18204 | 49 |
CELF6,CELF5,CELF4 |
1.687e-02 | -4.08 | DUF1041 | smart domains | SM01145 | 5 | 1 | 9717 | 33 |
UNC13C |
1.693e-02 | -4.08 | PKD2 (polycystin 2, transient receptor potential cation channel) | protein interactions | 5311 | 79 | 2 | 19454 | 49 |
PTPRG,INSYN1 |
1.738e-02 | -4.05 | muscle tissue morphogenesis | biological process | GO:0060415 | 75 | 2 | 18204 | 49 |
RYR2,ZFPM2 |
1.738e-02 | -4.05 | regulation of behavior | biological process | GO:0050795 | 75 | 2 | 18204 | 49 |
SLC24A4,OPRL1 |
1.738e-02 | -4.05 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | biological process | GO:0007193 | 75 | 2 | 18204 | 49 |
GABBR2,OPRL1 |
1.740e-02 | -4.05 | Phenytoin (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000327 | 77 | 2 | 1369 | 4 |
CACNA1C,RYR2 |
1.750e-02 | -4.05 | CR1 (complement C3b/C4b receptor 1 (Knops blood group)) | protein interactions | 1378 | 7 | 1 | 19454 | 49 |
CR2 |
1.750e-02 | -4.05 | KCNMB1 (potassium calcium-activated channel subfamily M regulatory beta subunit 1) | protein interactions | 3779 | 7 | 1 | 19454 | 49 |
KCNMA1 |
1.750e-02 | -4.05 | HCN2 (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2) | protein interactions | 610 | 7 | 1 | 19454 | 49 |
HCN1 |
1.750e-02 | -4.05 | KCNE2 (potassium voltage-gated channel subfamily E regulatory subunit 2) | protein interactions | 9992 | 7 | 1 | 19454 | 49 |
CACNA1C |
1.757e-02 | -4.04 | Phase 1 - inactivation of fast Na+ channels | REACTOME pathways | R-HSA-5576894 | 7 | 1 | 10285 | 26 |
KCNIP4 |
1.757e-02 | -4.04 | NrCAM interactions | REACTOME pathways | R-HSA-447038 | 7 | 1 | 10285 | 26 |
DLG3 |
1.782e-02 | -4.03 | G protein-coupled receptor dimeric complex | cellular component | GO:0038037 | 7 | 1 | 19108 | 49 |
GABBR2 |
1.782e-02 | -4.03 | actin-mediated cell contraction | biological process | GO:0070252 | 76 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
1.808e-02 | -4.01 | ADENYLATE_KINASE | prosite domains | PS00113 | 6 | 1 | 12186 | 37 |
AK5 |
1.827e-02 | -4.00 | regulation of synaptic transmission, glutamatergic | biological process | GO:0051966 | 77 | 2 | 18204 | 49 |
GRIN2A,NRXN1 |
1.829e-02 | -4.00 | cellular process | biological process | GO:0009987 | 14996 | 46 | 18204 | 49 |
SLC24A4,RYR2,GABRA1,GABRA6,LRRC7,IL1RAPL2,RIMS2,GABRD,MYT1L,TRPM3,KCNMA1,ZFPM2,ST8SIA5,DLG3,KCNT1,GRID2,PTPRG,NRXN3,GABRB2,UNC13C,AK5,RBFOX3,RIMS4,KSR2,INSYN1,KCNIP4,PPP2R5B,SMPD3,CR2,OPRL1,RBFOX1,PCLO,GALNT9,RGS7,CELF5,ASTN1,CELF4,GRIN2A,OLFM1,CELF6,CPLX1,HCN1,CACNA1C,GABBR2,STXBP5L,NRXN1 |
1.832e-02 | -4.00 | - | gene3d domains | 3.30.60.20 | 64 | 2 | 14470 | 47 |
UNC13C,KSR2 |
1.858e-02 | -3.99 | SLC27A3 (solute carrier family 27 member 3) | protein interactions | 11000 | 83 | 2 | 19454 | 49 |
GRIN2A,MARCHF4 |
1.858e-02 | -3.99 | RBPMS2 (RNA binding protein, mRNA processing factor 2) | protein interactions | 348093 | 83 | 2 | 19454 | 49 |
RBFOX1,CELF4 |
1.859e-02 | -3.98 | TGM1 (transglutaminase 1) | protein interactions | 7051 | 223 | 3 | 19454 | 49 |
RBFOX1,GALNT9,HCN1 |
1.869e-02 | -3.98 | AV node cell to bundle of His cell signaling | biological process | GO:0086027 | 7 | 1 | 18204 | 49 |
CACNA1C |
1.869e-02 | -3.98 | sleep | biological process | GO:0030431 | 7 | 1 | 18204 | 49 |
GRIN2A |
1.869e-02 | -3.98 | observational learning | biological process | GO:0098597 | 7 | 1 | 18204 | 49 |
NRXN1 |
1.869e-02 | -3.98 | regulation of eating behavior | biological process | GO:1903998 | 7 | 1 | 18204 | 49 |
SLC24A4 |
1.869e-02 | -3.98 | cerebellar granular layer formation | biological process | GO:0021684 | 7 | 1 | 18204 | 49 |
GRID2 |
1.869e-02 | -3.98 | modulation of inhibitory postsynaptic potential | biological process | GO:0098828 | 7 | 1 | 18204 | 49 |
RIMS2 |
1.869e-02 | -3.98 | spontaneous neurotransmitter secretion | biological process | GO:0061669 | 7 | 1 | 18204 | 49 |
RIMS2 |
1.869e-02 | -3.98 | cellular response to magnesium ion | biological process | GO:0071286 | 7 | 1 | 18204 | 49 |
SMPD3 |
1.869e-02 | -3.98 | regulation of female gonad development | biological process | GO:2000194 | 7 | 1 | 18204 | 49 |
ZFPM2 |
1.869e-02 | -3.98 | regulation of ATPase-coupled calcium transmembrane transporter activity | biological process | GO:1901894 | 7 | 1 | 18204 | 49 |
RYR2 |
1.869e-02 | -3.98 | urinary bladder smooth muscle contraction | biological process | GO:0014832 | 7 | 1 | 18204 | 49 |
KCNMA1 |
1.869e-02 | -3.98 | positive regulation of long-term synaptic depression | biological process | GO:1900454 | 7 | 1 | 18204 | 49 |
GRID2 |
1.869e-02 | -3.98 | olfactory nerve development | biological process | GO:0021553 | 7 | 1 | 18204 | 49 |
SLC24A4 |
1.869e-02 | -3.98 | dense core granule exocytosis | biological process | GO:1990504 | 7 | 1 | 18204 | 49 |
UNC13C |
1.869e-02 | -3.98 | AV node cell action potential | biological process | GO:0086016 | 7 | 1 | 18204 | 49 |
CACNA1C |
1.869e-02 | -3.98 | cerebellar granule cell differentiation | biological process | GO:0021707 | 7 | 1 | 18204 | 49 |
GRID2 |
1.872e-02 | -3.98 | regulation of cardiac muscle contraction | biological process | GO:0055117 | 78 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
1.873e-02 | -3.98 | response to nitrogen compound | biological process | GO:1901698 | 1021 | 7 | 18204 | 49 |
GABRB2,HCN1,GRIN2A,RYR2,SLC24A4,SMPD3,RGS7 |
1.875e-02 | -3.98 | GPHH_dom | interpro domains | IPR031649 | 7 | 1 | 18521 | 50 |
CACNA1C |
1.875e-02 | -3.98 | Znf_C2H2C | interpro domains | IPR002515 | 7 | 1 | 18521 | 50 |
MYT1L |
1.875e-02 | -3.98 | VDCC_a1su_IQ | interpro domains | IPR014873 | 7 | 1 | 18521 | 50 |
CACNA1C |
1.875e-02 | -3.98 | Munc13_1 | interpro domains | IPR014770 | 7 | 1 | 18521 | 50 |
UNC13C |
1.875e-02 | -3.98 | MUN_dom | interpro domains | IPR010439 | 7 | 1 | 18521 | 50 |
UNC13C |
1.881e-02 | -3.97 | interleukin-1 receptor activity | molecular function | GO:0004908 | 7 | 1 | 18094 | 49 |
IL1RAPL2 |
1.881e-02 | -3.97 | NMDA glutamate receptor activity | molecular function | GO:0004972 | 7 | 1 | 18094 | 49 |
GRIN2A |
1.881e-02 | -3.97 | sphingomyelin phosphodiesterase activity | molecular function | GO:0004767 | 7 | 1 | 18094 | 49 |
SMPD3 |
1.881e-02 | -3.97 | G protein-coupled opioid receptor activity | molecular function | GO:0004985 | 7 | 1 | 18094 | 49 |
OPRL1 |
1.890e-02 | -3.97 | protein-RNA complex organization | biological process | GO:0071826 | 210 | 3 | 18204 | 49 |
CELF6,CELF5,CELF4 |
1.894e-02 | -3.97 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 6 | 16828 | 48 |
RYR2,PCLO,GRID2,RIMS2,ASTN1,LRRC7 |
1.900e-02 | -3.96 | SMPD2 (sphingomyelin phosphodiesterase 2) | protein interactions | 6610 | 84 | 2 | 19454 | 49 |
MARCHF4,GRIN2A |
1.910e-02 | -3.96 | hairy_cell_leukaemia | COSMIC cancer mutations | hairy_cell_leukaemia | 1440 | 9 | 16828 | 48 |
MYT1L,NRXN1,GABBR2,RGS7,RIMS2,R3HDM1,RYR2,PCLO,CELF5 |
1.910e-02 | -3.96 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | 1440 | 9 | 16828 | 48 |
RYR2,R3HDM1,PCLO,CELF5,RGS7,RIMS2,GABBR2,MYT1L,NRXN1 |
1.912e-02 | -3.96 | Ca_chan_IQ | pfam domains | PF08763 | 7 | 1 | 17795 | 49 |
CACNA1C |
1.912e-02 | -3.96 | MUN | pfam domains | PF06292 | 7 | 1 | 17795 | 49 |
UNC13C |
1.912e-02 | -3.96 | GPHH | pfam domains | PF16905 | 7 | 1 | 17795 | 49 |
CACNA1C |
1.926e-02 | -3.95 | ATP2A3 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3) | protein interactions | 489 | 226 | 3 | 19454 | 49 |
GRIN2A,MARCHF4,GABRA6 |
1.933e-02 | -3.95 | - | gene3d domains | 4.10.320.30 | 6 | 1 | 14470 | 47 |
MYT1L |
1.933e-02 | -3.95 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 1 | 14470 | 47 |
RYR2 |
1.949e-02 | -3.94 | pleura-mesothelioma-epithelial | COSMIC cancer mutations | pleura-mesothelioma-epithelial | 362 | 4 | 16828 | 48 |
CELF4,RYR2,PCLO,RGS7 |
1.984e-02 | -3.92 | epithelial | COSMIC cancer mutations | epithelial | 364 | 4 | 16828 | 48 |
RYR2,PCLO,CELF4,RGS7 |
1.985e-02 | -3.92 | superpathway of adenosine nucleotides de novo biosynthesis I | BIOCYC pathways | META_PWY-7229 | 6 | 1 | 902 | 3 |
AK5 |
1.986e-02 | -3.92 | RBFOX1 (RNA binding fox-1 homolog 1) | protein interactions | 54715 | 86 | 2 | 19454 | 49 |
RBFOX1,RBFOX3 |
1.998e-02 | -3.91 | PEX5L (peroxisomal biogenesis factor 5 like) | protein interactions | 51555 | 8 | 1 | 19454 | 49 |
HCN1 |
1.998e-02 | -3.91 | TAFA1 (TAFA chemokine like family member 1) | protein interactions | 407738 | 8 | 1 | 19454 | 49 |
NRXN3 |
1.998e-02 | -3.91 | DHRS11 (dehydrogenase/reductase 11) | protein interactions | 79154 | 8 | 1 | 19454 | 49 |
DLG3 |
1.998e-02 | -3.91 | OR5H1 (olfactory receptor family 5 subfamily H member 1) | protein interactions | 26341 | 8 | 1 | 19454 | 49 |
RBFOX3 |
1.998e-02 | -3.91 | TMEM135 (transmembrane protein 135) | protein interactions | 65084 | 8 | 1 | 19454 | 49 |
SMPD3 |
1.998e-02 | -3.91 | DEFB104A (defensin beta 104A) | protein interactions | 140596 | 8 | 1 | 19454 | 49 |
PTPRG |
1.998e-02 | -3.91 | C18orf32 (chromosome 18 open reading frame 32) | protein interactions | 497661 | 8 | 1 | 19454 | 49 |
CACNA1C |
2.010e-02 | -3.91 | Hurthle_cell_carcinoma | COSMIC cancer mutations | Hurthle_cell_carcinoma | 203 | 3 | 16828 | 48 |
ZFPM2,GABRD,ASTN1 |
2.010e-02 | -3.91 | thyroid-carcinoma-Hurthle_cell_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-Hurthle_cell_carcinoma | 203 | 3 | 16828 | 48 |
ZFPM2,GABRD,ASTN1 |
2.034e-02 | -3.90 | cone photoreceptor outer segment | cellular component | GO:0120199 | 8 | 1 | 19108 | 49 |
SLC24A4 |
2.035e-02 | -3.89 | posterior_fossa | COSMIC cancer mutations | posterior_fossa | 77 | 2 | 16828 | 48 |
LRRC7,STXBP5L |
2.036e-02 | -3.89 | C1 | smart domains | SM00109 | 65 | 2 | 9717 | 33 |
UNC13C,KSR2 |
2.056e-02 | -3.88 | muscle organ morphogenesis | biological process | GO:0048644 | 82 | 2 | 18204 | 49 |
ZFPM2,RYR2 |
2.059e-02 | -3.88 | regulation of cell junction assembly | biological process | GO:1901888 | 217 | 3 | 18204 | 49 |
NRXN1,IL1RAPL2,GRID2 |
2.073e-02 | -3.88 | TAP2 (transporter 2, ATP binding cassette subfamily B member) | protein interactions | 6891 | 88 | 2 | 19454 | 49 |
GRIN2A,MARCHF4 |
2.073e-02 | -3.88 | RNF114 (ring finger protein 114) | protein interactions | 55905 | 88 | 2 | 19454 | 49 |
CPLX1,AK5 |
2.085e-02 | -3.87 | human chr16p13.2 | chromosome location | human chr16p13.2 | 11 | 1 | 26134 | 50 |
GRIN2A |
2.103e-02 | -3.86 | cardiac muscle contraction | biological process | GO:0060048 | 83 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
2.107e-02 | -3.86 | ZF_CCHHC | prosite domains | PS51802 | 7 | 1 | 12186 | 37 |
MYT1L |
2.107e-02 | -3.86 | MHD1 | prosite domains | PS51258 | 7 | 1 | 12186 | 37 |
UNC13C |
2.113e-02 | -3.86 | regulation of metal ion transport | biological process | GO:0010959 | 393 | 4 | 18204 | 49 |
KCNIP4,RGS7,RYR2,CACNA1C |
2.127e-02 | -3.85 | ConA-like_dom_sf | interpro domains | IPR013320 | 219 | 3 | 18521 | 50 |
NRXN3,NRXN1,RYR2 |
2.130e-02 | -3.85 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 5 | 16828 | 48 |
CACNA1C,ZNF804A,KSR2,DLG3,LRRC7 |
2.134e-02 | -3.85 | gonadal mesoderm development | biological process | GO:0007506 | 8 | 1 | 18204 | 49 |
ZFPM2 |
2.134e-02 | -3.85 | regulation of hyaluronan biosynthetic process | biological process | GO:1900125 | 8 | 1 | 18204 | 49 |
SMPD3 |
2.134e-02 | -3.85 | negative regulation of complement activation, classical pathway | biological process | GO:0045959 | 8 | 1 | 18204 | 49 |
CR2 |
2.134e-02 | -3.85 | negative regulation of G0 to G1 transition | biological process | GO:0070317 | 8 | 1 | 18204 | 49 |
PPP2R5B |
2.134e-02 | -3.85 | positive regulation of male gonad development | biological process | GO:2000020 | 8 | 1 | 18204 | 49 |
ZFPM2 |
2.134e-02 | -3.85 | micturition | biological process | GO:0060073 | 8 | 1 | 18204 | 49 |
KCNMA1 |
2.134e-02 | -3.85 | chondrocyte development involved in endochondral bone morphogenesis | biological process | GO:0003433 | 8 | 1 | 18204 | 49 |
SMPD3 |
2.134e-02 | -3.85 | atrioventricular valve formation | biological process | GO:0003190 | 8 | 1 | 18204 | 49 |
OLFM1 |
2.140e-02 | -3.84 | TRPM_SLOG | interpro domains | IPR041491 | 8 | 1 | 18521 | 50 |
TRPM3 |
2.146e-02 | -3.84 | immunoglobulin receptor binding | molecular function | GO:0034987 | 8 | 1 | 18094 | 49 |
CR2 |
2.151e-02 | -3.84 | regulation of release of sequestered calcium ion into cytosol | biological process | GO:0051279 | 84 | 2 | 18204 | 49 |
RYR2,CACNA1C |
2.151e-02 | -3.84 | odontogenesis of dentin-containing tooth | biological process | GO:0042475 | 84 | 2 | 18204 | 49 |
SMPD3,SLC24A4 |
2.180e-02 | -3.83 | UBQLN1 (ubiquilin 1) | protein interactions | 29979 | 424 | 4 | 19454 | 49 |
GABRA6,GABRA1,GABRB2,GABRD |
2.180e-02 | -3.83 | CAMK2A (calcium/calmodulin dependent protein kinase II alpha) | protein interactions | 815 | 237 | 3 | 19454 | 49 |
DLG3,LRRC7,GRIN2A |
2.182e-02 | -3.82 | LSDAT_euk | pfam domains | PF18139 | 8 | 1 | 17795 | 49 |
TRPM3 |
2.193e-02 | -3.82 | Platelet homeostasis | REACTOME pathways | R-HSA-418346 | 91 | 2 | 10285 | 26 |
PPP2R5B,KCNMA1 |
2.244e-02 | -3.80 | G alpha (i) signalling events | REACTOME pathways | R-HSA-418594 | 242 | 3 | 10285 | 26 |
GABBR2,OPRL1,RGS7 |
2.245e-02 | -3.80 | NETO1 (neuropilin and tolloid like 1) | protein interactions | 81832 | 9 | 1 | 19454 | 49 |
GRIN2A |
2.245e-02 | -3.80 | KLK4 (kallikrein related peptidase 4) | protein interactions | 9622 | 9 | 1 | 19454 | 49 |
KCNIP4 |
2.245e-02 | -3.80 | GABRB2 (gamma-aminobutyric acid type A receptor subunit beta2) | protein interactions | 2561 | 9 | 1 | 19454 | 49 |
GABRA1 |
2.245e-02 | -3.80 | Ubc (ubiquitin C) | protein interactions | 50522 | 9 | 1 | 19454 | 49 |
STXBP5L |
2.247e-02 | -3.80 | regulation of potassium ion transmembrane transport | biological process | GO:1901379 | 86 | 2 | 18204 | 49 |
KCNIP4,RGS7 |
2.252e-02 | -3.79 | - | gene3d domains | 6.10.250.2500 | 7 | 1 | 14470 | 47 |
CACNA1C |
2.252e-02 | -3.79 | - | gene3d domains | 6.10.250.2180 | 7 | 1 | 14470 | 47 |
CACNA1C |
2.253e-02 | -3.79 | Ca2+ activated K+ channels | REACTOME pathways | R-HSA-1296052 | 9 | 1 | 10285 | 26 |
KCNMA1 |
2.260e-02 | -3.79 | synovial | COSMIC cancer mutations | synovial | 8 | 1 | 16828 | 48 |
RYR2 |
2.260e-02 | -3.79 | bone-knee-chondrosarcoma-synovial | COSMIC cancer mutations | bone-knee-chondrosarcoma-synovial | 8 | 1 | 16828 | 48 |
RYR2 |
2.270e-02 | -3.79 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 14 | 16828 | 48 |
ZNF804A,GABRA6,KSR2,TRPM3,CR2,GRID2,ASTN1,GRIN2A,RIMS4,OLFM1,PCLO,R3HDM1,HCN1,PTPRG |
2.270e-02 | -3.79 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 14 | 16828 | 48 |
OLFM1,RIMS4,GRIN2A,HCN1,R3HDM1,PCLO,PTPRG,TRPM3,KSR2,CR2,ZNF804A,GABRA6,ASTN1,GRID2 |
2.272e-02 | -3.78 | human chr8q23.1 | chromosome location | human chr8q23.1 | 12 | 1 | 26134 | 50 |
ZFPM2 |
2.283e-02 | -3.78 | regulation of secretion | biological process | GO:0051046 | 605 | 5 | 18204 | 49 |
RIMS2,PCLO,RIMS4,SMPD3,CPLX1 |
2.285e-02 | -3.78 | NMDA selective glutamate receptor complex | cellular component | GO:0017146 | 9 | 1 | 19108 | 49 |
GRIN2A |
2.285e-02 | -3.78 | junctional sarcoplasmic reticulum membrane | cellular component | GO:0014701 | 9 | 1 | 19108 | 49 |
RYR2 |
2.296e-02 | -3.77 | associative learning | biological process | GO:0008306 | 87 | 2 | 18204 | 49 |
GRIN2A,OPRL1 |
2.313e-02 | -3.77 | sphingomyelin metabolism/ceramide salvage | BIOCYC pathways | HUMAN_PWY3DJ-11281 | 7 | 1 | 902 | 3 |
SMPD3 |
2.313e-02 | -3.77 | purine deoxyribonucleosides salvage | BIOCYC pathways | META_PWY-7224 | 7 | 1 | 902 | 3 |
AK5 |
2.318e-02 | -3.76 | RAF/MAP kinase cascade | REACTOME pathways | R-HSA-5673001 | 245 | 3 | 10285 | 26 |
PPP2R5B,GRIN2A,KSR2 |
2.318e-02 | -3.76 | GRB2 events in EGFR signaling | REACTOME pathways | R-HSA-179812 | 245 | 3 | 10285 | 26 |
PPP2R5B,GRIN2A,KSR2 |
2.318e-02 | -3.76 | SOS-mediated signalling | REACTOME pathways | R-HSA-112412 | 245 | 3 | 10285 | 26 |
GRIN2A,PPP2R5B,KSR2 |
2.318e-02 | -3.76 | SHC1 events in EGFR signaling | REACTOME pathways | R-HSA-180336 | 245 | 3 | 10285 | 26 |
KSR2,GRIN2A,PPP2R5B |
2.321e-02 | -3.76 | Synaptic vesicle cycle | KEGG pathways | ko04721 | 63 | 2 | 7161 | 27 |
CPLX1,UNC13C |
2.321e-02 | -3.76 | Synaptic vesicle cycle | KEGG pathways | hsa04721 | 63 | 2 | 7161 | 27 |
UNC13C,CPLX1 |
2.327e-02 | -3.76 | mRNA metabolic process | biological process | GO:0016071 | 608 | 5 | 18204 | 49 |
CELF4,RBFOX3,CELF6,RBFOX1,CELF5 |
2.345e-02 | -3.75 | GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) | protein interactions | 2902 | 94 | 2 | 19454 | 49 |
DLG3,GRIN2A |
2.354e-02 | -3.75 | Ca_chan_IQ | smart domains | SM01062 | 7 | 1 | 9717 | 33 |
CACNA1C |
2.387e-02 | -3.74 | parotid | COSMIC cancer mutations | parotid | 578 | 5 | 16828 | 48 |
CACNA1C,ZNF804A,KSR2,DLG3,LRRC7 |
2.393e-02 | -3.73 | Arrhythmogenic Right Ventricular Cardiomyopathy | WikiPathways | WP2118 | 76 | 2 | 5310 | 17 |
CACNA1C,RYR2 |
2.397e-02 | -3.73 | regulation of complement activation, classical pathway | biological process | GO:0030450 | 9 | 1 | 18204 | 49 |
CR2 |
2.397e-02 | -3.73 | spontaneous synaptic transmission | biological process | GO:0098814 | 9 | 1 | 18204 | 49 |
RIMS2 |
2.397e-02 | -3.73 | urinary tract smooth muscle contraction | biological process | GO:0014848 | 9 | 1 | 18204 | 49 |
KCNMA1 |
2.397e-02 | -3.73 | positive regulation of synapse maturation | biological process | GO:0090129 | 9 | 1 | 18204 | 49 |
NRXN1 |
2.397e-02 | -3.73 | synaptic vesicle docking | biological process | GO:0016081 | 9 | 1 | 18204 | 49 |
UNC13C |
2.397e-02 | -3.73 | negative regulation of cAMP-mediated signaling | biological process | GO:0043951 | 9 | 1 | 18204 | 49 |
OPRL1 |
2.397e-02 | -3.73 | regulation of male gonad development | biological process | GO:2000018 | 9 | 1 | 18204 | 49 |
ZFPM2 |
2.397e-02 | -3.73 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0014808 | 9 | 1 | 18204 | 49 |
RYR2 |
2.397e-02 | -3.73 | G protein-coupled opioid receptor signaling pathway | biological process | GO:0038003 | 9 | 1 | 18204 | 49 |
OPRL1 |
2.397e-02 | -3.73 | positive regulation of gonad development | biological process | GO:1905941 | 9 | 1 | 18204 | 49 |
ZFPM2 |
2.397e-02 | -3.73 | cerebellar granular layer morphogenesis | biological process | GO:0021683 | 9 | 1 | 18204 | 49 |
GRID2 |
2.403e-02 | -3.73 | EGF | smart domains | SM00181 | 184 | 3 | 9717 | 33 |
NRXN1,ASTN1,NRXN3 |
2.404e-02 | -3.73 | VDCCAlpha1 | interpro domains | IPR002077 | 9 | 1 | 18521 | 50 |
CACNA1C |
2.404e-02 | -3.73 | Adenylat/UMP-CMP_kin | interpro domains | IPR000850 | 9 | 1 | 18521 | 50 |
AK5 |
2.404e-02 | -3.73 | Quino_amine_DH_bsu | interpro domains | IPR011044 | 9 | 1 | 18521 | 50 |
OLFM1 |
2.404e-02 | -3.73 | NaCa_Exmemb | interpro domains | IPR004837 | 9 | 1 | 18521 | 50 |
SLC24A4 |
2.404e-02 | -3.73 | NCX_ion-bd_dom_sf | interpro domains | IPR044880 | 9 | 1 | 18521 | 50 |
SLC24A4 |
2.412e-02 | -3.72 | intracellularly cAMP-activated cation channel activity | molecular function | GO:0005222 | 9 | 1 | 18094 | 49 |
HCN1 |
2.412e-02 | -3.72 | adenylate kinase activity | molecular function | GO:0004017 | 9 | 1 | 18094 | 49 |
AK5 |
2.417e-02 | -3.72 | Signalling to p38 via RIT and RIN | REACTOME pathways | R-HSA-187706 | 249 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
2.417e-02 | -3.72 | ARMS-mediated activation | REACTOME pathways | R-HSA-170984 | 249 | 3 | 10285 | 26 |
PPP2R5B,GRIN2A,KSR2 |
2.430e-02 | -3.72 | human chr9q34.3 | chromosome location | human chr9q34.3 | 126 | 2 | 26134 | 50 |
OLFM1,KCNT1 |
2.438e-02 | -3.71 | HOMER1 (homer scaffold protein 1) | protein interactions | 9456 | 96 | 2 | 19454 | 49 |
RYR2,INSYN1 |
2.443e-02 | -3.71 | Frs2-mediated activation | REACTOME pathways | R-HSA-170968 | 250 | 3 | 10285 | 26 |
GRIN2A,PPP2R5B,KSR2 |
2.446e-02 | -3.71 | feeding behavior | biological process | GO:0007631 | 90 | 2 | 18204 | 49 |
OPRL1,SLC24A4 |
2.450e-02 | -3.71 | cellular component biogenesis | biological process | GO:0044085 | 2716 | 13 | 18204 | 49 |
GRID2,GABRA6,SMPD3,CELF6,UNC13C,HCN1,GABRB2,NRXN1,TRPM3,PCLO,CELF5,GABRA1,CELF4 |
2.452e-02 | -3.71 | Na_Ca_ex | pfam domains | PF01699 | 9 | 1 | 17795 | 49 |
SLC24A4 |
2.461e-02 | -3.70 | Renin secretion | KEGG pathways | hsa04924 | 65 | 2 | 7161 | 27 |
CACNA1C,KCNMA1 |
2.461e-02 | -3.70 | Renin secretion | KEGG pathways | ko04924 | 65 | 2 | 7161 | 27 |
CACNA1C,KCNMA1 |
2.468e-02 | -3.70 | MAPK1/MAPK3 signaling | REACTOME pathways | R-HSA-5684996 | 251 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
2.470e-02 | -3.70 | EGF-like_dom | interpro domains | IPR000742 | 232 | 3 | 18521 | 50 |
NRXN1,NRXN3,ASTN1 |
2.486e-02 | -3.69 | SNTA1 (syntrophin alpha 1) | protein interactions | 6640 | 97 | 2 | 19454 | 49 |
INSYN1,RYR2 |
2.486e-02 | -3.69 | ATP13A2 (ATPase cation transporting 13A2) | protein interactions | 23400 | 97 | 2 | 19454 | 49 |
MARCHF4,NRXN1 |
2.491e-02 | -3.69 | GRIN3A (glutamate ionotropic receptor NMDA type subunit 3A) | protein interactions | 116443 | 10 | 1 | 19454 | 49 |
GRIN2A |
2.491e-02 | -3.69 | ANKRD26P1 (ankyrin repeat domain 26 pseudogene 1) | protein interactions | 124149 | 10 | 1 | 19454 | 49 |
RBFOX3 |
2.491e-02 | -3.69 | FCER2 (Fc epsilon receptor II) | protein interactions | 2208 | 10 | 1 | 19454 | 49 |
CR2 |
2.493e-02 | -3.69 | neurogenesis | biological process | GO:0022008 | 1334 | 8 | 18204 | 49 |
NRXN3,GRID2,MYT1L,ASTN1,HCN1,GABRB2,GRIN2A,NRXN1 |
2.494e-02 | -3.69 | Prolonged ERK activation events | REACTOME pathways | R-HSA-169893 | 252 | 3 | 10285 | 26 |
KSR2,GRIN2A,PPP2R5B |
2.518e-02 | -3.68 | oesophagus | COSMIC cancer mutations | oesophagus | 14970 | 47 | 16828 | 48 |
RBFOX1,STXBP5L,KCNIP4,GABBR2,CELF6,NRXN3,DLG3,AK5,GABRD,OLFM1,MYT1L,CPLX1,RIMS4,GABRB2,ST8SIA5,RIMS2,R3HDM1,TRPM3,GALNT9,LRRC7,CELF4,ZFPM2,UNC13C,GRIN2A,GABRA1,IL1RAPL2,CELF5,KSR2,CR2,ZNF804A,SLC24A4,OPRL1,RYR2,GRID2,CACNA1C,RGS7,RBFOX3,SMPD3,GABRA6,ASTN1,KCNT1,NRXN1,PPP2R5B,KCNMA1,HCN1,PCLO,PTPRG |
2.518e-02 | -3.68 | ADENYLTKNASE | prints domains | PR00094 | 7 | 1 | 5227 | 19 |
AK5 |
2.519e-02 | -3.68 | Signaling by Leptin | REACTOME pathways | R-HSA-2586552 | 253 | 3 | 10285 | 26 |
GRIN2A,PPP2R5B,KSR2 |
2.531e-02 | -3.68 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 48 |
PTPRG,PCLO,KCNMA1,MYT1L,TRPM3 |
2.534e-02 | -3.68 | PTK2B (protein tyrosine kinase 2 beta) | protein interactions | 2185 | 98 | 2 | 19454 | 49 |
GRIN2A,DLG3 |
2.548e-02 | -3.67 | protein tetramerization | biological process | GO:0051262 | 92 | 2 | 18204 | 49 |
TRPM3,HCN1 |
2.570e-02 | -3.66 | Guanylate Kinase phosphate binding domain | gene3d domains | 3.30.63.10 | 8 | 1 | 14470 | 47 |
DLG3 |
2.571e-02 | -3.66 | Interleukin receptor SHC signaling | REACTOME pathways | R-HSA-912526 | 255 | 3 | 10285 | 26 |
PPP2R5B,GRIN2A,KSR2 |
2.578e-02 | -3.66 | blood circulation | biological process | GO:0008015 | 418 | 4 | 18204 | 49 |
KCNMA1,CACNA1C,RYR2,OPRL1 |
2.597e-02 | -3.65 | Signalling to RAS | REACTOME pathways | R-HSA-167044 | 256 | 3 | 10285 | 26 |
KSR2,GRIN2A,PPP2R5B |
2.604e-02 | -3.65 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 2 | 7161 | 27 |
GRIN2A,CACNA1C |
2.604e-02 | -3.65 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 2 | 7161 | 27 |
GRIN2A,CACNA1C |
2.607e-02 | -3.65 | Nitric Oxide Signaling Pathway | SMPDB pathways | SMP0063777 | 9 | 1 | 1369 | 4 |
GRIN2A |
2.616e-02 | -3.64 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 49 |
KCNIP4,LRRC7,GRIN2A |
2.616e-02 | -3.64 | muscle contraction | biological process | GO:0006936 | 238 | 3 | 18204 | 49 |
RYR2,KCNMA1,CACNA1C |
2.616e-02 | -3.64 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | biological process | GO:0007188 | 238 | 3 | 18204 | 49 |
RIMS2,OPRL1,GABBR2 |
2.646e-02 | -3.63 | human chr3p14.2 | chromosome location | human chr3p14.2 | 14 | 1 | 26134 | 50 |
PTPRG |
2.646e-02 | -3.63 | human chr2p16.3 | chromosome location | human chr2p16.3 | 14 | 1 | 26134 | 50 |
NRXN1 |
2.650e-02 | -3.63 | VEGFR2 mediated cell proliferation | REACTOME pathways | R-HSA-5218921 | 258 | 3 | 10285 | 26 |
KSR2,GRIN2A,PPP2R5B |
2.660e-02 | -3.63 | neurotransmitter receptor transport, endosome to postsynaptic membrane | biological process | GO:0098887 | 10 | 1 | 18204 | 49 |
LRRC7 |
2.660e-02 | -3.63 | postsynaptic density assembly | biological process | GO:0097107 | 10 | 1 | 18204 | 49 |
NRXN1 |
2.660e-02 | -3.63 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | biological process | GO:1903514 | 10 | 1 | 18204 | 49 |
RYR2 |
2.660e-02 | -3.63 | ribonucleoside diphosphate biosynthetic process | biological process | GO:0009188 | 10 | 1 | 18204 | 49 |
AK5 |
2.660e-02 | -3.63 | neurotransmitter receptor transport, endosome to plasma membrane | biological process | GO:0099639 | 10 | 1 | 18204 | 49 |
LRRC7 |
2.660e-02 | -3.63 | response to histamine | biological process | GO:0034776 | 10 | 1 | 18204 | 49 |
GABRB2 |
2.660e-02 | -3.63 | postsynaptic membrane assembly | biological process | GO:0097104 | 10 | 1 | 18204 | 49 |
NRXN1 |
2.660e-02 | -3.63 | learned vocalization behavior or vocal learning | biological process | GO:0098598 | 10 | 1 | 18204 | 49 |
NRXN1 |
2.660e-02 | -3.63 | inhibitory postsynaptic potential | biological process | GO:0060080 | 10 | 1 | 18204 | 49 |
INSYN1 |
2.660e-02 | -3.63 | serotonin metabolic process | biological process | GO:0042428 | 10 | 1 | 18204 | 49 |
GRIN2A |
2.668e-02 | -3.62 | MIR_motif | interpro domains | IPR016093 | 10 | 1 | 18521 | 50 |
RYR2 |
2.668e-02 | -3.62 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 1 | 18521 | 50 |
RYR2 |
2.668e-02 | -3.62 | FYVE_2 | interpro domains | IPR041282 | 10 | 1 | 18521 | 50 |
RIMS2 |
2.668e-02 | -3.62 | TPR_2 | interpro domains | IPR013105 | 10 | 1 | 18521 | 50 |
TTC9B |
2.676e-02 | -3.62 | profilin binding | molecular function | GO:0005522 | 10 | 1 | 18094 | 49 |
PCLO |
2.676e-02 | -3.62 | mitogen-activated protein kinase kinase binding | molecular function | GO:0031434 | 10 | 1 | 18094 | 49 |
KSR2 |
2.676e-02 | -3.62 | NAD+ nucleosidase activity | molecular function | GO:0003953 | 10 | 1 | 18094 | 49 |
IL1RAPL2 |
2.676e-02 | -3.62 | calcium:sodium antiporter activity | molecular function | GO:0005432 | 10 | 1 | 18094 | 49 |
SLC24A4 |
2.677e-02 | -3.62 | Amphetamine addiction | KEGG pathways | ko05031 | 68 | 2 | 7161 | 27 |
CACNA1C,GRIN2A |
2.677e-02 | -3.62 | Amphetamine addiction | KEGG pathways | hsa05031 | 68 | 2 | 7161 | 27 |
GRIN2A,CACNA1C |
2.679e-02 | -3.62 | LRP5 (LDL receptor related protein 5) | protein interactions | 4041 | 101 | 2 | 19454 | 49 |
ST8SIA5,MARCHF4 |
2.715e-02 | -3.61 | - | gene3d domains | 2.80.10.50 | 79 | 2 | 14470 | 47 |
GALNT9,RYR2 |
2.719e-02 | -3.60 | EGF-type_Asp/Asn_hydroxyl_site | interpro domains | IPR000152 | 95 | 2 | 18521 | 50 |
NRXN1,NRXN3 |
2.720e-02 | -3.60 | ADK | pfam domains | PF00406 | 10 | 1 | 17795 | 49 |
AK5 |
2.720e-02 | -3.60 | R3H | pfam domains | PF01424 | 10 | 1 | 17795 | 49 |
R3HDM1 |
2.720e-02 | -3.60 | MIR | pfam domains | PF02815 | 10 | 1 | 17795 | 49 |
RYR2 |
2.720e-02 | -3.60 | TPR_2 | pfam domains | PF07719 | 10 | 1 | 17795 | 49 |
TTC9B |
2.720e-02 | -3.60 | FYVE_2 | pfam domains | PF02318 | 10 | 1 | 17795 | 49 |
RIMS2 |
2.728e-02 | -3.60 | CTSV (cathepsin V) | protein interactions | 1515 | 102 | 2 | 19454 | 49 |
GALNT9,RBFOX1 |
2.737e-02 | -3.60 | PIP5K1P1 (phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 1) | protein interactions | 206426 | 11 | 1 | 19454 | 49 |
NRXN3 |
2.737e-02 | -3.60 | CACNA1D (calcium voltage-gated channel subunit alpha1 D) | protein interactions | 776 | 11 | 1 | 19454 | 49 |
RYR2 |
2.737e-02 | -3.60 | KCTD16 (potassium channel tetramerization domain containing 16) | protein interactions | 57528 | 11 | 1 | 19454 | 49 |
GABBR2 |
2.737e-02 | -3.60 | SYTL1 (synaptotagmin like 1) | protein interactions | 84958 | 11 | 1 | 19454 | 49 |
NRXN1 |
2.737e-02 | -3.60 | DUS4L (dihydrouridine synthase 4 like) | protein interactions | 11062 | 11 | 1 | 19454 | 49 |
PTPRG |
2.737e-02 | -3.60 | IL17A (interleukin 17A) | protein interactions | 3605 | 11 | 1 | 19454 | 49 |
KCNIP4 |
2.737e-02 | -3.60 | RIMS3 (regulating synaptic membrane exocytosis 3) | protein interactions | 9783 | 11 | 1 | 19454 | 49 |
RIMS2 |
2.758e-02 | -3.59 | Interleukin-2 signaling | REACTOME pathways | R-HSA-451927 | 262 | 3 | 10285 | 26 |
KSR2,GRIN2A,PPP2R5B |
2.767e-02 | -3.59 | signal transduction | biological process | GO:0007165 | 4637 | 19 | 18204 | 49 |
SLC24A4,PCLO,RGS7,KSR2,RYR2,CELF4,GRIN2A,INSYN1,SMPD3,PPP2R5B,OLFM1,GRID2,PTPRG,CR2,OPRL1,CACNA1C,GABBR2,IL1RAPL2,RIMS2 |
2.785e-02 | -3.58 | Signalling to ERKs | REACTOME pathways | R-HSA-187687 | 263 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
2.786e-02 | -3.58 | G protein-coupled receptor complex | cellular component | GO:0097648 | 11 | 1 | 19108 | 49 |
GABBR2 |
2.810e-02 | -3.57 | nerve development | biological process | GO:0021675 | 97 | 2 | 18204 | 49 |
SLC24A4,GABRB2 |
2.811e-02 | -3.57 | Stimuli-sensing channels | REACTOME pathways | R-HSA-2672351 | 104 | 2 | 10285 | 26 |
RYR2,TRPM3 |
2.828e-02 | -3.57 | SPP1 (secreted phosphoprotein 1) | protein interactions | 6696 | 104 | 2 | 19454 | 49 |
RIMS4,ZNF804A |
2.828e-02 | -3.57 | MSI1 (musashi RNA binding protein 1) | protein interactions | 4440 | 104 | 2 | 19454 | 49 |
CELF5,RBFOX3 |
2.840e-02 | -3.56 | FCERI mediated MAPK activation | REACTOME pathways | R-HSA-2871796 | 265 | 3 | 10285 | 26 |
GRIN2A,PPP2R5B,KSR2 |
2.872e-02 | -3.55 | mRNA binding | molecular function | GO:0003729 | 639 | 5 | 18094 | 49 |
CELF5,RBFOX1,RBFOX3,CELF6,CELF4 |
2.886e-02 | -3.55 | NCX, central ion-binding region | gene3d domains | 1.20.1420.30 | 9 | 1 | 14470 | 47 |
SLC24A4 |
2.886e-02 | -3.55 | - | gene3d domains | 1.10.357.50 | 9 | 1 | 14470 | 47 |
UNC13C |
2.886e-02 | -3.55 | R3H-like domain | gene3d domains | 3.30.1370.50 | 9 | 1 | 14470 | 47 |
R3HDM1 |
2.893e-02 | -3.54 | Methadone Metabolism Pathway | SMPDB pathways | SMP0000624 | 10 | 1 | 1369 | 4 |
GRIN2A |
2.917e-02 | -3.53 | regulation of striated muscle contraction | biological process | GO:0006942 | 99 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
2.917e-02 | -3.53 | heart contraction | biological process | GO:0060047 | 99 | 2 | 18204 | 49 |
RYR2,CACNA1C |
2.922e-02 | -3.53 | negative regulation of excitatory postsynaptic potential | biological process | GO:0090394 | 11 | 1 | 18204 | 49 |
CELF4 |
2.922e-02 | -3.53 | cellular response to peptide | biological process | GO:1901653 | 11 | 1 | 18204 | 49 |
SMPD3 |
2.922e-02 | -3.53 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 49 |
RYR2 |
2.922e-02 | -3.53 | negative regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002924 | 11 | 1 | 18204 | 49 |
CR2 |
2.922e-02 | -3.53 | nucleoside monophosphate phosphorylation | biological process | GO:0046940 | 11 | 1 | 18204 | 49 |
AK5 |
2.922e-02 | -3.53 | drinking behavior | biological process | GO:0042756 | 11 | 1 | 18204 | 49 |
SLC24A4 |
2.922e-02 | -3.53 | cellular response to epinephrine stimulus | biological process | GO:0071872 | 11 | 1 | 18204 | 49 |
RYR2 |
2.922e-02 | -3.53 | regulation of neurotrophin TRK receptor signaling pathway | biological process | GO:0051386 | 11 | 1 | 18204 | 49 |
PPP2R5B |
2.922e-02 | -3.53 | retinal cone cell development | biological process | GO:0046549 | 11 | 1 | 18204 | 49 |
HCN1 |
2.922e-02 | -3.53 | synaptic vesicle clustering | biological process | GO:0097091 | 11 | 1 | 18204 | 49 |
PCLO |
2.929e-02 | -3.53 | EF-hand_7 | pfam domains | PF13499 | 97 | 2 | 17795 | 49 |
RYR2,KCNIP4 |
2.931e-02 | -3.53 | IL-1_rcpt_fam | interpro domains | IPR015621 | 11 | 1 | 18521 | 50 |
IL1RAPL2 |
2.931e-02 | -3.53 | R3H_dom_sf | interpro domains | IPR036867 | 11 | 1 | 18521 | 50 |
R3HDM1 |
2.931e-02 | -3.53 | R3H_dom | interpro domains | IPR001374 | 11 | 1 | 18521 | 50 |
R3HDM1 |
2.931e-02 | -3.53 | Solute-binding_3/MltF_N | interpro domains | IPR001638 | 11 | 1 | 18521 | 50 |
GRIN2A |
2.940e-02 | -3.53 | acetylcholine receptor binding | molecular function | GO:0033130 | 11 | 1 | 18094 | 49 |
NRXN1 |
2.940e-02 | -3.53 | cyclic nucleotide-activated monoatomic ion channel activity | molecular function | GO:0043855 | 11 | 1 | 18094 | 49 |
HCN1 |
2.940e-02 | -3.53 | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | molecular function | GO:0005221 | 11 | 1 | 18094 | 49 |
HCN1 |
2.940e-02 | -3.53 | complement receptor activity | molecular function | GO:0004875 | 11 | 1 | 18094 | 49 |
CR2 |
2.958e-02 | -3.52 | breast-carcinoma | COSMIC cancer mutations | breast-carcinoma | 15030 | 47 | 16828 | 48 |
NRXN1,PPP2R5B,KCNMA1,PTPRG,HCN1,PCLO,SMPD3,GABRA6,ASTN1,KCNT1,CACNA1C,RGS7,RBFOX3,CR2,KSR2,OPRL1,SLC24A4,ZNF804A,RYR2,GRID2,LRRC7,ZFPM2,UNC13C,GRIN2A,CELF4,IL1RAPL2,GABRA1,CELF5,TRPM3,GALNT9,GABRD,MYT1L,OLFM1,AK5,RIMS4,RIMS2,GABRB2,ST8SIA5,R3HDM1,STXBP5L,RBFOX1,CELF6,TTC9B,KCNIP4,GABBR2,DLG3,NRXN3 |
2.976e-02 | -3.51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | KEGG pathways | ko05412 | 72 | 2 | 7161 | 27 |
RYR2,CACNA1C |
2.976e-02 | -3.51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | KEGG pathways | hsa05412 | 72 | 2 | 7161 | 27 |
CACNA1C,RYR2 |
2.976e-02 | -3.51 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 3 | 7161 | 27 |
RYR2,GRIN2A,CACNA1C |
2.976e-02 | -3.51 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 3 | 7161 | 27 |
GRIN2A,RYR2,CACNA1C |
2.979e-02 | -3.51 | RET signaling | REACTOME pathways | R-HSA-8853659 | 270 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
2.982e-02 | -3.51 | ANO5 (anoctamin 5) | protein interactions | 203859 | 12 | 1 | 19454 | 49 |
MARCHF4 |
2.982e-02 | -3.51 | SPDYC (speedy/RINGO cell cycle regulator family member C) | protein interactions | 387778 | 12 | 1 | 19454 | 49 |
RBFOX3 |
2.982e-02 | -3.51 | CACNA1S (calcium voltage-gated channel subunit alpha1 S) | protein interactions | 779 | 12 | 1 | 19454 | 49 |
RIMS2 |
2.982e-02 | -3.51 | SIRPB1 (signal regulatory protein beta 1) | protein interactions | 10326 | 12 | 1 | 19454 | 49 |
RBFOX1 |
2.982e-02 | -3.51 | ISG20 (interferon stimulated exonuclease gene 20) | protein interactions | 3669 | 12 | 1 | 19454 | 49 |
PTPRG |
2.988e-02 | -3.51 | RINGv | pfam domains | PF12906 | 11 | 1 | 17795 | 49 |
MARCHF4 |
2.988e-02 | -3.51 | SBP_bac_3 | pfam domains | PF00497 | 11 | 1 | 17795 | 49 |
GRIN2A |
2.993e-02 | -3.51 | Ionotropic activity of Kainate Receptors | REACTOME pathways | R-HSA-451306 | 12 | 1 | 10285 | 26 |
DLG3 |
2.993e-02 | -3.51 | Activation of Ca-permeable Kainate Receptor | REACTOME pathways | R-HSA-451308 | 12 | 1 | 10285 | 26 |
DLG3 |
2.996e-02 | -3.51 | MIR | prosite domains | PS50919 | 10 | 1 | 12186 | 37 |
RYR2 |
2.997e-02 | -3.51 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | biological process | GO:0000377 | 251 | 3 | 18204 | 49 |
CELF6,CELF5,CELF4 |
2.997e-02 | -3.51 | mRNA splicing, via spliceosome | biological process | GO:0000398 | 251 | 3 | 18204 | 49 |
CELF5,CELF6,CELF4 |
3.007e-02 | -3.50 | haemangiopericytic | COSMIC cancer mutations | haemangiopericytic | 95 | 2 | 16828 | 48 |
GRIN2A,PCLO |
3.007e-02 | -3.50 | meninges-meningioma-haemangiopericytic | COSMIC cancer mutations | meninges-meningioma-haemangiopericytic | 95 | 2 | 16828 | 48 |
PCLO,GRIN2A |
3.008e-02 | -3.50 | Interleukin-3, 5 and GM-CSF signaling | REACTOME pathways | R-HSA-512988 | 271 | 3 | 10285 | 26 |
GRIN2A,PPP2R5B,KSR2 |
3.016e-02 | -3.50 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 24 | 16828 | 48 |
RYR2,GRID2,NRXN3,KCNIP4,SLC24A4,ZNF804A,R3HDM1,GABRB2,RGS7,CACNA1C,OLFM1,MYT1L,KCNT1,ASTN1,GALNT9,TRPM3,SMPD3,PCLO,PTPRG,CELF4,ZFPM2,UNC13C,GRIN2A,PPP2R5B |
3.017e-02 | -3.50 | R3H | smart domains | SM00393 | 9 | 1 | 9717 | 33 |
R3HDM1 |
3.018e-02 | -3.50 | human chr2q21.3 | chromosome location | human chr2q21.3 | 16 | 1 | 26134 | 50 |
R3HDM1 |
3.027e-02 | -3.50 | actin filament-based movement | biological process | GO:0030048 | 101 | 2 | 18204 | 49 |
CACNA1C,RYR2 |
3.027e-02 | -3.50 | regulation of potassium ion transport | biological process | GO:0043266 | 101 | 2 | 18204 | 49 |
KCNIP4,RGS7 |
3.035e-02 | -3.49 | L-type voltage-gated calcium channel complex | cellular component | GO:1990454 | 12 | 1 | 19108 | 49 |
CACNA1C |
3.120e-02 | -3.47 | RNA splicing, via transesterification reactions | biological process | GO:0000375 | 255 | 3 | 18204 | 49 |
CELF5,CELF6,CELF4 |
3.124e-02 | -3.47 | soft_tissue-fat-liposarcoma-myxoid-round_cell | COSMIC cancer mutations | soft_tissue-fat-liposarcoma-myxoid-round_cell | 97 | 2 | 16828 | 48 |
HCN1,GABRA6 |
3.124e-02 | -3.47 | myxoid-round_cell | COSMIC cancer mutations | myxoid-round_cell | 97 | 2 | 16828 | 48 |
HCN1,GABRA6 |
3.125e-02 | -3.47 | regulation of biological process | biological process | GO:0050789 | 12079 | 39 | 18204 | 49 |
MYT1L,RGS7,PCLO,ZFPM2,KCNMA1,CELF5,GRIN2A,CELF4,DLG3,GRID2,OLFM1,CELF6,PTPRG,CACNA1C,GABBR2,UNC13C,GABRB2,HCN1,CPLX1,NRXN1,SLC24A4,RBFOX3,RIMS4,ZNF804A,GABRA1,RYR2,KSR2,KCNIP4,INSYN1,PPP2R5B,GABRA6,SMPD3,CR2,OPRL1,LRRC7,RBFOX1,RIMS2,GABRD,IL1RAPL2 |
3.130e-02 | -3.46 | Cardiac muscle contraction | KEGG pathways | hsa04260 | 74 | 2 | 7161 | 27 |
CACNA1C,RYR2 |
3.130e-02 | -3.46 | Cardiac muscle contraction | KEGG pathways | ko04260 | 74 | 2 | 7161 | 27 |
RYR2,CACNA1C |
3.138e-02 | -3.46 | regulation of heart rate | biological process | GO:0002027 | 103 | 2 | 18204 | 49 |
RYR2,CACNA1C |
3.155e-02 | -3.46 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 14 | 18204 | 49 |
NRXN1,RIMS2,CACNA1C,OPRL1,PTPRG,SMPD3,GRID2,OLFM1,CELF4,GRIN2A,KSR2,RYR2,ZFPM2,SLC24A4 |
3.172e-02 | -3.45 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 11 | 18204 | 49 |
DLG3,RYR2,NRXN1,HCN1,CACNA1C,ZFPM2,SLC24A4,NRXN3,SMPD3,OLFM1,GRID2 |
3.184e-02 | -3.45 | regulation of synaptic vesicle membrane organization | biological process | GO:1901632 | 12 | 1 | 18204 | 49 |
CPLX1 |
3.184e-02 | -3.45 | regulation of synaptic vesicle fusion to presynaptic active zone membrane | biological process | GO:0031630 | 12 | 1 | 18204 | 49 |
CPLX1 |
3.184e-02 | -3.45 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 49 |
NRXN1 |
3.184e-02 | -3.45 | excitatory chemical synaptic transmission | biological process | GO:0098976 | 12 | 1 | 18204 | 49 |
GRIN2A |
3.184e-02 | -3.45 | AV node cell to bundle of His cell communication | biological process | GO:0086067 | 12 | 1 | 18204 | 49 |
CACNA1C |
3.185e-02 | -3.45 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 13 | 16828 | 48 |
ASTN1,RYR2,CR2,STXBP5L,TRPM3,ZNF804A,GABBR2,RIMS2,PCLO,MYT1L,GRIN2A,UNC13C,ZFPM2 |
3.185e-02 | -3.45 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 13 | 16828 | 48 |
PCLO,RIMS2,UNC13C,GRIN2A,ZFPM2,MYT1L,RYR2,ASTN1,GABBR2,ZNF804A,STXBP5L,CR2,TRPM3 |
3.193e-02 | -3.44 | K_chnl_volt-dep_EAG/ELK/ERG | interpro domains | IPR003938 | 12 | 1 | 18521 | 50 |
HCN1 |
3.193e-02 | -3.44 | Rab_BD | interpro domains | IPR010911 | 12 | 1 | 18521 | 50 |
RIMS2 |
3.193e-02 | -3.44 | MACPF | interpro domains | IPR020864 | 12 | 1 | 18521 | 50 |
ASTN1 |
3.193e-02 | -3.44 | V_SNARE_CC | interpro domains | IPR042855 | 12 | 1 | 18521 | 50 |
STXBP5L |
3.194e-02 | -3.44 | inorganic ion import across plasma membrane | biological process | GO:0099587 | 104 | 2 | 18204 | 49 |
CACNA1C,SLC24A4 |
3.194e-02 | -3.44 | inorganic cation import across plasma membrane | biological process | GO:0098659 | 104 | 2 | 18204 | 49 |
SLC24A4,CACNA1C |
3.202e-02 | -3.44 | Helix hairpin bin | gene3d domains | 1.10.287.630 | 10 | 1 | 14470 | 47 |
HCN1 |
3.203e-02 | -3.44 | MAP-kinase scaffold activity | molecular function | GO:0005078 | 12 | 1 | 18094 | 49 |
KSR2 |
3.226e-02 | -3.43 | MYO16 (myosin XVI) | protein interactions | 23026 | 13 | 1 | 19454 | 49 |
NRXN1 |
3.226e-02 | -3.43 | IGLC6 (immunoglobulin lambda constant 6) | protein interactions | 3542 | 13 | 1 | 19454 | 49 |
HCN1 |
3.226e-02 | -3.43 | PCAT1 (prostate cancer associated transcript 1) | protein interactions | 100750225 | 13 | 1 | 19454 | 49 |
PCLO |
3.226e-02 | -3.43 | CABP1 (calcium binding protein 1) | protein interactions | 9478 | 13 | 1 | 19454 | 49 |
CACNA1C |
3.226e-02 | -3.43 | RAB3C (RAB3C, member RAS oncogene family) | protein interactions | 115827 | 13 | 1 | 19454 | 49 |
RIMS2 |
3.226e-02 | -3.43 | ULBP1 (UL16 binding protein 1) | protein interactions | 80329 | 13 | 1 | 19454 | 49 |
MARCHF4 |
3.226e-02 | -3.43 | ACBD7 (acyl-CoA binding domain containing 7) | protein interactions | 414149 | 13 | 1 | 19454 | 49 |
PTPRG |
3.227e-02 | -3.43 | CACHANNEL | prints domains | PR00167 | 9 | 1 | 5227 | 19 |
CACNA1C |
3.239e-02 | -3.43 | Sodium/Calcium exchangers | REACTOME pathways | R-HSA-425561 | 13 | 1 | 10285 | 26 |
SLC24A4 |
3.241e-02 | -3.43 | PDE3B (phosphodiesterase 3B) | protein interactions | 5140 | 112 | 2 | 19454 | 49 |
GRIN2A,MARCHF4 |
3.241e-02 | -3.43 | VPS50 (VPS50 subunit of EARP/GARPII complex) | protein interactions | 55610 | 112 | 2 | 19454 | 49 |
INSYN1,R3HDM1 |
3.251e-02 | -3.43 | regulation of postsynapse organization | biological process | GO:0099175 | 105 | 2 | 18204 | 49 |
GRID2,ZNF804A |
3.251e-02 | -3.43 | biomineral tissue development | biological process | GO:0031214 | 105 | 2 | 18204 | 49 |
SLC24A4,SMPD3 |
3.275e-02 | -3.42 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 5 | 18204 | 49 |
LRRC7,PTPRG,GRID2,PPP2R5B,ZNF804A |
3.291e-02 | -3.41 | ZF_RING_CH | prosite domains | PS51292 | 11 | 1 | 12186 | 37 |
MARCHF4 |
3.291e-02 | -3.41 | G_PROTEIN_RECEP_F3_3 | prosite domains | PS00981 | 11 | 1 | 12186 | 37 |
GABBR2 |
3.291e-02 | -3.41 | R3H | prosite domains | PS51061 | 11 | 1 | 12186 | 37 |
R3HDM1 |
3.298e-02 | -3.41 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 42 | 16828 | 48 |
CR2,STXBP5L,KSR2,OPRL1,CELF6,ZNF804A,GABBR2,DLG3,NRXN3,GRID2,RYR2,OLFM1,MYT1L,GABRD,AK5,RIMS4,CACNA1C,CPLX1,RGS7,RBFOX3,RIMS2,ST8SIA5,GABRB2,R3HDM1,SMPD3,TRPM3,GABRA6,GALNT9,ASTN1,KCNT1,LRRC7,PPP2R5B,UNC13C,GRIN2A,ZFPM2,CELF4,IL1RAPL2,GABRA1,PTPRG,PCLO,CELF5,HCN1 |
3.346e-02 | -3.40 | MIR | smart domains | SM00472 | 10 | 1 | 9717 | 33 |
RYR2 |
3.349e-02 | -3.40 | axon terminus | cellular component | GO:0043679 | 112 | 2 | 19108 | 49 |
UNC13C,CPLX1 |
3.349e-02 | -3.40 | endometrium-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-endometrioid_carcinoma | 15680 | 48 | 16828 | 48 |
NRXN1,PPP2R5B,KCNMA1,PTPRG,HCN1,PCLO,SMPD3,GABRA6,ASTN1,KCNT1,CACNA1C,RGS7,RBFOX3,CR2,KSR2,OPRL1,ZNF804A,SLC24A4,GRID2,RYR2,LRRC7,ZFPM2,GRIN2A,UNC13C,CELF4,GABRA1,IL1RAPL2,CELF5,TRPM3,GALNT9,OLFM1,GABRD,MYT1L,AK5,RIMS4,CPLX1,RIMS2,GABRB2,ST8SIA5,R3HDM1,STXBP5L,RBFOX1,TTC9B,CELF6,GABBR2,KCNIP4,DLG3,NRXN3 |
3.364e-02 | -3.39 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 3 | 16828 | 48 |
IL1RAPL2,GABBR2,GRIN2A |
3.364e-02 | -3.39 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 3 | 16828 | 48 |
IL1RAPL2,GABBR2,GRIN2A |
3.371e-02 | -3.39 | blastoma | COSMIC cancer mutations | blastoma | 12 | 1 | 16828 | 48 |
GRIN2A |
3.374e-02 | -3.39 | heart morphogenesis | biological process | GO:0003007 | 263 | 3 | 18204 | 49 |
RYR2,ZFPM2,OLFM1 |
3.374e-02 | -3.39 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 5 | 16828 | 48 |
LRRC7,ASTN1,GRIN2A,GABBR2,GRID2 |
3.389e-02 | -3.38 | human chr7q21.11 | chromosome location | human chr7q21.11 | 18 | 1 | 26134 | 50 |
PCLO |
3.398e-02 | -3.38 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | 249 | 3 | 16828 | 48 |
RIMS2,PCLO,KCNIP4 |
3.429e-02 | -3.37 | generation of neurons | biological process | GO:0048699 | 1158 | 7 | 18204 | 49 |
ASTN1,HCN1,GABRB2,NRXN1,NRXN3,GRID2,MYT1L |
3.444e-02 | -3.37 | cerebellar granular layer development | biological process | GO:0021681 | 13 | 1 | 18204 | 49 |
GRID2 |
3.444e-02 | -3.37 | activation of cysteine-type endopeptidase activity | biological process | GO:0097202 | 13 | 1 | 18204 | 49 |
GRIN2A |
3.444e-02 | -3.37 | detection of calcium ion | biological process | GO:0005513 | 13 | 1 | 18204 | 49 |
RYR2 |
3.444e-02 | -3.37 | regulation of gonad development | biological process | GO:1905939 | 13 | 1 | 18204 | 49 |
ZFPM2 |
3.444e-02 | -3.37 | regulation of dendritic spine maintenance | biological process | GO:1902950 | 13 | 1 | 18204 | 49 |
ZNF804A |
3.444e-02 | -3.37 | response to peptide | biological process | GO:1901652 | 13 | 1 | 18204 | 49 |
SMPD3 |
3.444e-02 | -3.37 | negative regulation of complement activation | biological process | GO:0045916 | 13 | 1 | 18204 | 49 |
CR2 |
3.444e-02 | -3.37 | positive regulation of urine volume | biological process | GO:0035810 | 13 | 1 | 18204 | 49 |
OPRL1 |
3.444e-02 | -3.37 | prepulse inhibition | biological process | GO:0060134 | 13 | 1 | 18204 | 49 |
GRID2 |
3.444e-02 | -3.37 | retinal cone cell differentiation | biological process | GO:0042670 | 13 | 1 | 18204 | 49 |
HCN1 |
3.444e-02 | -3.37 | regulation of postsynaptic density assembly | biological process | GO:0099151 | 13 | 1 | 18204 | 49 |
GRID2 |
3.444e-02 | -3.37 | nucleoside diphosphate biosynthetic process | biological process | GO:0009133 | 13 | 1 | 18204 | 49 |
AK5 |
3.444e-02 | -3.37 | postsynaptic specialization assembly | biological process | GO:0098698 | 13 | 1 | 18204 | 49 |
NRXN1 |
3.453e-02 | -3.37 | endometrioid_carcinoma | COSMIC cancer mutations | endometrioid_carcinoma | 15690 | 48 | 16828 | 48 |
GABBR2,KCNIP4,TTC9B,CELF6,RBFOX1,STXBP5L,NRXN3,DLG3,CPLX1,RIMS4,AK5,OLFM1,GABRD,MYT1L,R3HDM1,GABRB2,ST8SIA5,RIMS2,TRPM3,GALNT9,CELF4,ZFPM2,UNC13C,GRIN2A,LRRC7,CELF5,GABRA1,IL1RAPL2,SLC24A4,ZNF804A,OPRL1,KSR2,CR2,RYR2,GRID2,CACNA1C,RBFOX3,RGS7,GABRA6,SMPD3,KCNT1,ASTN1,NRXN1,PPP2R5B,HCN1,PCLO,PTPRG,KCNMA1 |
3.454e-02 | -3.37 | Olfac-like_dom | interpro domains | IPR003112 | 13 | 1 | 18521 | 50 |
OLFM1 |
3.465e-02 | -3.36 | calcium:monoatomic cation antiporter activity | molecular function | GO:0015368 | 13 | 1 | 18094 | 49 |
SLC24A4 |
3.465e-02 | -3.36 | diacylglycerol binding | molecular function | GO:0019992 | 13 | 1 | 18094 | 49 |
UNC13C |
3.465e-02 | -3.36 | myosin II binding | molecular function | GO:0045159 | 13 | 1 | 18094 | 49 |
STXBP5L |
3.465e-02 | -3.36 | calcium-activated potassium channel activity | molecular function | GO:0015269 | 13 | 1 | 18094 | 49 |
KCNMA1 |
3.470e-02 | -3.36 | SYT5 (synaptotagmin 5) | protein interactions | 6861 | 14 | 1 | 19454 | 49 |
NRXN1 |
3.470e-02 | -3.36 | KCNIP2 (potassium voltage-gated channel interacting protein 2) | protein interactions | 30819 | 14 | 1 | 19454 | 49 |
KCNIP4 |
3.470e-02 | -3.36 | GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2) | protein interactions | 2977 | 14 | 1 | 19454 | 49 |
DLG3 |
3.470e-02 | -3.36 | Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) | protein interactions | 17999 | 14 | 1 | 19454 | 49 |
GRIN2A |
3.470e-02 | -3.36 | SLC38A6 (solute carrier family 38 member 6) | protein interactions | 145389 | 14 | 1 | 19454 | 49 |
RBFOX3 |
3.470e-02 | -3.36 | CSF3 (colony stimulating factor 3) | protein interactions | 1440 | 14 | 1 | 19454 | 49 |
PTPRG |
3.474e-02 | -3.36 | endometrium | COSMIC cancer mutations | endometrium | 15692 | 48 | 16828 | 48 |
STXBP5L,RBFOX1,TTC9B,CELF6,KCNIP4,GABBR2,DLG3,NRXN3,MYT1L,GABRD,OLFM1,AK5,RIMS4,CPLX1,RIMS2,ST8SIA5,GABRB2,R3HDM1,TRPM3,GALNT9,LRRC7,UNC13C,GRIN2A,ZFPM2,CELF4,IL1RAPL2,GABRA1,CELF5,CR2,KSR2,OPRL1,SLC24A4,ZNF804A,GRID2,RYR2,CACNA1C,RGS7,RBFOX3,SMPD3,GABRA6,ASTN1,KCNT1,PPP2R5B,NRXN1,KCNMA1,PTPRG,PCLO,HCN1 |
3.484e-02 | -3.36 | AXIN mutants destabilize the destruction complex, activating WNT signaling | REACTOME pathways | R-HSA-4839735 | 14 | 1 | 10285 | 26 |
PPP2R5B |
3.484e-02 | -3.36 | AMER1 mutants destabilize the destruction complex | REACTOME pathways | R-HSA-4839748 | 14 | 1 | 10285 | 26 |
PPP2R5B |
3.484e-02 | -3.36 | AXIN missense mutants destabilize the destruction complex | REACTOME pathways | R-HSA-5467340 | 14 | 1 | 10285 | 26 |
PPP2R5B |
3.484e-02 | -3.36 | Truncations of AMER1 destabilize the destruction complex | REACTOME pathways | R-HSA-5467348 | 14 | 1 | 10285 | 26 |
PPP2R5B |
3.484e-02 | -3.36 | truncated APC mutants destabilize the destruction complex | REACTOME pathways | R-HSA-4839744 | 14 | 1 | 10285 | 26 |
PPP2R5B |
3.484e-02 | -3.36 | APC truncation mutants have impaired AXIN binding | REACTOME pathways | R-HSA-5467337 | 14 | 1 | 10285 | 26 |
PPP2R5B |
3.496e-02 | -3.35 | ATXN2 (ataxin 2) | protein interactions | 6311 | 285 | 3 | 19454 | 49 |
CELF5,RBFOX1,R3HDM1 |
3.510e-02 | -3.35 | DUSP23 (dual specificity phosphatase 23) | protein interactions | 54935 | 117 | 2 | 19454 | 49 |
PTPRG,ZFPM2 |
3.522e-02 | -3.35 | OLF | pfam domains | PF02191 | 13 | 1 | 17795 | 49 |
OLFM1 |
3.539e-02 | -3.34 | positive regulation of cell junction assembly | biological process | GO:1901890 | 110 | 2 | 18204 | 49 |
GRID2,NRXN1 |
3.549e-02 | -3.34 | face | COSMIC cancer mutations | face | 2139 | 11 | 16828 | 48 |
GABBR2,ZNF804A,GABRA6,GRIN2A,TRPM3,AK5,STXBP5L,LRRC7,CR2,HCN1,ASTN1 |
3.565e-02 | -3.33 | BRI3BP (BRI3 binding protein) | protein interactions | 140707 | 118 | 2 | 19454 | 49 |
GABRD,SMPD3 |
3.565e-02 | -3.33 | MTX1 (metaxin 1) | protein interactions | 4580 | 118 | 2 | 19454 | 49 |
KCNIP4,OPRL1 |
3.565e-02 | -3.33 | CDC7 (cell division cycle 7) | protein interactions | 8317 | 118 | 2 | 19454 | 49 |
RBFOX3,RBFOX1 |
3.574e-02 | -3.33 | MAPK family signaling cascades | REACTOME pathways | R-HSA-5683057 | 290 | 3 | 10285 | 26 |
GRIN2A,PPP2R5B,KSR2 |
3.574e-02 | -3.33 | human chr2q32.1 | chromosome location | human chr2q32.1 | 19 | 1 | 26134 | 50 |
ZNF804A |
3.585e-02 | -3.33 | RABBD | prosite domains | PS50916 | 12 | 1 | 12186 | 37 |
RIMS2 |
3.585e-02 | -3.33 | V_SNARE | prosite domains | PS50892 | 12 | 1 | 12186 | 37 |
STXBP5L |
3.593e-02 | -3.33 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 5 | 18204 | 49 |
LRRC7,ZNF804A,PPP2R5B,GRID2,PTPRG |
3.618e-02 | -3.32 | purine deoxyribonucleosides salvage | BIOCYC pathways | HUMAN_PWY-7224 | 11 | 1 | 902 | 3 |
AK5 |
3.673e-02 | -3.30 | calcium ion binding | molecular function | GO:0005509 | 683 | 5 | 18094 | 49 |
NRXN1,PCLO,UNC13C,KCNIP4,RYR2 |
3.676e-02 | -3.30 | LRP6 (LDL receptor related protein 6) | protein interactions | 4040 | 120 | 2 | 19454 | 49 |
GRIN2A,ST8SIA5 |
3.677e-02 | -3.30 | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 649 | 5 | 16828 | 48 |
ZFPM2,TRPM3,NRXN3,ASTN1,LRRC7 |
3.686e-02 | -3.30 | ASX_HYDROXYL | prosite domains | PS00010 | 100 | 2 | 12186 | 37 |
NRXN3,NRXN1 |
3.686e-02 | -3.30 | Laminin | gene3d domains | 2.10.25.10 | 226 | 3 | 14470 | 47 |
ASTN1,NRXN1,NRXN3 |
3.700e-02 | -3.30 | IRS-mediated signalling | REACTOME pathways | R-HSA-112399 | 294 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
3.704e-02 | -3.30 | deoxyribose phosphate biosynthetic process | biological process | GO:0046385 | 14 | 1 | 18204 | 49 |
AK5 |
3.704e-02 | -3.30 | synaptic vesicle priming | biological process | GO:0016082 | 14 | 1 | 18204 | 49 |
UNC13C |
3.704e-02 | -3.30 | enamel mineralization | biological process | GO:0070166 | 14 | 1 | 18204 | 49 |
SLC24A4 |
3.704e-02 | -3.30 | protein localization to endosome | biological process | GO:0036010 | 14 | 1 | 18204 | 49 |
LRRC7 |
3.704e-02 | -3.30 | 2'-deoxyribonucleotide biosynthetic process | biological process | GO:0009265 | 14 | 1 | 18204 | 49 |
AK5 |
3.704e-02 | -3.30 | response to epinephrine | biological process | GO:0071871 | 14 | 1 | 18204 | 49 |
RYR2 |
3.704e-02 | -3.30 | negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | biological process | GO:0106072 | 14 | 1 | 18204 | 49 |
OPRL1 |
3.704e-02 | -3.30 | regulation of long-term synaptic depression | biological process | GO:1900452 | 14 | 1 | 18204 | 49 |
GRID2 |
3.704e-02 | -3.30 | chondrocyte differentiation involved in endochondral bone morphogenesis | biological process | GO:0003413 | 14 | 1 | 18204 | 49 |
SMPD3 |
3.704e-02 | -3.30 | negative regulation of adenylate cyclase activity | biological process | GO:0007194 | 14 | 1 | 18204 | 49 |
GABBR2 |
3.704e-02 | -3.30 | neurotransmitter receptor transport to postsynaptic membrane | biological process | GO:0098969 | 14 | 1 | 18204 | 49 |
LRRC7 |
3.704e-02 | -3.30 | deoxyribonucleotide biosynthetic process | biological process | GO:0009263 | 14 | 1 | 18204 | 49 |
AK5 |
3.704e-02 | -3.30 | complement receptor mediated signaling pathway | biological process | GO:0002430 | 14 | 1 | 18204 | 49 |
CR2 |
3.704e-02 | -3.30 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 49 |
NRXN1 |
3.704e-02 | -3.30 | atrial cardiac muscle cell to AV node cell signaling | biological process | GO:0086026 | 14 | 1 | 18204 | 49 |
CACNA1C |
3.704e-02 | -3.30 | atrial cardiac muscle cell action potential | biological process | GO:0086014 | 14 | 1 | 18204 | 49 |
CACNA1C |
3.704e-02 | -3.30 | cellular response to oxidised low-density lipoprotein particle stimulus | biological process | GO:0140052 | 14 | 1 | 18204 | 49 |
SMPD3 |
3.704e-02 | -3.30 | response to light intensity | biological process | GO:0009642 | 14 | 1 | 18204 | 49 |
SLC24A4 |
3.704e-02 | -3.30 | primary amino compound metabolic process | biological process | GO:1901160 | 14 | 1 | 18204 | 49 |
GRIN2A |
3.704e-02 | -3.30 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 49 |
RYR2 |
3.714e-02 | -3.29 | CACNA1H (calcium voltage-gated channel subunit alpha1 H) | protein interactions | 8912 | 15 | 1 | 19454 | 49 |
KCNMA1 |
3.714e-02 | -3.29 | IFNA1 (interferon alpha 1) | protein interactions | 3439 | 15 | 1 | 19454 | 49 |
CR2 |
3.714e-02 | -3.29 | PNOC (prepronociceptin) | protein interactions | 5368 | 15 | 1 | 19454 | 49 |
OPRL1 |
3.714e-02 | -3.29 | CCNG2 (cyclin G2) | protein interactions | 901 | 15 | 1 | 19454 | 49 |
PPP2R5B |
3.715e-02 | -3.29 | GPCR_3 | interpro domains | IPR000337 | 14 | 1 | 18521 | 50 |
GABBR2 |
3.715e-02 | -3.29 | Recoverin | interpro domains | IPR028846 | 14 | 1 | 18521 | 50 |
KCNIP4 |
3.715e-02 | -3.29 | GPCR_3_CS | interpro domains | IPR017979 | 14 | 1 | 18521 | 50 |
GABBR2 |
3.717e-02 | -3.29 | regulation of regulated secretory pathway | biological process | GO:1903305 | 113 | 2 | 18204 | 49 |
RIMS2,RIMS4 |
3.717e-02 | -3.29 | heart process | biological process | GO:0003015 | 113 | 2 | 18204 | 49 |
RYR2,CACNA1C |
3.727e-02 | -3.29 | mRNA regulatory element binding translation repressor activity | molecular function | GO:0000900 | 14 | 1 | 18094 | 49 |
CELF4 |
3.727e-02 | -3.29 | protein kinase A catalytic subunit binding | molecular function | GO:0034236 | 14 | 1 | 18094 | 49 |
RYR2 |
3.727e-02 | -3.29 | high voltage-gated calcium channel activity | molecular function | GO:0008331 | 14 | 1 | 18094 | 49 |
CACNA1C |
3.728e-02 | -3.29 | phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | REACTOME pathways | R-HSA-4839743 | 15 | 1 | 10285 | 26 |
PPP2R5B |
3.728e-02 | -3.29 | S45 mutants of beta-catenin aren't phosphorylated | REACTOME pathways | R-HSA-5358751 | 15 | 1 | 10285 | 26 |
PPP2R5B |
3.728e-02 | -3.29 | T41 mutants of beta-catenin aren't phosphorylated | REACTOME pathways | R-HSA-5358752 | 15 | 1 | 10285 | 26 |
PPP2R5B |
3.728e-02 | -3.29 | Misspliced GSK3beta mutants stabilize beta-catenin | REACTOME pathways | R-HSA-5339716 | 15 | 1 | 10285 | 26 |
PPP2R5B |
3.728e-02 | -3.29 | S37 mutants of beta-catenin aren't phosphorylated | REACTOME pathways | R-HSA-5358749 | 15 | 1 | 10285 | 26 |
PPP2R5B |
3.728e-02 | -3.29 | S33 mutants of beta-catenin aren't phosphorylated | REACTOME pathways | R-HSA-5358747 | 15 | 1 | 10285 | 26 |
PPP2R5B |
3.759e-02 | -3.28 | human chr18q12.2 | chromosome location | human chr18q12.2 | 20 | 1 | 26134 | 50 |
CELF4 |
3.796e-02 | -3.27 | Insulin receptor signalling cascade | REACTOME pathways | R-HSA-74751 | 297 | 3 | 10285 | 26 |
PPP2R5B,GRIN2A,KSR2 |
3.828e-02 | -3.26 | IRS-related events triggered by IGF1R | REACTOME pathways | R-HSA-2428928 | 298 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
3.828e-02 | -3.26 | IGF1R signaling cascade | REACTOME pathways | R-HSA-2428924 | 298 | 3 | 10285 | 26 |
PPP2R5B,GRIN2A,KSR2 |
3.844e-02 | -3.26 | EXOC7 (exocyst complex component 7) | protein interactions | 23265 | 123 | 2 | 19454 | 49 |
DLG3,INSYN1 |
3.859e-02 | -3.25 | Reelin signaling pathway | Pathway Interaction DB | reelinpathway | 29 | 1 | 2226 | 3 |
GRIN2A |
3.860e-02 | -3.25 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | REACTOME pathways | R-HSA-2404192 | 299 | 3 | 10285 | 26 |
PPP2R5B,GRIN2A,KSR2 |
3.863e-02 | -3.25 | Hypertrophic cardiomyopathy (HCM) | KEGG pathways | hsa05410 | 83 | 2 | 7161 | 27 |
CACNA1C,RYR2 |
3.863e-02 | -3.25 | Hypertrophic cardiomyopathy (HCM) | KEGG pathways | ko05410 | 83 | 2 | 7161 | 27 |
RYR2,CACNA1C |
3.878e-02 | -3.25 | OLF | prosite domains | PS51132 | 13 | 1 | 12186 | 37 |
OLFM1 |
3.901e-02 | -3.24 | HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) | protein interactions | 3156 | 124 | 2 | 19454 | 49 |
MARCHF4,GABRA6 |
3.901e-02 | -3.24 | EPS15L1 (epidermal growth factor receptor pathway substrate 15 like 1) | protein interactions | 58513 | 124 | 2 | 19454 | 49 |
INSYN1,LRRC7 |
3.956e-02 | -3.23 | CR2 (complement C3d receptor 2) | protein interactions | 1380 | 16 | 1 | 19454 | 49 |
CR2 |
3.956e-02 | -3.23 | C1orf122 (chromosome 1 open reading frame 122) | protein interactions | 127687 | 16 | 1 | 19454 | 49 |
INSYN1 |
3.956e-02 | -3.23 | SYT4 (synaptotagmin 4) | protein interactions | 6860 | 16 | 1 | 19454 | 49 |
NRXN1 |
3.956e-02 | -3.23 | SYTL2 (synaptotagmin like 2) | protein interactions | 54843 | 16 | 1 | 19454 | 49 |
NRXN1 |
3.956e-02 | -3.23 | SYT9 (synaptotagmin 9) | protein interactions | 143425 | 16 | 1 | 19454 | 49 |
NRXN1 |
3.956e-02 | -3.23 | WASH6P (WASP family homolog 6, pseudogene) | protein interactions | 653440 | 16 | 1 | 19454 | 49 |
INSYN1 |
3.956e-02 | -3.23 | TAMALIN (trafficking regulator and scaffold protein tamalin) | protein interactions | 160622 | 16 | 1 | 19454 | 49 |
GABBR2 |
3.956e-02 | -3.23 | AKAP6 (A-kinase anchoring protein 6) | protein interactions | 9472 | 16 | 1 | 19454 | 49 |
RYR2 |
3.964e-02 | -3.23 | heart valve formation | biological process | GO:0003188 | 15 | 1 | 18204 | 49 |
OLFM1 |
3.964e-02 | -3.23 | atrial cardiac muscle cell to AV node cell communication | biological process | GO:0086066 | 15 | 1 | 18204 | 49 |
CACNA1C |
3.964e-02 | -3.23 | intracellular potassium ion homeostasis | biological process | GO:0030007 | 15 | 1 | 18204 | 49 |
KCNMA1 |
3.964e-02 | -3.23 | dense core granule localization | biological process | GO:0032253 | 15 | 1 | 18204 | 49 |
UNC13C |
3.964e-02 | -3.23 | complement activation, alternative pathway | biological process | GO:0006957 | 15 | 1 | 18204 | 49 |
CR2 |
3.964e-02 | -3.23 | apical protein localization | biological process | GO:0045176 | 15 | 1 | 18204 | 49 |
HCN1 |
3.964e-02 | -3.23 | positive regulation of exosomal secretion | biological process | GO:1903543 | 15 | 1 | 18204 | 49 |
SMPD3 |
3.964e-02 | -3.23 | negative regulation of cyclase activity | biological process | GO:0031280 | 15 | 1 | 18204 | 49 |
GABBR2 |
3.964e-02 | -3.23 | negative regulation of B cell mediated immunity | biological process | GO:0002713 | 15 | 1 | 18204 | 49 |
CR2 |
3.964e-02 | -3.23 | neurotransmitter receptor transport to plasma membrane | biological process | GO:0098877 | 15 | 1 | 18204 | 49 |
LRRC7 |
3.964e-02 | -3.23 | negative regulation of immunoglobulin mediated immune response | biological process | GO:0002890 | 15 | 1 | 18204 | 49 |
CR2 |
3.964e-02 | -3.23 | establishment of protein localization to postsynaptic membrane | biological process | GO:1903540 | 15 | 1 | 18204 | 49 |
LRRC7 |
3.964e-02 | -3.23 | endosome to plasma membrane protein transport | biological process | GO:0099638 | 15 | 1 | 18204 | 49 |
LRRC7 |
3.964e-02 | -3.23 | sarcoplasmic reticulum calcium ion transport | biological process | GO:0070296 | 15 | 1 | 18204 | 49 |
RYR2 |
3.964e-02 | -3.23 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 49 |
RYR2 |
3.973e-02 | -3.23 | cell adhesion | biological process | GO:0007155 | 942 | 6 | 18204 | 49 |
DLG3,LRRC7,NRXN1,NRXN3,ASTN1,GRID2 |
3.975e-02 | -3.23 | Sialyl_trans | interpro domains | IPR012163 | 15 | 1 | 18521 | 50 |
ST8SIA5 |
3.995e-02 | -3.22 | liposarcoma | COSMIC cancer mutations | liposarcoma | 111 | 2 | 16828 | 48 |
GABRA6,HCN1 |
4.002e-02 | -3.22 | MACPF | smart domains | SM00457 | 12 | 1 | 9717 | 33 |
ASTN1 |
4.061e-02 | -3.20 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 47 | 16828 | 48 |
NRXN3,DLG3,GABBR2,KCNIP4,TTC9B,CELF6,RBFOX1,STXBP5L,R3HDM1,ST8SIA5,GABRB2,RIMS2,CPLX1,RIMS4,AK5,OLFM1,GABRD,MYT1L,GALNT9,TRPM3,CELF5,IL1RAPL2,GABRA1,CELF4,GRIN2A,UNC13C,ZFPM2,LRRC7,GRID2,RYR2,ZNF804A,SLC24A4,OPRL1,KSR2,CR2,RGS7,CACNA1C,KCNT1,ASTN1,GABRA6,SMPD3,PCLO,HCN1,PTPRG,KCNMA1,PPP2R5B,NRXN1 |
4.087e-02 | -3.20 | Ganglio Sphingolipid Metabolism | WikiPathways | WP1423 | 13 | 1 | 5310 | 17 |
ST8SIA5 |
4.087e-02 | -3.20 | Cell-type Dependent Selectivity of CCK2R Signaling | WikiPathways | WP3679 | 13 | 1 | 5310 | 17 |
RYR2 |
4.116e-02 | -3.19 | regulation of localization | biological process | GO:0032879 | 2028 | 10 | 18204 | 49 |
RIMS2,RYR2,KCNIP4,GRIN2A,CACNA1C,CPLX1,RGS7,PCLO,RIMS4,SMPD3 |
4.127e-02 | -3.19 | human chr5p12 | chromosome location | human chr5p12 | 22 | 1 | 26134 | 50 |
HCN1 |
4.144e-02 | -3.18 | striated muscle contraction | biological process | GO:0006941 | 120 | 2 | 18204 | 49 |
RYR2,CACNA1C |
4.156e-02 | -3.18 | regulation of cell communication | biological process | GO:0010646 | 3541 | 15 | 18204 | 49 |
NRXN1,RIMS2,CPLX1,UNC13C,OPRL1,SMPD3,PPP2R5B,GRID2,CELF4,GRIN2A,RYR2,KSR2,RIMS4,RGS7,SLC24A4 |
4.198e-02 | -3.17 | LY6D (lymphocyte antigen 6 family member D) | protein interactions | 8581 | 17 | 1 | 19454 | 49 |
GRIN2A |
4.198e-02 | -3.17 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 49 |
NRXN3 |
4.198e-02 | -3.17 | CPNE6 (copine 6) | protein interactions | 9362 | 17 | 1 | 19454 | 49 |
AK5 |
4.198e-02 | -3.17 | GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C) | protein interactions | 2905 | 17 | 1 | 19454 | 49 |
DLG3 |
4.203e-02 | -3.17 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 11 | 16828 | 48 |
PCLO,PTPRG,GRIN2A,ASTN1,NRXN3,KSR2,SMPD3,CR2,STXBP5L,GABBR2,GABRA6 |
4.207e-02 | -3.17 | renal system process | biological process | GO:0003014 | 121 | 2 | 18204 | 49 |
KCNMA1,OPRL1 |
4.215e-02 | -3.17 | Beta-catenin phosphorylation cascade | REACTOME pathways | R-HSA-196299 | 17 | 1 | 10285 | 26 |
PPP2R5B |
4.215e-02 | -3.17 | CREB phosphorylation through the activation of CaMKII | REACTOME pathways | R-HSA-442729 | 17 | 1 | 10285 | 26 |
GRIN2A |
4.215e-02 | -3.17 | Platelet sensitization by LDL | REACTOME pathways | R-HSA-432142 | 17 | 1 | 10285 | 26 |
PPP2R5B |
4.215e-02 | -3.17 | Unblocking of NMDA receptor, glutamate binding and activation | REACTOME pathways | R-HSA-438066 | 17 | 1 | 10285 | 26 |
GRIN2A |
4.215e-02 | -3.17 | Acetylcholine Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-264642 | 17 | 1 | 10285 | 26 |
CPLX1 |
4.223e-02 | -3.16 | estrous cycle | biological process | GO:0044849 | 16 | 1 | 18204 | 49 |
OPRL1 |
4.223e-02 | -3.16 | glutamatergic neuron differentiation | biological process | GO:1905962 | 16 | 1 | 18204 | 49 |
GRID2 |
4.223e-02 | -3.16 | purine deoxyribonucleotide metabolic process | biological process | GO:0009151 | 16 | 1 | 18204 | 49 |
AK5 |
4.223e-02 | -3.16 | sphingolipid mediated signaling pathway | biological process | GO:0090520 | 16 | 1 | 18204 | 49 |
SMPD3 |
4.223e-02 | -3.16 | cardiac left ventricle morphogenesis | biological process | GO:0003214 | 16 | 1 | 18204 | 49 |
RYR2 |
4.223e-02 | -3.16 | regulation of postsynaptic specialization assembly | biological process | GO:0099150 | 16 | 1 | 18204 | 49 |
GRID2 |
4.223e-02 | -3.16 | G1 to G0 transition | biological process | GO:0070314 | 16 | 1 | 18204 | 49 |
SMPD3 |
4.235e-02 | -3.16 | Guanylate_kinase_CS | interpro domains | IPR020590 | 16 | 1 | 18521 | 50 |
DLG3 |
4.235e-02 | -3.16 | cNMP-bd_CS | interpro domains | IPR018488 | 16 | 1 | 18521 | 50 |
HCN1 |
4.235e-02 | -3.16 | Endo/exonuclease/phosphatase | interpro domains | IPR005135 | 16 | 1 | 18521 | 50 |
SMPD3 |
4.248e-02 | -3.16 | glutamate-gated receptor activity | molecular function | GO:0004970 | 16 | 1 | 18094 | 49 |
GRIN2A |
4.248e-02 | -3.16 | NAD+ nucleotidase, cyclic ADP-ribose generating | molecular function | GO:0061809 | 16 | 1 | 18094 | 49 |
IL1RAPL2 |
4.248e-02 | -3.16 | protein phosphatase activator activity | molecular function | GO:0072542 | 16 | 1 | 18094 | 49 |
PPP2R5B |
4.249e-02 | -3.16 | PKP1 (plakophilin 1) | protein interactions | 5317 | 130 | 2 | 19454 | 49 |
RBFOX1,HCN1 |
4.259e-02 | -3.16 | secretory | COSMIC cancer mutations | secretory | 115 | 2 | 16828 | 48 |
GRIN2A,CACNA1C |
4.259e-02 | -3.16 | meninges-meningioma-secretory | COSMIC cancer mutations | meninges-meningioma-secretory | 115 | 2 | 16828 | 48 |
CACNA1C,GRIN2A |
4.266e-02 | -3.15 | superpathway of purine nucleotides de novo biosynthesis I | BIOCYC pathways | META_PWY-841 | 13 | 1 | 902 | 3 |
AK5 |
4.266e-02 | -3.15 | superpathway of purine nucleotide salvage | BIOCYC pathways | META_PWY66-409 | 13 | 1 | 902 | 3 |
AK5 |
4.267e-02 | -3.15 | neuron projection terminus | cellular component | GO:0044306 | 128 | 2 | 19108 | 49 |
UNC13C,CPLX1 |
4.270e-02 | -3.15 | odontogenesis | biological process | GO:0042476 | 122 | 2 | 18204 | 49 |
SMPD3,SLC24A4 |
4.280e-02 | -3.15 | INTRLKN1R1F | prints domains | PR01537 | 12 | 1 | 5227 | 19 |
IL1RAPL2 |
4.280e-02 | -3.15 | EAGCHANLFMLY | prints domains | PR01463 | 12 | 1 | 5227 | 19 |
HCN1 |
4.311e-02 | -3.14 | human chr2p25.3 | chromosome location | human chr2p25.3 | 23 | 1 | 26134 | 50 |
MYT1L |
4.318e-02 | -3.14 | Exo_endo_phos | pfam domains | PF03372 | 16 | 1 | 17795 | 49 |
SMPD3 |
4.329e-02 | -3.14 | OLF | smart domains | SM00284 | 13 | 1 | 9717 | 33 |
OLFM1 |
4.367e-02 | -3.13 | HAL (histidine ammonia-lyase) | protein interactions | 3034 | 132 | 2 | 19454 | 49 |
GALNT9,HCN1 |
4.385e-02 | -3.13 | Dilated cardiomyopathy | KEGG pathways | ko05414 | 89 | 2 | 7161 | 27 |
RYR2,CACNA1C |
4.385e-02 | -3.13 | Dilated cardiomyopathy | KEGG pathways | hsa05414 | 89 | 2 | 7161 | 27 |
CACNA1C,RYR2 |
4.388e-02 | -3.13 | Z disc | cellular component | GO:0030018 | 130 | 2 | 19108 | 49 |
RYR2,CACNA1C |
4.393e-02 | -3.13 | central_nervous_system-brain-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligoastrocytoma_Grade_III | 117 | 2 | 16828 | 48 |
HCN1,RYR2 |
4.393e-02 | -3.13 | fat | COSMIC cancer mutations | fat | 117 | 2 | 16828 | 48 |
GABRA6,HCN1 |
4.427e-02 | -3.12 | GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1) | protein interactions | 2554 | 133 | 2 | 19454 | 49 |
GABRB2,GABRA1 |
4.440e-02 | -3.11 | RYR3 (ryanodine receptor 3) | protein interactions | 6263 | 18 | 1 | 19454 | 49 |
RYR2 |
4.440e-02 | -3.11 | GNA14 (G protein subunit alpha 14) | protein interactions | 9630 | 18 | 1 | 19454 | 49 |
OPRL1 |
4.440e-02 | -3.11 | RHBDL1 (rhomboid like 1) | protein interactions | 9028 | 18 | 1 | 19454 | 49 |
DLG3 |
4.440e-02 | -3.11 | protein-containing complex | cellular component | GO:0032991 | 6542 | 23 | 19108 | 49 |
KCNMA1,CACNA1C,GABRB2,KCNIP4,GRIN2A,CELF6,STXBP5L,CELF5,RYR2,GABRA6,RGS7,GABRA1,CELF4,GABRD,DLG3,PPP2R5B,HCN1,GABBR2,MYT1L,GRID2,ZFPM2,CPLX1,CR2 |
4.457e-02 | -3.11 | cGMP effects | REACTOME pathways | R-HSA-418457 | 18 | 1 | 10285 | 26 |
KCNMA1 |
4.457e-02 | -3.11 | Serotonin Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-181429 | 18 | 1 | 10285 | 26 |
CPLX1 |
4.457e-02 | -3.11 | Norepinephrine Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-181430 | 18 | 1 | 10285 | 26 |
CPLX1 |
4.469e-02 | -3.11 | flank | COSMIC cancer mutations | flank | 16 | 1 | 16828 | 48 |
GRIN2A |
4.481e-02 | -3.11 | regulation of excitatory synapse assembly | biological process | GO:1904889 | 17 | 1 | 18204 | 49 |
GRID2 |
4.481e-02 | -3.11 | negative regulation of humoral immune response | biological process | GO:0002921 | 17 | 1 | 18204 | 49 |
CR2 |
4.481e-02 | -3.11 | N-glycan processing | biological process | GO:0006491 | 17 | 1 | 18204 | 49 |
ST8SIA5 |
4.481e-02 | -3.11 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 49 |
CACNA1C |
4.481e-02 | -3.11 | positive regulation of sequestering of calcium ion | biological process | GO:0051284 | 17 | 1 | 18204 | 49 |
RYR2 |
4.481e-02 | -3.11 | regulation of postsynaptic density organization | biological process | GO:1905874 | 17 | 1 | 18204 | 49 |
GRID2 |
4.493e-02 | -3.10 | CA_dom | interpro domains | IPR001148 | 17 | 1 | 18521 | 50 |
PTPRG |
4.493e-02 | -3.10 | CA_dom_sf | interpro domains | IPR036398 | 17 | 1 | 18521 | 50 |
PTPRG |
4.493e-02 | -3.10 | G-protein_gamma-like_dom | interpro domains | IPR015898 | 17 | 1 | 18521 | 50 |
RGS7 |
4.493e-02 | -3.10 | GGL_sf | interpro domains | IPR036284 | 17 | 1 | 18521 | 50 |
RGS7 |
4.493e-02 | -3.10 | Znf_RING-CH | interpro domains | IPR011016 | 17 | 1 | 18521 | 50 |
MARCHF4 |
4.507e-02 | -3.10 | nucleoside diphosphate kinase activity | molecular function | GO:0004550 | 17 | 1 | 18094 | 49 |
AK5 |
4.507e-02 | -3.10 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 1 | 18094 | 49 |
PTPRG |
4.507e-02 | -3.10 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 1 | 18094 | 49 |
PTPRG |
4.519e-02 | -3.10 | protein phosphatase type 2A complex | cellular component | GO:0000159 | 18 | 1 | 19108 | 49 |
PPP2R5B |
4.525e-02 | -3.10 | response to ethanol | biological process | GO:0045471 | 126 | 2 | 18204 | 49 |
GRIN2A,RGS7 |
4.569e-02 | -3.09 | muscle system process | biological process | GO:0003012 | 297 | 3 | 18204 | 49 |
KCNMA1,CACNA1C,RYR2 |
4.581e-02 | -3.08 | Carb_anhydrase | pfam domains | PF00194 | 17 | 1 | 17795 | 49 |
PTPRG |
4.581e-02 | -3.08 | G-gamma | pfam domains | PF00631 | 17 | 1 | 17795 | 49 |
RGS7 |
4.590e-02 | -3.08 | cardiac ventricle development | biological process | GO:0003231 | 127 | 2 | 18204 | 49 |
RYR2,ZFPM2 |
4.590e-02 | -3.08 | cardiac chamber morphogenesis | biological process | GO:0003206 | 127 | 2 | 18204 | 49 |
RYR2,ZFPM2 |
4.608e-02 | -3.08 | TRIM13 (tripartite motif containing 13) | protein interactions | 10206 | 136 | 2 | 19454 | 49 |
CACNA1C,MARCHF4 |
4.645e-02 | -3.07 | Signaling by Insulin receptor | REACTOME pathways | R-HSA-74752 | 322 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
4.652e-02 | -3.07 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 4 | 18204 | 49 |
HCN1,GABRB2,RYR2,GRIN2A |
4.669e-02 | -3.06 | C3 (complement C3) | protein interactions | 718 | 137 | 2 | 19454 | 49 |
CR2,HCN1 |
4.681e-02 | -3.06 | LRRTM3 (leucine rich repeat transmembrane neuronal 3) | protein interactions | 347731 | 19 | 1 | 19454 | 49 |
NRXN3 |
4.681e-02 | -3.06 | TCF7 (transcription factor 7) | protein interactions | 6932 | 19 | 1 | 19454 | 49 |
RBFOX3 |
4.681e-02 | -3.06 | KCNG1 (potassium voltage-gated channel modifier subfamily G member 1) | protein interactions | 3755 | 19 | 1 | 19454 | 49 |
MARCHF4 |
4.681e-02 | -3.06 | HIGD2A (HIG1 hypoxia inducible domain family member 2A) | protein interactions | 192286 | 19 | 1 | 19454 | 49 |
GRIN2A |
4.681e-02 | -3.06 | SYT7 (synaptotagmin 7) | protein interactions | 9066 | 19 | 1 | 19454 | 49 |
NRXN1 |
4.681e-02 | -3.06 | OSM (oncostatin M) | protein interactions | 5008 | 19 | 1 | 19454 | 49 |
TRPM3 |
4.681e-02 | -3.06 | ANKRD13C (ankyrin repeat domain 13C) | protein interactions | 81573 | 19 | 1 | 19454 | 49 |
MARCHF4 |
4.681e-02 | -3.06 | HSFX1 (heat shock transcription factor family, X-linked 1) | protein interactions | 100506164 | 19 | 1 | 19454 | 49 |
RBFOX1 |
4.699e-02 | -3.06 | Ras activation uopn Ca2+ infux through NMDA receptor | REACTOME pathways | R-HSA-442982 | 19 | 1 | 10285 | 26 |
GRIN2A |
4.699e-02 | -3.06 | GABA synthesis, release, reuptake and degradation | REACTOME pathways | R-HSA-888590 | 19 | 1 | 10285 | 26 |
CPLX1 |
4.737e-02 | -3.05 | circulatory system process | biological process | GO:0003013 | 508 | 4 | 18204 | 49 |
RYR2,OPRL1,KCNMA1,CACNA1C |
4.738e-02 | -3.05 | secretory granule localization | biological process | GO:0032252 | 18 | 1 | 18204 | 49 |
UNC13C |
4.738e-02 | -3.05 | regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002923 | 18 | 1 | 18204 | 49 |
CR2 |
4.738e-02 | -3.05 | negative regulation of lyase activity | biological process | GO:0051350 | 18 | 1 | 18204 | 49 |
GABBR2 |
4.752e-02 | -3.05 | CNMP_BINDING_1 | prosite domains | PS00888 | 16 | 1 | 12186 | 37 |
HCN1 |
4.752e-02 | -3.05 | GUANYLATE_KINASE_1 | prosite domains | PS00856 | 16 | 1 | 12186 | 37 |
DLG3 |
4.766e-02 | -3.04 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 49 |
RYR2 |
4.792e-02 | -3.04 | EXOC3 (exocyst complex component 3) | protein interactions | 11336 | 139 | 2 | 19454 | 49 |
DLG3,INSYN1 |
4.792e-02 | -3.04 | TMEM131 (transmembrane protein 131) | protein interactions | 23505 | 139 | 2 | 19454 | 49 |
ST8SIA5,GABRD |
4.824e-02 | -3.03 | animal organ morphogenesis | biological process | GO:0009887 | 988 | 6 | 18204 | 49 |
RYR2,ZFPM2,OLFM1,SMPD3,SLC24A4,HCN1 |
4.852e-02 | -3.03 | response to calcium ion | biological process | GO:0051592 | 131 | 2 | 18204 | 49 |
KCNMA1,RYR2 |
4.900e-02 | -3.02 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | 485 | 4 | 16828 | 48 |
PPP2R5B,ASTN1,IL1RAPL2,RYR2 |
4.900e-02 | -3.02 | medullomyoblastoma | COSMIC cancer mutations | medullomyoblastoma | 485 | 4 | 16828 | 48 |
PPP2R5B,ASTN1,IL1RAPL2,RYR2 |
4.921e-02 | -3.01 | PDZD2 (PDZ domain containing 2) | protein interactions | 23037 | 20 | 1 | 19454 | 49 |
NRXN1 |
4.921e-02 | -3.01 | GGT1 (gamma-glutamyltransferase 1) | protein interactions | 2678 | 20 | 1 | 19454 | 49 |
KCNMA1 |
4.921e-02 | -3.01 | ABCA7 (ATP binding cassette subfamily A member 7) | protein interactions | 10347 | 20 | 1 | 19454 | 49 |
MARCHF4 |
4.929e-02 | -3.01 | metal ion binding | molecular function | GO:0046872 | 4239 | 17 | 18094 | 49 |
NRXN1,CACNA1C,ZNF804A,GRIN2A,NRXN3,GALNT9,MYT1L,ZFPM2,SMPD3,MARCHF4,RYR2,PCLO,UNC13C,KCNMA1,RIMS2,KSR2,KCNIP4 |
4.931e-02 | -3.01 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 2 | 7161 | 27 |
KCNMA1,RYR2 |
4.931e-02 | -3.01 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 2 | 7161 | 27 |
RYR2,KCNMA1 |
4.935e-02 | -3.01 | VEGFA-VEGFR2 Pathway | REACTOME pathways | R-HSA-4420097 | 330 | 3 | 10285 | 26 |
KSR2,PPP2R5B,GRIN2A |
4.937e-02 | -3.01 | positive regulation of cellular component biogenesis | biological process | GO:0044089 | 515 | 4 | 18204 | 49 |
NRXN1,GRID2,PPP2R5B,SMPD3 |
4.946e-02 | -3.01 | knee | COSMIC cancer mutations | knee | 125 | 2 | 16828 | 48 |
GRIN2A,RYR2 |
4.957e-02 | -3.00 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 10 | 16828 | 48 |
GRIN2A,ZFPM2,ZNF804A,SLC24A4,MYT1L,TRPM3,KSR2,PTPRG,PCLO,NRXN3 |
4.957e-02 | -3.00 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 10 | 16828 | 48 |
NRXN3,PTPRG,PCLO,MYT1L,TRPM3,KSR2,ZFPM2,GRIN2A,ZNF804A,SLC24A4 |
4.976e-02 | -3.00 | GPCRMGR | prints domains | PR00248 | 14 | 1 | 5227 | 19 |
GABBR2 |
4.978e-02 | -3.00 | OPRM1 (opioid receptor mu 1) | protein interactions | 4988 | 142 | 2 | 19454 | 49 |
CPLX1,OPRL1 |
4.985e-02 | -3.00 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 2 | 18204 | 49 |
RYR2,CACNA1C |
4.992e-02 | -3.00 | salivary_gland-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma-adenoid_cystic_carcinoma | 488 | 4 | 16828 | 48 |
ASTN1,GABRA1,RYR2,PTPRG |
4.995e-02 | -3.00 | regulation of exosomal secretion | biological process | GO:1903541 | 19 | 1 | 18204 | 49 |
SMPD3 |
4.995e-02 | -3.00 | excretion | biological process | GO:0007588 | 19 | 1 | 18204 | 49 |
KCNMA1 |
4.995e-02 | -3.00 | presynapse assembly | biological process | GO:0099054 | 19 | 1 | 18204 | 49 |
PCLO |
4.995e-02 | -3.00 | sphingomyelin metabolic process | biological process | GO:0006684 | 19 | 1 | 18204 | 49 |
SMPD3 |